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In a world with an increasing population and changing climate, the availability of food is 
a growing concern. Crop plants struggle in the face of increasing stresses, including the 
pressure of diseases that are spread by microbial pathogens. Understanding how plants 
defend themselves against disease is vital for finding solutions to food shortages. 
Microbial pathogens deploy effector proteins as tools to promote infection, and plants 
evolve to recognise effectors and launch an immune response accordingly. This PhD 
project focuses on structure/function studies of two effectors from pathogens of 
important crop plants: the Magnaporthe oryzae (rice blast) effector AVR-Pia, and the 
Phytophthora infestans (potato late blight) effector PexRD24. 
This work shows that a rice immune receptor pair, Pikp-1/Pikp-2, is able to recognise 
AVR-Pia, even though this effector is genetically characterised as being recognised by a 
different receptor. The structural basis of Pikp-1 interacting with AVR-Pia through an 
integrated domain is shown, and attempts are made to engineer this integrated domain 
to recognise AVR-Pia more strongly in planta, with some success. 
For PexRD24, the interaction with a potato host target enzyme, protein phosphatase 1, 
is explored. While many issues were encountered with the production of stable, soluble 
protein, it is shown that PexRD24 can interact with the enzyme in vitro. The enzyme still 
retains function in complex with the effector, indicating that the role of the effector is not 
to inhibit phosphatase activity, and may enhance it. 
This research uses both biochemical and structural techniques, alongside in planta 
assays, to broaden the field of knowledge in molecular plant-microbe interactions. By 
gaining a detailed understanding of how such interactions take place, it will be possible 
to start engineering plants with a more robust immune system. Through protecting 
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When people look outside at the world around them, most don’t give plants a second 
thought; the ‘green background’ lining our roads and parks is dismissed as rather banal. 
On reflection, we appreciate plants as being a major food source and key to life on our 
planet, but only recently have we begun to understand just how complex their 
interactions with other organisms can be. These complex interactions are at the very 
centre of this project. The plants discussed here are crops that are responsible for feeding 
millions of people around the globe, and the relationship between humans and the plants 
we grow is increasingly elaborate as we engineer and breed plants specifically for our 
own use. On the other side of this tug of war are the insects, fungi, bacteria, oomycetes 
and viruses that rely on the plants for their own survival - these interactions are not 
necessarily destructive, as symbiotic relationships between plants and microorganisms 
can be found in many ecosystems. In the middle are the plants trying to defend 
themselves from attack on all sides and promote their own growth and survival. 
In this project, we focus on the interaction of pathogenic microorganisms with important 
crop plants. Due to the breadth of research in this field, a fully comprehensive review of 
plant immunity is beyond the scope of this introduction, so the focus will be on pathogen 
effectors and effector-triggered immunity. This chapter outlines firstly how plants use a 
complex immune system to defend themselves from attack, with a focus on their 
response to effector proteins delivered by disease-causing microorganisms. The two 
pathogens of interest are Phytophthora infestans, the potato late blight pathogen, and 
Magnaporthe oryzae, the rice blast fungus; the deadly diseases caused by these 
pathogens are widely studied and highly relevant to global food security. Finally, the 
chapter will delve deeper into the details of the plant-pathogen interactions, examining 
the different component proteins at the molecular level.  
1.1 The Plant Immune System 
1.1.1 Responding to stress 
Plants encounter stresses in many different forms. Abiotic stresses such as temperature 
fluctuations, drought, salt stress and soil pollutants are encountered to different extents 
all over the world and are responsible for reducing the productivity of many different 
plants (dos Reis et al., 2012). Biotic stresses such as herbivores, feeding insects and 
disease-causing microorganisms are also highly destructive, and it is against these 
stresses that plants have developed a complex defensive immune system (figure 1.1-1). 




secondary metabolite deterrents (Dangl & Jones, 2001; Heath, 2000), and these outer 
defences are designed to be non-specifically effective against any pathogens in the 
environment. Disease-causing microorganisms such as bacteria and fungi that are able 
to breach the surface will encounter further levels of inducible resistance. This 
introduction will focus primarily on how the plant detects a threat and recognises the 
presence of a pathogen. Following activation of the immune system, many downstream 
signalling responses are triggered, which include hormonal responses (Pieterse et al., 
2012), ion fluxes (Seybold et al., 2014), triggering of MAP kinase cascades (Thulasi 
Devendrakumar et al., 2018) and transcriptional changes. 
1.1.2 MAMPs and cell surface immunity 
If a microbial pathogen can overcome the passive outer defences and breach the plant 
cell wall, they will encounter the first active line of defence, which is at the cell surface 
plasma membrane (Spoel & Dong, 2012). Microorganisms contain conserved 
characteristic features that can be recognised as potential threats by a plant and trigger 
an immune response. These are known as microbe-associated molecular patterns 
(MAMPs) but are also sometimes called PAMPs (pathogen-associated molecular 
patterns). However, as discussed elsewhere (Boller & Felix, 2009) the term ‘MAMPs’ will 
be used throughout this thesis because these signature features can be found in a wide 
range of microbes regardless of whether they are pathogenic to the plant, and therefore 
the term ‘pathogen-associated’ seems somewhat misleading. MAMPs are found in all 
classes of microbes and are essential to organism fitness – typical examples include 
bacterial flagellin, chitin from fungi and β-glucan from oomycetes (Newman et al., 2013). 
In addition to MAMPs, endogenous molecules (deriving from the plant cells) known as 
DAMPs (damage-associated molecular patterns) can also be responsible for inducing an 
immune response when they are released into the extracellular space from cells that 
have been damaged by wounding or infection (Choi & Klessig, 2016). There are several 
different defined classes of plant DAMPs, which may be peptide-based or polysaccharide-
based, and even extracellular ATP was recently identified as acting as a DAMP in plants 
(Choi & Klessig, 2016). However, the focus in this section will be on the recognition of 
the ‘non-self’ MAMP danger signals. 
MAMPs are detected by receptors on the cell surface, which are known as PRRs (pattern-
recognition receptors). In plants, PRRs are located at the cell surface and consist of an 
extracellular domain, a single-pass transmembrane domain and a cytosolic domain that 




intracellular kinase domain determines the class of PRR. RLKs (receptor-like kinases) 
possess the kinase domain while RLPs (receptor-like proteins) do not. Given that RLPs 
lack this signalling domain, they likely act together with RLKs to induce downstream 
signalling following recognition of the MAMP (Zipfel, 2014). Recognition of non-self 
danger signals leads to MAMP-triggered, cell surface immunity, also known as MTI 
(MAMP-triggered immunity), which is characterised by downstream responses that 
include the production of ROS (reactive oxygen species), the activation of MAP kinase 
pathways and callose deposition (Zipfel, 2008). These responses either directly provide 
protection for the plant (e.g. callose deposition reinforces cell walls) or indirectly assist 
by modifying transcription of defence-related genes. 
One of the most well-characterised examples of MAMP recognition by a PRR in plants is 
the flg22/FLS2 interaction (Trdá et al., 2015). Flg22 is a short epitope (twenty-two 
amino acids) of the flagellin protein, which is the major component of bacterial flagella. 
Flg22 is recognised by the PRR FLS2 (flagellin-sensitive 2) (Gómez-Gómez & Boller, 
2000). Upon binding of flg22, FLS2 rapidly forms a complex with the protein BAK1 
(brassinosteroid insensitive 1-associated receptor kinase 1), which leads to downstream 
signalling and immunity (Sun et al., 2013). 
1.1.3 Effectors and effector-triggered immunity 
One characteristic of MAMPs is that they are essential to the structure or life cycle of the 
pathogen. This means that parts of the molecule which are essential for folding or 
function are under strong negative selection. However, immunogenic regions of the 
MAMP can be under diversifying selection, in an attempt to generate new MAMPs that 
can still carry out their essential function and yet evade host recognition (McCann et al., 
2012). However, pathogens have also developed an array of specialist molecules known 
as effectors, which are not generally considered essential for the basic survival of the 
pathogen. These effectors are virulence molecules that facilitate infection by 
manipulating the structure and function of the host cells. Effectors can have a wide range 
of functions, and are targeted spatially and temporally for maximum potency. Pathogens 
will frequently produce a whole arsenal of effectors that can be deployed. For example, 
Pseudomonas syringae can secrete a repertoire of around thirty effectors (Chang et al., 
2005), while fungi and oomycetes appear to have many more effector candidates that 
are still being identified (Sonah et al., 2016). Effectors may be targeted to the plant 
apoplast, or pathogens may use a specialised translocation system to deliver them to the 




and vesicle trafficking pathways (Deslandes & Rivas, 2012; Petre et al., 2015). Further 
details about effectors, including their different characteristics, methods of translocation 
and techniques for identification will be discussed later. 
One common function of effector proteins is to disrupt components of the MAMP-
triggered, cell-surface signalling pathway. If the pathogen is able to overcome this 
important first line of active defence, the plant must launch a counter-attack, or risk 
being left defenceless. Plants have therefore developed an additional defence against 
these pathogen effectors, which is an intracellular immune response, traditionally 
known as effector-triggered immunity (also called ETI). The immune components 
responsible for recognising the effectors and triggering this response are R or resistance 
proteins, of which the most abundant are the NLR (Nucleotide-binding leucine-rich 
repeat) proteins, which can recognise effectors from diverse pathogens (Dodds & 
Rathjen, 2010). The architecture and function of NLR proteins will be discussed further 
in section 1.4. The hallmark feature of effector-triggered immune signalling is the 
hypersensitive response, which involves programmed cell death around the site of 
infection that helps to isolate and halt the spread of the pathogen (Spoel & Dong, 2012). 
When an effector is recognised by a host resistance protein, its role becomes one of 
avirulence. The pathogen then faces pressure to delete or mutate an effector to avoid 
recognition and regain the virulence activity of that effector molecule (Bent & Mackey, 
2007). 
Many features of the immune signalling pathway are shared between responses that are 
triggered at the cell surface and those triggered inside the cell, but effector-triggered 
responses appear to be stronger and extended compared to those triggered by MAMPs 
(Cui et al., 2015). Despite these distinctions, it has been argued that the boundary 
between MAMP-triggered and effector-triggered immunity is not as clear-cut as 
sometimes depicted. Although these definitions of ‘MTI’ and ‘ETI’ can sometimes be 
helpful for simplicity, the responses to MAMPs and effectors may have varying 
intensities, and some MAMPs may have a narrow distribution while some effectors might 
be so widespread that they could easily be defined as MAMPs – therefore the boundary 
between intracellular and cell surface signalling might be somewhat ‘blurred’ (Thomma 





1.1.4 Modelling the plant immune system 
Over the last decade or so, there have been a number of models proposed to help 
conceptualise the plant immune system. 
One such proposal is the ‘zigzag model’ developed by Jones and Dangl in 2006, which 
describes the hierarchy of different levels of immunity (Jones & Dangl, 2006). In brief, 
the model shows that plants are able to recognise MAMPs using their cell surface PRRs, 
then the pathogen deploys effectors to undermine this layer of defence (leading to 
effector-triggered susceptibility), before the plant evolves intracellular NLR proteins 
that are able to recognise specific pathogen effectors and launch an immune response. 
An ‘arms race’ analogy is often used to describe this process, where pathogen and host 
plant are in a race to evolve new ways to undermine defences or recognise invasion.  
Other, more recent, models have expanded upon the original zigzag concept, arguing that 
it has limitations, and does not show the full scope of immunity.  Pritchard and Birch 
(Pritchard & Birch, 2014) discuss that the model only includes MAMPs, effectors and 
their corresponding immune receptors, excluding the contribution from other molecules 
Figure 1.1-1: The plant immune system. 
Diagram showing the interactions of the different components of the molecular plant 
immune system. DAMPs = damage-associated molecular patterns, MAMPs = microbe-
associated molecular patterns, PRRs = pattern-recognition receptors, NLRs = nucleotide-




that are involved in the plant/pathogen interaction, or environmental factors. The 
authors also argue that the model cannot be quantified in any way, and they propose a 
new model with the scope to add in new processes and modify parameters to address 
some limitations of the zigzag model. Other authors have suggested further 
modifications to the classic zigzag model, including the ‘invasion model’ that replaces the 
immune receptors (either PRRs or NLRs) with invasion pattern receptors (IPRs) and 
replaces effectors and MAMPs with the term invasion patterns (IPs), which can also be 
extended to include DAMPs, as they are simply ligands that indicate the chance of an 
invasion event (Cook et al., 2015). This view of immunity becomes somewhat more 
generalised but can also prevent constraining a particular pathogen-derived molecule to 
be either an ‘effector’ or a ‘MAMP’. Finally, the ‘multicompetent model’ (Andolfo & 
Ercolano, 2015) attempts to take into consideration the lifecycle and feeding habit of the 
plant pathogen, arguing that PRRs and NLRs cannot distinguish specifically how the plant 
is being fed upon; this model attempts to integrate other aspects of the plant defence 
response that involve a change in primary metabolism. 
In reality, the ever-expanding breadth and depth of research on plant immune signalling 
means that a comprehensive model does not seem feasible. Nevertheless, it remains 
useful to develop simple models that help to conceptualise and understand generalised 
plant/pathogen interactions. 
1.2 Oomycete and Fungal Pathogens 
1.2.1 The threat to food security 
The number of people on the planet is increasing, and is predicted to reach 9.6 billion by 
2050, up from a current population of around 7.2 billion (Gerland et al., 2014). Adding to 
this pressure on land and resources is the fact that trade, global movement and 
agricultural practises are spreading crop pests and pathogens to new regions, where 
they can infect new populations and thrive. There is also speculation that global warming 
may play a part in the spread of pathogens to hitherto unaffected areas (Bebber, 2015). 
Global food security is therefore threatened not just by the growing population and 




It has long been known that fungal and oomycete pathogens are a huge problem in 
agriculture, and this project focuses on two globally important crop diseases – potato 
late blight disease, caused by the oomycete pathogen Phytophthora infestans, and rice 
blast disease caused by the fungal pathogen Magnaporthe oryzae (figure 1.2-1). 
 
Potato late blight disease spread to Europe in the nineteenth century, and its effects were 
particularly devastating in Ireland, where the population was heavily dependent on 
potatoes as a food source. In the Great Famine (also called the Irish Potato Famine), it is 
estimated that around one million people died, and late blight remains the most 
destructive disease of potato, which is one of the world’s most important food crops 
(Yoshida et al., 2013). In a recent survey, scientists agreed that P. infestans was currently 
the most important oomycete pathogen for both its scientific and economic impact 
(Kamoun et al., 2015). P. infestans has been widely studied, and with the sequencing of 
its genome completed in 2009 (Haas et al., 2009), it is hoped that more can be learnt 
about its life cycle and method of infection, so that the scientific field will be able to 
propose better methods of control for agriculture. 
Rice blast disease is caused by the ascomycete fungal pathogen Magnaporthe oryzae. Rice 
is a vital food source for billions of people worldwide, and M. oryzae is responsible for 
annual crop losses of an estimated 10-35 % of this total harvest. In context, this means 
the rice that is destroyed by this pathogen could feed between 212 and 742 million 
additional people (Fisher et al., 2012). With genome sequence information also available 
for the pathogen, it has become an important model organism in recent years (Xue et al., 
2012). 
Figure 1.2-1: Photographs of disease symptoms on important crop plants. 
A) Rice blast disease lesions (caused by Magnaporthe oryzae) seen on rice leaves. Photo 
sourced from the International Rice Research Institute at 
http://www.knowledgebank.irri.org/training/fact-sheets/pest-
management/diseases/item/blast-leaf-collar. B) Late blight disease lesions (caused by 





1.2.2 Pathogen life cycle 
Oomycetes and fungi share some apparent similarities in morphology and life cycle, but 
they in fact derive from different kingdoms; oomycetes are part of the Stramenopiles, 
whereas fungi form their own taxonomic kingdom (Birch et al., 2006). 
1.2.2.1 Magnaporthe oryzae 
When a fungal spore of M. oryzae lands on a rice leaf, it generates a germ tube that forms 
an infection structure known as an appressorium on the surface. When the appressorium 
matures, rapid synthesis of glycerol and similar compounds creates turgor pressure 
inside the structure. A thick inner layer of melanin helps to maintain rigidity and 
prevents the efflux of glycerol, thus creating an inflexible structure that ruptures the 
cuticle of the infected cell, allowing hyphae to spread out from the site of infection (Ryder 
& Talbot, 2015). The initial stages of infection occur in the living rice tissue, but once 
visible brown disease lesions are present on the rice leaf, the pathogen adopts a more 
necrotrophic lifestyle, making it a hemibiotrophic pathogen (Wilson & Talbot, 2009). 
During infection, the host cells are sequentially invaded by specialised invasive hyphae, 
which allow colonisation of the plant and secretion of effector proteins. Apoplastic 
effectors are distributed throughout the extrainvasive hyphal membrane (EIHM) 
compartment, which surrounds the hyphae. Cytoplasmic effectors are localised in the 
biotrophic interfacial complex (BIC), a plant-derived membrane-rich structure that is 
initially seen at the primary hyphal tips and remains in place when the hyphae move to 
a different cell (Giraldo et al., 2013). From the BIC, the cytoplasmic effectors are 
translocated into the host cell using this pathogen-host interface, although the 
mechanism for this process is not yet fully understood. 
1.2.2.2 Phytophthora infestans 
Like Magnaporthe oryzae, P. infestans is hemibiotrophic (Fry, 2008) and can reproduce 
both sexually and asexually (Goss et al., 2014), but the asexual lifecycle allows rapid 
spreading of the pathogen across large areas. This life cycle involves sporangia 
germinating on the plant leaf surface to produce a germ tube that penetrates the plant 
tissue via formation of an appressorium. Following this initial infection, hyphae spread 
through the apoplast and projections from the hyphae known as haustoria enter the 
plant cells by invagination of the surface plasma membrane (Whisson et al., 2011). 
Several days after infection, the symptoms of P. infestans can be seen all over the potato 
plant, from lesions on the leaf and stem to brown necrotic tissue in the tubers (Fry, 2008). 




invasion of the host cell the host plasma membrane undergoes significant alteration and 
rearrangement to form a different structure known as the extrahaustorial membrane. 
However, it is still not clear how effectors are translocated across these barriers into the 
host cell, and there has been significant debate on the process (Petre & Kamoun, 2014), 
which is outside the scope of this thesis. However, recent live cell imaging has shown the 
delivery of a cytoplasmic P. infestans effector into the host cell via the pathogen haustoria 
and through the extrahaustorial matrix (Wang et al., 2017). 
1.3 Pathogen Effectors 
As discussed in previous sections, microbial pathogens use effector proteins to 
undermine host defences and promote pathogen colonisation. Effectors can have a wide 
range of different structures and functions, and new effector properties are being 
uncovered on a regular basis. 
Gram-negative bacterial pathogens use a Type III secretion system for effector delivery, 
and recently the translocation of Pseudomonas syringae and Ralstonia solanacearum 
effectors into the host cell using this system was visualised (Henry et al., 2017). It is 
interesting to note that P. syringae and R. solanacearum only secrete around thirty to 
seventy effectors into the host cell (Henry et al., 2017), whereas the fungal and oomycete 
pathogens discussed here are predicted to have several hundreds of effector proteins, 
many of which appear to be important for virulence. This subject has been recently 
discussed by Thordal-Christensen et al., who proposed that the complexity of infection 
strategy of filamentous pathogens compared to bacteria might be a factor in the disparity 
of effector numbers (Thordal-Christensen et al., 2018). Additionally, the considerably 
larger genome of filamentous pathogens allow for greater diversity of effectors 
compared to bacterial pathogens. 
With so many putative effectors found in fungal and oomycete pathogens, the 
identification and characterisation of these large catalogues can be a challenge. Although 
bacterial effectors are not the focus of this thesis, an outline of computational methods 
used to predict effectors delivered from the Type III secretion system in gram-negative 
bacteria can be found in McDermott et al. (McDermott et al., 2011). For filamentous 
pathogens, the in silico prediction of novel effectors can be beneficial for directing 
further in vitro and in planta studies (Jones et al., 2018). Some effector families (such as 
the RxLR effectors described below) have signature motifs or conserved regions that can 




to use the highly conserved RxLR amino acid motif to predict 563 RxLR genes in the 
pathogen genome, although only around 79 were shown to be significantly upregulated 
during host infection (Haas et al., 2009). Another defined class of oomycete effectors are 
the Crinkler (CRN) proteins, which also contain conserved N-terminal motifs (Schornack 
et al., 2010), allowing them to be more readily identified in sequenced genomes. A 
number of tools have been generated that use genome and transcriptome data to identify 
putative effectors with conserved motifs and particular sequences (reviewed by Sonah 
et al. (Sonah et al., 2016)). 
For those effectors, particularly fungal effectors, that do not contain conserved sequence 
motifs, accurate identification can be more difficult. Effectors are commonly small 
proteins and often lack sequence similarity to proteins of known function; possibly a 
result of the pathogen’s need to rapidly evolve and diversify its effector repertoire to 
evade detection (Franceschetti et al., 2017).  EffectorP is a tool that was developed 
specifically for the purpose of identifying such effector proteins (Sperschneider, Dodds, 
Gardiner, et al., 2018; Sperschneider et al., 2016). Using machine learning, this method 
can use information gathered from the fungal effectors discovered to date, such as size 
and amino acid content, and apply these parameters to give sensitive results for effector 
identification.  
As well as specific sequence features, other effector characteristics have been exploited 
to identify new candidates. As discussed in later sections (sections 1.3.1 and 1.3.2), some 
pathogen effectors have been shown to have conserved structural elements, including 
the WY-domain, which is enriched in RxLR effectors (Boutemy et al., 2011), and the MAX 
fold, found in sequence divergent M. oryzae effectors (de Guillen et al., 2015). Using 
knowledge of these conserved structural elements, it has been possible to identify new 
putative effectors. 
In addition to using bioinformatic approaches to identify effectors, new tools are being 
developed to assist with effector research in other areas. For example, the LOCALIZER 
tool predicts the subcellular localisation of effector and plant proteins (Sperschneider et 
al., 2017). Another machine learning approach, ApoplastP, has been developed to help 
distinguish whether an effector will be apoplastic or cytoplasmic using known protein 
features (Sperschneider, Dodds, Singh, et al., 2018). In conjunction with other research 
methods, such tools could help develop understanding of effector function and 




Despite great advances being made in pathogen genome sequencing and identification 
of novel effectors, in silico predictions may identify false positives or false negatives in 
their searches. For putative effectors identified, it is important to use in planta and/or in 
vitro methods to characterise the proteins fully and understand their biological 
relevance. 
In the following sections, the effector classes of most relevance to this project will be 
discussed in more detail. 
1.3.1 RxLR effectors 
RxLR effectors describe a class of oomycete effectors that are comprised of two domains. 
The C-terminal domain is responsible for the effector’s function, and the N-terminal 
domain contains a highly conserved R-x-L-R motif (where R is arginine, x is any amino 
acid and L is leucine) often followed by an E-E-R motif (where E is glutamic acid) within 
thirty amino acids (Grouffaud et al., 2010). The structure of the N-terminal domain of an 
RxLR effector is predicted to be disordered (Boutemy et al., 2011). The RxLR motif is 
thought to be involved in translocation of effectors (Whisson et al., 2007), but an 
understanding of exactly how this occurs is still being developed (Wawra et al., 2017). 
The C-terminal domain of RxLR effectors is highly varied and generally does not share 
similarity with proteins of known function (Boutemy et al., 2011). As previously 
discussed, these domains are likely under high selection pressure to counteract plant 
defences, and in P. infestans, they are located in dynamic, repetitive regions of the 
genome, which may contribute to rapid diversification (Haas et al., 2009). Despite this 
diversity, conserved features have been identified in the C-terminal domain, and it has 
been suggested that many RxLR effectors derive from a common ancestor (Jiang et al., 
2008). Both the RxLR effectors AVR3a11 and PexRD2 were characterised structurally 
and were shown to contain a core α-helical fold, called the WY domain, which was 
predicted to be present in around 44 % of oomycete effectors (Boutemy et al., 2011). It 
was hypothesised that the WY domain could allow for significant variation upon this core 
structural fold, including additions and deletions at protein termini and within loop 
regions, oligomerisations and repeats of the WY-domain fold; provided the hydrophobic 
core of the helical bundle is maintained (Boutemy et al., 2011; Win et al., 2012). To date, 
all except one of the RxLR effectors to have been structurally characterised contain the 
WY-domain (Franceschetti et al., 2017). 
Studies over a number of years have revealed the diversity of RxLR effector function and 




et al., 2015; Wang et al., 2015), while the P. infestans effector Pi03192 functions by 
preventing two host transcription factors (known as NTP1 and 2) from re-localising to 
the nucleus, where they assist in inducing defence responses (McLellan et al., 2013). 
AVRblb2, in contrast, localises to the plasma membrane around the pathogen haustoria, 
and prevents a defensive host protease from being secreted into the apoplast (Bozkurt 
et al., 2011). In terms of effector function, only one RxLR effector is known to have 
enzymatic activity itself (Dong et al., 2011) but there are a number that are known to 
inhibit or alter host enzyme activity in some way (for a recent example, see Fan et al. 
(Fan et al., 2018)). The manipulation of enzyme activity by effector proteins is an 
interesting strategy given the relative abundance of effector proteins and their targets. 
For a relatively small complement of effectors to successful impact all or sufficient of the 
of active plant enzyme molecules seems difficult to achieve. Other functions include the 
suppression of host RNA silencing activity (Vetukuri et al., 2017; Xiong et al., 2014), and 
the targeting of host MAP kinases, either to disrupt signalling (King et al., 2014) or to 
potentially enhance or direct the MAPK activity elsewhere (Murphy et al., 2018). Finally, 
a group of RxLR effectors from P. infestans have been shown to suppress signalling 
responses to the MAMP flg22. Although P. infestans does not contain the flg22 epitope, it 
appears that it must contain a MAMP that also activates the same signalling pathway 
(Zheng et al., 2014). 
These examples show the diversity of RxLR effector function. This project will investigate 
the function of another RxLR effector, PexRD24, which will be discussed in detail in 
chapter 5. 
1.3.2 MAX effectors 
Although fungal effectors do not contain obvious conserved sequence motifs like the 
RxLR effectors, families of effectors are emerging. 
The first M. oryzae effector to be structurally characterised was AVR-Pizt (Zhang et al., 
2013). The core of the effector folds into a six-stranded β-sandwich structure, with a 
disulphide bond linking strands β-4 and β-5. The N- and C-termini of the protein were 
disordered (Zhang et al., 2013). The authors of the study noted that a similar β-sandwich 
fold was present in other known effector protein structures, namely AvrL567 from the 
flax rust pathogen (Wang et al., 2007) and ToxA from the wheat tan spot fungal pathogen, 
Pyrenophora tritici-repentis (Sarma et al., 2005). Another host-selective toxin from 
P. tritici-repentis, ToxB, was found to be a structural homolog to AVR-Pizt, despite the 




other M. oryzae effectors that have been structurally characterised also share this β-
sandwich fold, while lacking any sequence similarity – AVR-PikD, AVR-Pia and AVR1-
CO39 (de Guillen et al., 2015; Maqbool et al., 2015; Ose et al., 2015).  
Although previous authors had noted the similarity in these effector structures, it was a 
study by de Guillen et al. that first named this conserved three-dimensional structural 
fold the MAX (Magnaporthe Avrs and ToxB like) fold. The MAX fold is comprised of a six-
stranded β-sandwich fold, made up of two β-sheets stabilised by a disulphide bond (de 
Guillen et al., 2015). A key feature of the MAX effectors was that they had high sequence 
diversity, allowing substantial variation in parts of their structure, such as variation in 
the length of β-strands, the size of exposed loops and the size and charge of surface-
exposed residues (de Guillen et al., 2015). 
This study (de Guillen et al., 2015) analysed the prevalence of the MAX effector family in 
fungal pathogens and found that it was greatly expanded in M. oryzae and M. grisea, 
accounting for 5-10 % of effector candidates in these species, suggesting that MAX 
effectors may derive from a common ancestor of these two Magnaporthe species. The 
authors suggest that effectors which are forced to adapt and evolve quickly, leading to 
diversity in sequence and function, maintain a core structural fold that facilitates 
translocation into the host and preserves protein stability (de Guillen et al., 2015). 
Work to understand the function of MAX effectors from M. oryae is still ongoing, but some 
have been characterised. For example, AVR-Pizt is known to interact with host E3 ligases 
that play a role in immunity (Park et al., 2016). 
The MAX effectors AVR-PikD and AVR-Pia form a major part of this project, and their 
structure and function will be discussed in more detail in chapter 3. 
1.3.3 Effector targets 
Effectors often have little sequence similarity to proteins of known function, so it can be 
difficult to predict their host targets or interacting partners from sequence information. 
However, to understand the function and biological relevance of an effector, it is 
important to identify and characterise its interaction with host cellular components. 
Yeast two-hybrid is a high-throughput method to identify interactors, by screening 
effectors against bespoke libraries made from infected pathogen tissue (Lu, 2012). This 
technique has been used to successfully identify interactors for effectors from a range of 
pathogens, including the effector AVR3a from P. infestans (Bos et al., 2010),  SnTox3 from 




Pseudomonas syringae (Block et al., 2014). In the context of this thesis, yeast two-hybrid 
was used to identify the host target of PexRD24, the P. infestans effector that is the focus 
of chapter 5 (Boevink, Wang, et al., 2016). Although not an interaction with a host target, 
the direct interaction of the effector and corresponding NLR was also determined by 
yeast two-hybrid for the AVR-Pik/Pik-1 interaction (Kanzaki et al., 2012) and AVR-
Pia/RGA5 interaction (Cesari et al., 2013). These interactions will be discussed in more 
detail in chapter 3. 
Another common method to identify effector targets is to purify the effectors from plant 
tissue using immunoprecipitation, which should pull down interactors from the plant. 
The co-immunoprecipitation is coupled with mass spectrometry for identification of 
purified targets (Win et al., 2011). Examples of using this technique to successfully 
identify effector targets include Petre et al. (Petre et al., 2015) and Chaparro-Garcia et al. 
(Chaparro-Garcia et al., 2015). 
Following identification of potential effector targets, these must be validated using a 
range of techniques in vitro and in planta. Pairwise yeast two-hybrid and co-
immunoprecipitation can be used as confirmatory methods, as well as techniques such 
as bimolecular fluorescence complementation (BiFC).  In vitro techniques are also 
powerful methods to characterise protein interactions, including qualitative methods 
such as analytical gel filtration, and quantitative methods such as surface plasmon 
resonance. These techniques will be discussed in more detail in chapter 3, as these in 
vitro methods are central to assessing effector interactions in this project. 
1.4 Immune Receptors 
NLR immune receptors are responsible for detecting effectors deployed from plant 
pathogens. Since their discovery, much has been learned about the modular structure of 
these receptors, and different models have been proposed for how they are able to detect 
and respond to effectors. However, there are still many details to be understood, 
particularly relating to the downstream signalling that leads to an immune response 
following effector detection. 
Their important role in immunity means that scientists have deployed NLR proteins in 
crop plants as a way to mediate resistance to important plant pathogens such as P. 
infestans. One setback in these trials is the fact that microbial pathogens can evolve at a 
rapid rate to undermine the defensive advantage conferred by addition of new NLRs into 




receptors function, it is becoming plausible that this technique could provide a route to 
more durable resistance (Jones et al., 2014). 
1.4.1 Structure of NLRs 
NLR proteins have a multidomain architecture, that comprises an N-terminal domain of 
either a coiled coil (CC) or toll interleukin-1-like (TIR) type, a nucleotide binding domain 
known as the NB-ARC domain (nucleotide-binding domain found in Apaf1, R proteins 
and CED4) and a C-terminal leucine-rich repeat domain (LRR) (Sukarta et al., 2016). The 
structural and functional analysis of these modular proteins is a major area of current 
research, but many features have been elucidated in recent years. There are many 
similarities between plant NLRs and immune receptors from the animal kingdom, 
meaning that it may be possible to gain further insight by sharing research between the 
two systems (Bentham et al., 2017).  
The N-terminal domain of the receptor is thought to have a signalling function (Bai et al., 
2012; Swiderski et al., 2009). Several structures of plant TIR type domains have been 
solved, and the domain can self-associate through different interfaces (Zhang et al., 
2017). Recently the structures of several coiled coil domains have been uncovered, 
although these revealed some interesting contradictions. It was shown that the CC 
domain of Sr33, which confers resistance to the wheat stem rust pathogen, had a more 
similar structure to the CC domain of the unrelated NLR Rx than to its orthologue MLA10, 
which confers resistance to barley powdery mildew (Casey et al., 2016). One possibility 
is that the different structures are actually showing different functional states for the CC 
domain – the MLA10 structure (a dimer of two elongated antiparallel helix-turn-helix 
monomers) may be showing the active form of the domain, which is dimeric, whereas 
the Sr33 and Rx CC domains (both found to be four helix bundles) are in the inactive 
monomeric state (El Kasmi & Nishimura, 2016). However, further work is needed to 
uncover the exact mechanism of signalling and function of the NLR N-terminal domain. 
It should be noted that not all NLR proteins have an N-terminal domain of the class TIR 
or CC. Other types of N-terminal domain have been identified and defined, although less 
abundant that the two main classes, and will not be discussed further (Shao et al., 2016). 
The NB-ARC domain is responsible for the ATPase activity of the NLR and is made up of 
three subunits that form a nucleotide binding pocket (Sukarta et al., 2016). The 
nucleotide exchange function of this domain is thought to be important in the activation 




The C-terminal domain of the NLR protein is a leucine-rich repeat domain. The LRR 
domain is thought to have a role in effector recognition specificity and mediating effector 
interaction (Krasileva et al., 2010). No crystal structure of an LRR domain from a plant 
NLR has yet been solved, but structures of LRR domains from other proteins have been 
determined, including the animal NLR protein NLRC4 (Hu et al., 2013). These studies 
have indicated that the LRR domain may play a role in maintaining the autoinhibited 
state of the receptor in the absence of pathogen effectors. LRR domains are narrow and 
arc-shaped, and contain repeating patterns of leucine residues that form a hydrophobic 
core (Padmanabhan et al., 2009). 
One commonly accepted model for NLR activation is that the immune receptor functions 
as a molecular switch, whereby recognition of an effector disrupts the autoinhibited state 
of the NLR (which is stabilised by the LRR domain) allowing the formation of an ‘open’ 
conformation, which involves nucleotide exchange (exchange of ADP for ATP) in the NB-
ARC domain. As the protein undergoes a conformational change, it initiates interaction 
with downstream signalling partners to trigger an immune response (Lukasik & Takken, 
2009). More recent studies have proposed a modification to this model, indicating that 
the NLR might exist in an equilibrium between the closed and open state, but that the 
recognition of a pathogen effector stabilises the open state, leading to immune signalling 
(Bernoux et al., 2016). 
Dimerisation, or indeed oligomerisation, of NLRs in immune signalling also appears 
important. In animals, NLRs become active through the formation of an apoptosome, a 
heptamer formed by intermolecular interactions that enables signalling. However, 
similar oligomeric structures formed by the entire NLR have not been conclusively 
observed in plant immune signalling (Wróblewski et al., 2018). The N-terminal 
(generally CC or TIR) domain of plant NLRs is capable of forming homo- and hetero- 
dimers (e.g. (M. Bernoux et al., 2011; Williams et al., 2014)) that are involved in cell death 
signalling. The formation of such heteromers aligns with the concept of ‘sensor’ and 
‘helper’ NLRs discussed in section 1.4.3. During evolution, it may be important that these 
N-terminal domains retain the ability to oligomerise with each other by conserving 
particular features (Wróblewski et al., 2018). However, dimerisation of these N-terminal 
domains is frequently not sufficient to enable downstream signalling, and other NLR 
domains appear to play a role in the transduction of the signal following association (El 
Kasmi et al., 2017). Further structural and functional studies are required to determine 




Despite extensive research into NLR structure and function, and much recent progress, 
the exact details of how the conformational change and downstream signalling events 
occur are still lacking. 
1.4.2 Models for effector recognition 
Aside from ongoing research regarding the downstream signalling of the NLR proteins, 
there has also been much debate regarding how these receptors recognise effectors. 
Perhaps the simplest explanation for this question is a solution of one resistance gene 
having the responsibility of recognising one pathogen effector protein. This was 
proposed as the ‘gene-for-gene’ concept (Flor, 1971), and examples of direct binding 
between NLR and effector proteins have been discovered (Maud Bernoux et al., 2011). 
However, other observed effector/NLR interactions suggest that the gene-for-gene 
concept is unlikely to be the only method of detection.  
Other models have been proposed for effector recognition (figure 1.4-1) that involve the 
presence of an additional protein functioning as a mediator between the resistance 
protein and the effector. These models are known as the ‘guard’ and ‘decoy’ models. The 
guard hypothesis is that NLR proteins monitor the perturbation of other plant proteins 
by pathogen effectors and induce defence responses when they notice the activity of the 
effector. Using the example of bacterial speck disease of tomato, it was proposed that the 
bacterial effector AvrPto was interacting with a host Ser/Thr kinase Pto, which was 
responsible for interaction with a number of defence-related transcription factors. The 
host NLR Prf is thought to monitor the Pto kinase protein and initiate downstream 
defence signalling when it recognises the formation of the complex with AvrPto (van der 
Biezen & Jones, 1998). Other examples of the guard hypothesis include the host target 
RIN4, which is targeted by multiple effectors and monitored by two NLR proteins RPS2 
and RPM1 (Jones & Dangl, 2006). The decoy model proposes a modification to the guard 
model, whereby the host factor that is targeted by the effector is actually functioning as 
a decoy, and plays no part in plant development or immunity, but is required for function 
of the resistance protein (van der Hoorn & Kamoun, 2008). Later research suggested that 
the AvrPto interaction system might also fit within this decoy model. It was found that 
although AvrPto inhibits the kinase activity of Pto, this inhibition was not required for 
initiating Prf-mediated defence responses, indicating that AvrPto might have other host 
virulence targets. FLS2 was identified as another such target. This evidence suggests that 
Pto might be mimicking FLS2 and acting as a decoy, whereby the binding of AvrPto 




on plant fitness (Zipfel & Rathjen, 2008). Other types of decoy systems are present in 
host/pathogen interactions, including pathogen-derived decoys that are designed to 
prevent recognition by the host (Paulus & van der Hoorn, 2018). 
Another strategy employed by the host immune system is to integrate the ‘decoy’ protein 
into the NLR itself, as an additional domain. This model has been previously known as 
the ‘integrated decoy’ hypothesis (Cesari, Bernoux, et al., 2014), but in fact there has been 
some debate whether this term is accurate. For many such situations, it is not clear 
whether the integrated domain is a true decoy, or whether it has biochemical activity 
alongside its role in immune signalling - for this reason, the term ‘sensor domain’ is 
preferred by many (Wu et al., 2015). To maintain clarity, these domains will simply be 
referred to as ‘integrated domains’ in this thesis. The nature and function of these 
domains will be discussed in section 1.4.3. 
 
1.4.3 Integrated domains 
One emerging theme for NLR proteins is that they frequently function in pairs (Eitas & 
Dangl, 2010), where both NLR genes are found at a single locus, tightly linked and 
transcribed in opposite directions (Cesari, Kanzaki, et al., 2014). It was found that both 
NLRs in these pairs are vital for immune signalling, and they often appear to have 
Figure 1.4-1: Models for effector perception by NLRs. 
Diagrams highlighting the four different models for effector perception by NLR 
proteins. Individual domains of NLR proteins are labelled, namely: CC = coiled coil, NB-
ARC = Nucleotide-binding, LRR = leucine-rich repeat, ID = integrated domain. Effector 
is represented by a red circle. Note that CC is being used as a representative N-terminal 




different architecture, suggesting that they might play separate roles in initiating the 
defence response. One proposed mechanism was that one NLR would function as an 
effector sensor, and the other NLR would function as a ‘helper’ that was required for 
immune signalling but not specifically for detection of the effector (Bonardi et al., 2011). 
Recent work has uncovered more about the concept of ‘helper’ NLRs in plant immunity 
to reveal complex signalling networks, for example the NRC (NLR required for cell death) 
family in N. benthamiana. Members of the NRC family act as helpers for a variety of 
sensor NLRs, and it is believed that by diversifying from genetically linked pairs into an 
unlinked network, the immune system has the potential to accelerate gain-of-immunity 
to a variety of pathogens. These NRC helpers are not thought to be involved in direct 
contact with pathogen proteins, and therefore evolve at a slower rate. The functional 
redundancy in the family may help sensor NLRs to evolve more rapidly and gain new 
functionality (Wu et al., 2017). 
NLR proteins that contain novel integrated domains have been shown in several 
examples to function in pairs with an additional NLR. The concept of the ‘sensor’ and 
‘helper’ NLRs fits this model well, as the NLR that contains the integrated domain could 
function to recognise the effector through its ‘decoy’ or ‘sensor’ integrated domain, and 
the second member of the NLR pair could function as the helper NLR that translates this 
recognition into an immune signalling response. 
One striking feature of these integrated domains is that they can be of varied size and 
function, and are widespread. In one study, all 31 plant species tested were shown to 
contain NLRs with integrated domains; on average 3.5 % of the NLR complement for each 
genome (Kroj et al., 2016). Sarris et al. discovered 265 unique integrated domains from 
40 plant genomes (Sarris et al., 2016) but the authors predict this to be an underestimate. 
Separately to Kroj et al., Sarris et al. predicted that around 10 % of NLRs in each genome 
contain integrated domains. Both studies used a range of plant genomes in their study, 
including monocots, dicots and mosses. The discovery of such a wide repertoire of 
integrated domains may aid the discovery of new effector targets for functional analysis. 
However, if only 3.5 % of NLR proteins from a typical plant genome contain an integrated 
domain, this raises questions about the spread and specialisation of these integrations. 
If they confer a significant advantage onto the resistance capabilities of a plant, it might 
be expected that this percentage would be considerably larger. 
The advantage of integrating these domains into the NLR protein itself, rather than 
maintaining them as separate proteins, has been discussed (Ellis, 2016). It seems 




interaction strength with the pathogen effector (or multiple effectors), rather than 
maintaining a focus on its original function (Ellis, 2016) (which is not to say that the 
integrated domain does not retain any biochemical activity). However, the actual 
evolutionary advantage of integration is still open to debate and conjecture. One logical 
advantage of integration over maintaining the NLR and pathogen-binding domain 
separately is that proteins will always be maintained in a physically linked fashion. This 
ensures identical stoichiometry and identical subcellular localisation, which should aid 
effector detection and translate binding to signalling even in the presence of a weak 
interaction. Similarly, by genetically linking the NLR with its partner domain, the two will 
coexpress more readily and are less likely to be disrupted by genetic recombination 
(Baggs et al., 2017). From an evolutionary perspective, this genetic linkage might cause 
the integration to be maintained longer term in the host. This could perhaps be 
disadvantageous if a pathogen was able to overcome recognition by that particular 
integrated domain – as the host would have to modify or lose an entire immune receptor, 
rather than simply by modifying a guard or decoy protein. 
Two of the most widely studied NLR pairs containing integrated domains are the rice 
NLRs Pik-1/Pik-2 and RGA5/RGA4; both these pairs contain an integrated heavy metal-
associated (HMA) domain and will be discussed in more detail in chapter 3. Other NLRs 
known to contain integrated domains include the RRS1/RPS4 pair, which utilises an 
integrated WRKY domain, a known target of the Ralstonia solanacearum effector PopP2 
(Le Roux et al., 2015). 
1.5 Project Aims and Objectives 
The overall aim of this project is to better understand the function and recognition of 
plant pathogen effectors using biochemical and structural methods. In doing this, it is 
hoped that this work will become part of a growing field of research that aims to tackle 
the issue of global food security. Although engineering crop plants to convey greater 
resistance to disease has its challenges, both scientifically and ethically, it may become 
essential as we face a growing population and fluctuating climatic conditions. The first 
step towards engineering of crop plants is to gain a thorough understanding of how the 
plant and pathogen are interacting at the molecular level. 
The first part of the project will investigate the recognition of the Magnaporthe oryzae 





➢ To understand how the integrated heavy metal-associated domain of Pikp-1 
binds to AVR-Pia (using X-ray crystallography and biophysical protein-protein 
interaction techniques). Given that the overall structure of AVR-Pia is known to 
be similar to AVR-PikD, we hypothesise that the interaction of the effector with 
the HMA domain will take a similar form in both cases. 
➢ To engineer the NLR protein to strengthen or extend the recognition in planta. 
We hypothesise that it will be possible to modify Pikp-HMA to bind AVR-Pia more 
strongly in vitro, and that this would lead to a stronger immune response in 
planta. By rational structure-based design, we predict that it will be feasible to 
maintain an interaction with the ‘matched’ effector AVR-PikD 
The second part of the project will investigate the Phytophthora infestans effector 
PexRD24, and its interaction with a host enzyme protein phosphatase 1. The aims of this 
part of the project are: 
➢ To gain structural insight into how PexRD24 binds to the catalytic subunit of its 
target. We predict that this interaction will involve the conserved RVxF motif 
found in PexRD24, which is known to be important in the interaction of 
phosphatase regulatory subunits with PP1c. 
➢ To investigate whether effector binding modulates the enzymatic activity of the 
phosphatase. Based on work from a collaborating group, we hypothesise that the 
phosphatase activity of PP1c towards a generic substrate will not be inhibited by 
the interaction of PexRD24, as PexRD24 appears to be acting as a relocaliser of 
the catalytic subunit, rather than simply as an inhibitor. 
Overall, this project will contribute new insights into the structure/function diversity of 










2.1.1 Chemicals and Reagents 
Chemicals were purchased from Sigma-Aldrich (now Merck), VWR (now Avantor), 
Melford Laboratories, or Thermo Fisher Scientific unless otherwise specified. 
2.2 DNA Techniques 
2.2.1 Plasmid vectors 
The following plasmid vectors were used in this thesis (table 1). Note that a complete list 
of primers used is shown in Appendix 2. 
Table 1: Vectors used for cloning the constructs generated in this project. 







pOPINS3C 6xHis-SUMO (N) Carb In-Fusion® E. coli OPPF 
pOPINF 6xHis (N) Carb In-Fusion® E. coli OPPF 
pOPINM 6xHis-MBP (N) Carb In-Fusion® E. coli OPPF 
pOPINE 6xHis (C)  Carb In-Fusion® E. coli OPPF 
pOPINA Untagged Kan In-Fusion® E. coli OPPF 
pOPIN/GG 
F1-F6 
Allows insertion of 
various tags for 
E.coli expression 
(C or N) 





Efficient cloning of 
A-tailed DNA (used 
as holding vector 
before GG cloning) 
Spec TOPO® - Invitrogen 
pICH47751 
Lvl 1 acceptor 
vector, position 3 






Lvl 1 acceptor 
vector, position 2 






2.2.2 Agarose gel electrophoresis 
Agarose gel electrophoresis is used to separate DNA fragments according to size. Agarose 
gels were made by adding ethidium bromide at a final concentration of 0.5 μg/ml to the 
required volume of molten 1.0 % w/v agarose made up in TAE buffer (40 mM Tris-
acetate pH 8.0, 1.0 mM EDTA), and setting in a mould with well-comb. DNA samples were 
mixed with 4x loading dye (12 % ficoll 400 and 0.25 % w/v Orange G) and loaded into 
the wells with an accompanying Quick-Load® 1 kb DNA ladder (New England Biolabs, 
NEB). Electrophoresis was carried out at 90V in 1x TAE buffer. DNA bands were then 




2.2.3 Polymerase Chain Reaction 
Polymerase Chain Reaction (PCR) was used for several different purposes in this project. 
2.2.3.1 Standard PCR for cloning 
PCR was used to amplify DNA for cloning into the vector of interest. Unless specified 
otherwise, PfuUltra II Fusion HS DNA Polymerase (Agilent Technologies) was used for 
amplification in a 50 μl reaction volume. 1x PfuUltra II buffer, 100 ng template DNA, 0.2 
μM each primer, 0.25 mM dNTP mix and 1 μl PfuUltra II polymerase (at supplied 
concentration) were mixed on ice and immediately loaded into a T3000 Thermocycler 
(Biometra) for PCR. Parameters are shown in table 2, below. 







Activation 95 120 x1 
Denaturation 95 20 
x40 Annealing 57 20 
Extension 72 30 
Final extension 72 180 x1 
Hold 12 Hold x1 
 
Following PCR, 45 µl reaction mixture was mixed with 4x loading dye and used for 
agarose gel electrophoresis as described in 2.2.2. 
2.2.3.2 Overlap extension PCR 
Overlap extension PCR was used to generate the H129A point mutation in PP1c-3 
(Chapter 5). The protocol for this method was adapted from S.King, Ph.D. thesis, 2013. 
Four primers were designed to generate two overlapping sections of PP1c-3 DNA that 
contained the required base changes to code for the H129A point mutation. Two 
standard PCR reactions were carried out (using PfuUltra II, with a 55 oC annealing 
temperature) to amplify the fragments – i.e. each PCR product is generated from one 
flanking primer (from outside the mutation site) and one mutation primer (containing 
the point mutation). The template DNA for the reaction was PP1c-3 in pDONR201 vector 
(Supplied by Paul Birch). Although this vector is not used elsewhere in the project, it was 
used as the template for this reaction because it has a different antibiotic resistance 
(kanamycin) to the cloning vector (pOPINS3C is carbenicillin resistant), which will 





Overlap extension PCR was then carried out by mixing 1 μl of each purified PCR product 
(above) and diluting 100-fold. PCR was then carried out in a 47.5 μl reaction, containing 
1x PfuTurbo® reaction buffer, 0.2 mM dNTP mix, 0.5 μl mixed PCR template and 0.5 μl 
PfuTurbo® DNA polymerase (Agilent Technologies). The mixture was subjected to 7 
cycles of PCR (table 3) to cause extension from the overlapping regions of PCR template. 







Activation 95 120 x1 
Denaturation 95 30 x7 
then  
x40 
Annealing 60 30 
Extension 72 60 
Final extension 72 600 x1 
Hold 12 Hold x1 
 
0.1 mM dNTP mix and 0.1 μM of each flanking primer were then added to the PCR 
mixture to a final volume of 50 μl. 40 more cycles of PCR (table 3) were carried out, with 
the annealing temperature reduced to 55 oC. The resultant full-length PCR product 
containing the desired mutations was purified and used for In-Fusion cloning (section 
2.2.5.1) to clone into pOPINS3C. 
2.2.3.3 Colony PCR 







Activation 95 120 x1 
Denaturation 95 15 
x30 Annealing 60 15 
Extension 72 15-70 
Hold 12 Hold x1 
To test for the success of generating plasmids containing the correct insert DNA, colony 
PCR was used to investigate transformed Escherichia coli. MyTaq™ Red (Bioline) was 
used for colony PCR because the red dye element allows direct loading for agarose gel 
electrophoresis, allowing quick and efficient PCR experiments. For each colony PCR 
reaction, 1x MyTaq™ Red buffer and 0.15 µM appropriate primers were mixed to a final 
volume of 19 µl. A single colony was then picked from the agar plate and partially 
inoculated into the PCR mixture, and 1 µl MyTaq™ polymerase was added. The remainder 
of the colony was then inoculated into 1 ml Lysogeny broth (LB) media and shaken at 37 
oC. Thermal cycling was performed as described in table 4. Extension time was varied 




Success of colony PCR was assessed using agarose gel electrophoresis (10 µl PCR 
reaction was loaded directly onto an agarose gel). For colonies containing inserts of the 
correct size, the 1 ml LB culture was transferred to 10 ml LB media (supplemented with 
appropriate antibiotics) and grown up overnight at 37 oC, 200 rpm. These cultures were 
then used for DNA preparation and subsequent sequencing. 
2.2.3.4 Purification of PCR products 
Following electrophoresis, bands of interest were excised from the agarose gel and 
purification of PCR products (except for colony PCR) was carried out using the 
NucleoSpin® Gel and PCR Clean-up kit (Macherey-Nagel) according to the kit protocol. 
2.2.4 DNA fragment synthesis 
Some DNA fragments used in this project were commercially synthesised by Integrated 
DNA Technologies as gBlocks® Gene Fragments, which are sequence-verified double-
stranded linear chains of nucleic acids. Fragments were designed with correct overhangs 
and BsaI sites for direct cloning into the appropriate vector (pCR™8 in this case). Upon 
receipt, synthesised DNA was resuspended in 2.5 mM Tris pH 8.5 buffer to a final 
concentration of 20 ng/μl. Resuspended DNA was heated at 50 oC for 10 minutes then 
vortexed to ensure full resuspension. 
2.2.5 Cloning 
2.2.5.1 In-Fusion® cloning 
In-Fusion® cloning was used for generating constructs in pOPIN vectors. pOPIN vectors, 
developed by the Oxford Protein Production Facility (OPPF), are a suite of vectors 
designed for expression of constructs with different purification and solubility tags in a 
range of expression hosts. To clone into the vectors, specific primer extensions are used, 
allowing direct cloning of PCR product (with appropriate extensions) into the linearised 
vector (Berrow et al., 2007). Prior to cloning, purified pOPIN vectors must be cut with 
the appropriate restriction enzymes to allow insertion of the PCR fragment. pOPINF, 
pOPINS3C and pOPINM were treated with restriction enzymes KpnI and HindIII, pOPINE 
with NcoI and PmeI, and pOPINA with NcoI and DraI. Cut vector is then purified by gel 
extraction (section 2.2.3.4). In-Fusion® cloning was carried out by mixing 50-100 ng 
linearised pOPIN vector with 50-100 ng purified PCR product (generated as described in 
2.2.3.1), and 5x In-Fusion® HD Enzyme Premix (Clontech) in a 5 µl reaction. The reaction 




was transformed into competent E. coli DH5α cells (see section 2.3). Transformed cells 
were plated onto LB agar supplemented with the appropriate antibiotic (carbenicillin or 
kanamycin), 1 mM IPTG (isopropyl β-D-1-thiogalactopyranoside) and 0.02 % w/v X-gal 
(5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) for blue/white selection. Due to 
high efficiency of In-Fusion® cloning, only two white colonies from transformed plates 
were taken and grown up in LB media for DNA preparation and subsequent sequencing. 
2.2.5.2 TOPO® cloning 
Commercially-synthesised DNA fragments (section 2.2.4) for Golden Gate cloning were 
cloned into the pCR™8 vector using TOPO® cloning. These constructs were subsequently 
used for cloning into level 1 acceptor vectors by Golden Gate cloning. DNA fragments 
were first modified by A-tailing, to allow ligation into the pCR™8 vector. 6.8 μl 
resuspended DNA fragment was mixed with 1x Standard Taq Reaction buffer (NEB), 0.2 
mM dATP and 0.2 μl Taq DNA polymerase (NEB) in a final volume of 10 μl. Mixture was 
incubated at 72 oC for 20 minutes. 4.5 μl A-tailed DNA from the reaction was then mixed 
with 0.5 μl of pCR™8 vector and 1 μl salt solution (both from the Invitrogen 
pCR™8/GW/TOPO® kit). Mixed components were incubated at room temperature for 
30-60 minutes, before 3 μl was transformed into One Shot™ TOP10 competent E. coli 
cells (section 2.3). Transformed E. coli were plated onto LB agar supplemented with 
spectinomycin, and plates were incubated at 37 oC overnight. Colony PCR and DNA 
sequencing were used to confirm insertion of the correct construct. 
2.2.5.3 Golden Gate cloning 
Golden Gate cloning was used to generate constructs for in planta transient expression. 
Several constructs used had been generated previously (de la Concepcion et al., 2018) 
for other projects, but several effector proteins and Pik-1 mutants were generated 
specifically for this work. 
Golden Gate cloning is carried out using a ‘one pot one step’ approach in a digestion-
ligation reaction (Engler et al., 2008), where restriction enzymes are used to cut out the 
required fragments for cloning, and ligase enzymes then join the fragments up in the 
specified order in the acceptor vector. Only level 1 cloning was used in this project, 
meaning that only BsaI restriction sites were used, and all constructs were cloned into 
level 1 acceptor vectors. Standard parts (such as promoters and tags) are supplied by 
TSL SynBio. 
To clone the effectors AVR-Pia, AVR-PiaNAVR-PikD and AVR-PikDΔ22-52, PCR was first carried 




were designed to flank the coding sequence with BsaI restriction sites and a four-base 
overhang that defines how the pieces ligate together in the acceptor vector. Each 
standard part used is derived from a level 0 module and is also flanked with BsaI 
restriction sites and overhangs. The overhangs are pre-defined as described in Patron et 
al. (Patron et al., 2015) . Complete effector transcriptional units are made using the 
following parts (table 5). 
















Promoter + 5’ UTR pICSL13005 Ubi10 GGAG CCAT 
Mark 
Youles 
N-terminal tag pICSL30009 4xMyc CCAT AATG 
Mark 
Youles 
Coding sequence - PCR product AATG GCTT - 




All parts are mixed together in a 2:1 molar ratio of part:acceptor, where 100 ng acceptor 
vector is used. In a final volume of 20 μl (in H20), DNA parts were mixed with 1.5 μl 10x 
BSA (bovine serum albumin), 1.5 μl 10x T4 DNA ligase buffer (NEB), 200 U T4 DNA ligase 
(0.5 μl) (NEB) and 5 U BsaI (0.5 μl) (Thermo Scientific). The mixture was then subjected 
to the digestion-ligation reaction (table 6) carried out in the T3000 Thermocycler 
(Biometra). 
 










50 300 x1 
80 300 x1 
12 Hold x1 
 
Following the digestion-ligation reaction, 2 μl of reaction mixture was transformed into 
Stellar™ competent E. coli cells (see section 2.3) and plated onto LB agar supplemented 




colonies were then selected for colony PCR (section 2.2.3.3), and subsequent DNA 
sequencing. 
For cloning of mutant Pik-1 NLRs, a similar procedure was used. However, for simplicity 
of cloning, Pik-1 had previously been divided into separate domains, and Golden Gate 
standard parts created for each domain (by M. Franceschetti, J. C. de la Concepcion). 
Therefore, as the mutations were only created inside the HMA domains, only new HMAs 
needed to be created. Mutant HMA domains were made synthetically (section 2.2.4) and 
were created with BsaI sites and appropriate overhangs in place. The synthetic HMA 
domains were cloned into the pCR™8 vector (section 2.2.5.2), which generated them as 
standard parts for cloning into the level 1 NLR transcriptional unit (table 7). 
















Promoter + 5’ 
UTR 





CC - Domain Pikp-1 AATG CAGA M. F. 
HMA - Domain Pikp-1 CAGA GACG - 
NB-ARC - Domain Pikp-1 GACG CTTT M. F. 
LRR - Domain Pikp-1 CTTT TTCG M. F. 






3’ UTR + 
Terminator 




Golden Gate cloning was then carried out exactly as described above for effector 
transcriptional units, using parts in a 2:1 molar ratio of parts:acceptor as before. 
Digestion-ligation reaction and colony PCR were carried out as described. 
Appendix 1 describes a new technique tested as part of this PhD project, known as 
pOPIN/GG; a hybrid of pOPIN based and Golden Gate based cloning. pOPIN/GG 
constructs were also generated using a Golden Gate cloning procedure. This process was 
exactly the same as described above but using different standard parts. The coding 
sequence for the protein of interest was amplified using PCR with BsaI site and 























N-terminal tag pICSL30019 C3_6xHis CCAT AATG 
Mark 
Youles 
Coding sequence - PCR product AATG GCTT - 
 
Table 8 shows the pOPIN/GG F5 version of the vector, here used for generating 
constructs with an N-terminal cleavable 6xHis tag. Digestion-ligation reaction was 
carried out as described previously. 
2.2.6 Plasmid purification 
To prepare purified DNA, a single colony of transformed E. coli (usually the cloning 
strains DH5α or Stellar™) was grown up overnight at 37 oC, 200 rpm in a 10 ml culture. 
10 ml culture was harvested by centrifugation at 3,400 xg for 10 minutes to pellet cells. 
DNA was purified from the cell pellet using the ISOLATE II Plasmid Mini Kit (Bioline) or 
the NucleoSpin® Plasmid Kit (Macherey-Nagel) according to kit protocols. 
Concentration of purified DNA was measured using the NanoDrop™ ND-1000 or 
NanoDrop™ One Spectrophotometers (Thermo Fisher). 
For purifications of larger quantities of DNA of higher quality, DNA was prepared using 
the Plasmid Midi Kit (QIAGEN) according to the kit protocol. Concentration of purified 
DNA was measured as above. 
2.2.7 DNA sequencing 
DNA sequencing was performed by LightRun sequencing (GATC Biotech, now Eurofins) 
using 500 ng DNA mixed with appropriate sequencing primer at 2.5 μM concentration. 
2.3 Bacterial Techniques 
2.3.1 Bacterial growth media 




2.3.1.1 Lysogeny broth 
Lysogeny broth (LB) media (LB Broth Miller, Formedium) is composed of 1.0 % w/v 
tryptone, 0.5 % w/v yeast extract and 1.0 % w/v sodium chloride, at pH 7.0. For making 
LB agar (used to culture bacteria on plates), 1.0 % w/v agar was also added, and plates 
were poured while agar was molten. 
2.3.1.2 Auto-induction media 
Auto-induction media LB base (AIM) (Formedium) is composed of 1.0 % w/v tryptone, 
0.5 % w/v yeast extract, 0.33 % w/v (NH4)2SO4, 0.68 % w/v KH2PO4, 0.71 % w/v 
Na2HPO4, 0.05 % w/v glucose, 0.2 % w/v α-lactose, 0.015 % w.v MgSO4, trace elements. 
2.3.1.3 PowerBroth™ 
PowerBroth™ media (Molecular Dimensions) was made up from a powder preparation, 
using 5.2 % w/v PowerBroth™ powder and 0.4 % v/v glycerol. 
2.3.1.4 EnPresso® 
EnPresso® B Media (BioSilta, now Merck) Starter Pack was used according to the 
manufacturer’s protocol to test for protein expression. 
2.3.2 Antibiotics 
Antibiotics were used for plasmid and bacterial selection throughout this project. In each 
case, stock solutions were made at 1000x concentration and used as required. Final 
concentrations used were: carbenicillin 100 μg/ml, kanamycin 30 μg/ml, spectinomycin 
100 μg/ml, rifampicin 50 μg/ml, gentamycin 20 μg/ml, chloramphenicol 34 μg/ml. Most 
antibiotic stocks were dissolved in de-ionised H2O and filter sterilised using 0.22 μm 
Minisart® syringe filters. Rifampicin is dissolved in 100 % DMSO, and chloramphenicol 
is prepared in 100 % ethanol. 
2.3.3 Bacterial strains used 
2.3.3.1 Cloning strains 
Escherichia coli DH5α (Hanahan, 1983), Stellar™ (Clontech), One Shot™ TOP10 
(Invitrogen). 
2.3.3.2 Expression strains 
Escherichia coli cell strains used were BL21(DE3) (NEB), BL21-AI™ (Invitrogen), 




(Genlantis). Agrobacterium tumefaciens GV3.101 (Larebeke et al., 1974) was used for 
transient expression in planta. 
2.3.4 Bacterial glycerol stocks 
For bacteria transformed with plasmids of interest, saturated overnight liquid culture 
(with appropriate antibiotics) was mixed with 50 % v/v sterile glycerol and stored at -
80 oC. 
2.3.5 Making chemically competent E. coli 
For each cloning and expression strain used, the bacteria were either purchased as 
chemically competent from commercial suppliers or made chemically competent before 
use.  
To generate chemically competent E. coli, a glycerol stock of the strain of interest was 
inoculated into 10 ml LB media containing appropriate antibiotics and shaken overnight 
at either 30 or 37 oC (strain dependent) at 200 rpm. 1 ml of overnight culture was diluted 
into 100 ml fresh LB media and shaken as before until OD600 0.3. Cells were chilled on ice 
for 5 minutes before being harvested by centrifugation at 2,800 xg for 7 minutes at 4 oC. 
Supernatant was discarded and the cell pellet was then resuspended in 40 ml TfbI buffer 
(100 mM rubidium chloride, 10 mM calcium chloride, 50 mM manganese chloride, 30 
mM potassium acetate, 15 % v/v glycerol, pH 5.8) and incubated on ice for 5 minutes. 
After a further centrifugation step (2,800 xg, 7 minutes, 4 oC) the supernatant was 
discarded and cell pellets were resuspended in 4 ml TfbII buffer (10 mM MOPS, pH 6.5, 
10 mM rubidium chloride, 75 mM calcium chloride, 15 % v/v glycerol). Cells were 
incubated on ice for 20 minutes and then aliquoted into pre-chilled, sterile Eppendorf 
tubes (50 μl aliquots), flash frozen in liquid nitrogen and stored at -80 oC. 
2.3.6 Transforming chemically competent E. coli 
To transform chemically competent E. coli with the construct of interest, an aliquot of 
competent cells was thawed on ice, and 50-100 ng of DNA was added directly to the cells. 
After incubating on ice for 30 minutes, cells were heat-shocked for 30 seconds at 42 oC. 
450 μl LB media was added and cells were recovered for 60 minutes at 37 oC with shaking 
at 200 rpm. Typically, 50-200 μl recovered cells were plated onto an LB agar plate (with 




2.3.7 Transforming competent A. tumefaciens 
Electrocompetent Agrobacterium tumefaciens are prepared as described in S.King, Ph.D. 
thesis, 2013. To transform the cells, a 50 μl aliquot of electrocompetent A. tumefaciens 
GV3.101 was thawed on ice and added to a sterile, cold electroporation cuvette. 50-200 
ng DNA was added to the cuvette and placed on ice. Cells were immediately shocked at 
2,500 V and 500 μl LB media was added. Cells were recovered for 60 minutes at 28 oC 
with shaking at 180 rpm. 20-50 μl recovered cells were plated onto an LB agar plate (with 
rifampicin and gentamycin along with appropriate antibiotics) and incubated at 28 oC 
overnight. 
2.4 SDS-PAGE 
Two different SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) 
systems were used for this project. 
Method 1: SDS-PAGE gels were made within the lab and stored at 4 oC prior to use. 
Resolving gel was made with either 12 or 17 % w/v polyacrylamide, diluted in 375 mM 
Tris-HCl, pH 8.8 stock with 0.1 % w/v SDS. 0.1 % w/v ammonium persulfate and 0.04 % 
v/v N,N,N’,N’-tetramethylethylenediamine was added immediately prior to pouring into 
Mini-PROTEAN (Bio-Rad) 1.0 mm glass gel casting plates, up to 2 cm below the top of the 
shorter plate. Water-saturated butanol was added to the top of the resolving gel during 
the polymerisation process to ensure a level boundary. After setting, the butanol was 
removed and the stacking gel was added (5 % w/v polyacrylamide, 63 mM Tris-HCl, pH 
6.8 with 0.1 % w/v SDS, 0.1 % w/v ammonium persulfate and 0.1 % v/v N,N,N’,N’-
tetramethylethylenediamine). Gel casting combs were added to the stacking gel and 
allowed to set. After gels were set, they were fitted into the Mini-PROTEAN Tetra Cell 
assembly (Bio-Rad), which was filled with 1x Tris/tricine SDS running buffer (25 mM 
Tris-HCl, 250 mM NaCl, 0.1 % w/v SDS). Protein samples were prepared by heating at 95 
oC for 5 minutes in SDS loading dye (50 mM Tris-HCl, pH 6.8, 100 mM dithiothreitol 
(DTT), 2.0 % w/v SDS, 0.1 % bromophenol blue, 10 % glycerol). Combs were removed 
from gels and denatured samples were loaded along with a molecular weight marker 
ladder (RunBlue™ Prestained Molecular Weight marker (Expedeon) or SeeBlue™ Plus2 
Prestained Protein Standard (Invitrogen)). Gels were run at 140-180 V until dye front 
was near the bottom edge of the gel. Gels were then stained with InstantBlue™ Coomassie 
Protein Stain (Expedeon) at room temperature for at least 60 minutes, before being 




Method 2: All gels and associated equipment were purchased pre-made from Expedeon, 
with a range of resolving percentages (12, 16, or 4-20 %). The RunBlue™ Teo-Tricine SDS 
Mini Protein gels were fitted into the RunBlue™ gel running tank and the tank was filled 
with 1x RunBlue™ Teo-Tricine SDS running buffer. Protein samples were prepared by 
heating at 95 oC for 5 minutes in RunBlue™ 4x LDS Sample Buffer, with addition of 100 
mM DTT. Denatured samples were loaded along with a molecular weight marker ladder 
(RunBlue™ Prestained Molecular Weight marker (Expedeon), or PageRuler™ Plus 
prestained protein ladder (Thermo Fisher) if used for subsequent Western blotting). 
Gels were run at 140-180 V (or 70-100 V if used for subsequent Western blotting), until 
dye front was near the bottom edge of the gel. Unless being transferred for Western blot 
analysis, gels were then stained with InstantBlue™ Coomassie Protein Stain (Expedeon) 
at room temperature for at least 60 minutes, before being rinsed and stored in deionised 
H2O. 
 
2.5 E. coli Expression Screening 
2.5.1 Small-scale expression testing 
For testing expression on a small scale with no purification steps, a single colony was 
taken from an agar plate or a scraping was taken from a glycerol stock and inoculated 
into 10 ml LB media (supplemented with appropriate antibiotics). Cultures were shaken 
overnight at 30 or 37 oC (depending on bacterial strain) at 200 rpm. 200-500 μl overnight 
bacterial culture were then subcultured into 10 ml fresh LB media and shaken until OD600 
0.4-0.8. Expression was then induced with the appropriate reagent, either 1 mM IPTG, or 
0.2 % L-arabinose if using BL21-AI™ cells. Following induction of expression construct, 
cells were shaken at 200 rpm at a reduced temperature of 18 oC for around 16 hours, or 
at 30/37 oC for 4 hours. Cells were then harvested by taking 1 ml culture and spinning at 
5,000 xg for 1 minute in an Eppendorf tube. Supernatant was fully removed, and cell 
pellet was resuspended in 500 μl 1x BugBuster® Protein Extraction Reagent 
(supplemented with 0.25 μl benzonase) (Merck). Cells were lysed in extraction reagent, 
with gentle agitation, for 20 minutes at room temperature, and a sample (crude cell 
lysate) was taken for SDS-PAGE analysis. Lysed cells were then centrifuged at 17,000 xg, 
4 oC for 15 minutes to pellet insoluble material. A sample of the supernatant (soluble 




2.5.2 Medium-throughput expression screening 
To perform a medium-throughput expression screen, constructs were first transformed 
into the appropriate expression strain. 4 ml LB media supplemented with appropriate 
antibiotics was added to each well of a 24-deep-well block and single colonies were 
added to individual wells. Plate was sealed with a gas-permeable seal and shaken 
overnight at 37 oC, 200 rpm. Fresh 24-deep-well blocks were filled with expression 
media (LB or PowerBroth™) supplemented with antibiotics and chemical chaperones 
dimethyl sulfoxide (DMSO) or ethanol (3 % v/v) as needed, and 200 µl of overnight 
samples were subcultured into the fresh media. Plates were shaken at 37 oC until OD600 
0.4-0.8 for each culture. Cells were then induced with either 1 mM IPTG or 0.2 % L-
arabinose as appropriate. Plates were covered with gas-permeable seals and shaken at 
18 oC, 200 rpm overnight. Cells were harvested by centrifugation at 3,800 xg for 10 
minutes in the 24-deep-well block and supernatant was discarded. Cells were 
resuspended in varying quantities of lysis buffer (50 mM Tris-HCl pH 8.0, 500 mM NaCl, 
20 mM imidazole, 5 % v/v glycerol, 50 mM glycine, 1 protease inhibitor tablet (per 50 ml 
buffer) (Roche), 1 mM MgCl2, 0.5 μl benzonase (per ml buffer) and 0.25 mg lysozyme (per 
ml buffer)) to give approximately the same visual density of cells in solution. Cells were 
then sonicated using a Vibra-Cell™ (Sonics) sonicator fitted with a 24-well probe on ice 
(40 % amplitude, with sonication frequency 1 second on followed by 3 seconds off for 2 
minutes). 30 µl of each lysed cell culture was added to SDS-PAGE loading dye (with DTT) 
in a 96-well PCR plate in a known orientation. 24-deep-well block containing the lysed 
cells was centrifuged for 40 minutes at 4,800 xg and 4 oC. 30 µl clarified supernatant was 
added to SDS-PAGE loading dye in the same 96-well PCR block as the crude cell lysate 
samples. PCR block was heated for 5 minutes at 95 oC, sealed with a foil seal to prevent 
evaporation. Using a multichannel pipette, cell lysate and soluble fraction samples were 
loaded into the required number of SDS-PAGE gels and success of expression screen was 
analysed using SDS-PAGE. 
2.6 Protein Purification from E. coli 
2.6.1 Large-scale expression 
Once an expression condition had been shown to be successful using a small-scale 
expression technique, the expression was scaled up to obtain purified protein. A scraping 
of glycerol stock for E. coli transformed with the construct of interest was inoculated into 




overnight (with shaking at 200 rpm) at 30 or 37 oC depending on the strain of E. coli. 20 
ml of overnight culture was then subcultured into 1 L of expression media supplemented 
with appropriate antibiotics. For LB expression media, the culture was then grown for 3-
6 hours until OD600 0.4-0.8. Expression was then induced with 1 mM IPTG or 0.2 % L-
arabinose (depending on E. coli strain) and shaken (200 rpm) at 18 oC for another 16 
hours or overnight. For AIM expression media (auto-induction media) the induction step 
is not necessary. When cells are grown in AIM, they metabolise glucose in preference to 
lactose. When the glucose supplies are exhausted (as cells reach log phase), the cells 
convert lactose to allolactose, release the lac repressor and induce expression of the T7 
RNA polymerase (Studier, 2005). Therefore, when grown in AIM, cultures are shaken at 
30 or 37 oC for around 3-5 hours, until OD600 0.4-0.8, then the temperature is simply 
reduced to 18 oC for a further 16 hours as before. 
Cells were harvested at 5,410 xg for 7 minutes to pellet cells. Cell pellets were then frozen 
at -80 oC until use. 
2.6.2 Purification 
Cell pellets of E. coli containing expressed protein were thawed from -80 oC at room 
temperature. Cells were resuspended in lysis buffer (50 mM Tris-HCl pH 8.0, 500 mM 
NaCl, 20 mM imidazole, 5 % v/v glycerol, 50 mM glycine, 1 protease inhibitor tablet (per 
60 ml buffer) (Roche)), using 60 ml lysis buffer for each cell pellet (derived from 2L 
expression culture). Once homogenous, cells were sonicated on ice using the Vibra-Cell™ 
(Sonics) sonicator, with a single 10-12 mm probe. Sonicator was used at 40 % amplitude, 
with sonication frequency 1 second on followed by 3 seconds off for 4-8 minutes, 
depending on cell density. Lysed cells were then centrifuged at 36,250 xg for 30 minutes 
at 4 oC to pellet insoluble material. Soluble fraction supernatant was poured into a fresh 
tube and placed on ice. If necessary, a sample was taken for SDS-PAGE analysis to confirm 
production of soluble protein. Automated protein purification was carried out using the 
ÄKTAxpress system (GE Healthcare). In this procedure, soluble fraction was first loaded 
onto a nickel-charged 5 ml HisTrap™ HP IMAC column (GE Healthcare) and was washed 
with binding buffer (50 mM Tris-HCl pH 8.0, 500 mM NaCl, 20 mM imidazole, 5 % v/v 
glycerol, 50 mM glycine) to remove any unbound proteins from the column. The His-
tagged protein was then eluted from the Ni-IMAC column in elution buffer (50 mM Tris-
HCl pH 8.0, 500 mM NaCl, 500 mM imidazole, 5 % v/v glycerol, 50 mM glycine) and 
immediately loaded onto a Superdex™ 75 HiLoad™ 26/600 gel filtration column (GE 




preparations, a HEPES-based gel filtration buffer was used (20 mM HEPES pH 7.5, 150 
mM NaCl), but for certain purifications, a phosphate-based gel filtration buffer was used 
(100 mM sodium phosphate pH 7.5, 250 mM NaCl). Protein was flowed through and 
eluted from the gel filtration column in fractions, that were analysed by SDS-PAGE to 
determine which fractions contained the proteins of interest. Purified, tagged protein 
was then pooled and 3C protease enzyme (10 μg per mg of protein) was added.  Protein 
and enzyme were incubated overnight at 4 oC to cleave the His/solubility tag. Untagged 
protein was then separated from its tag by manually loading onto a pre-equilibrated Ni-
IMAC column in binding buffer. Once loaded, Ni-IMAC column was washed with 15 ml 
binding buffer, to wash out untagged protein. Untagged protein of interested was then 
loaded onto the Superdex™ 75 HiLoad™ 26/600 column in the ÄKTAxpress system and 
a further cycle of gel filtration provided further separation from contaminants. Fractions 
containing purified protein were analysed by SDS-PAGE and pooled. Purified protein was 
then concentrated by ultrafiltration using Vivaspin® centrifugal concentrators 
(Sartorius) at 7,500 xg and 4 oC. Vivaspin® concentrators of varying sizes and molecular 
weight cut offs (MWCO) were used, depending on the size of the protein of interest. A 
MWCO would be chosen to be less than half the molecular weight of the protein e.g. a 
protein of 8 kDa in size would be concentrated using a concentrator of 3 kDa MWCO. 
When at an appropriate concentration (depending on intended use) purified protein was 
either used immediately or flash frozen in liquid nitrogen, followed by storage at – 80 oC. 
For smaller scale partial purifications, soluble cell lysate fraction (from a 100 ml 
expression cell culture) would be loaded manually onto a Ni-IMAC column (5 ml 
HisTrap™ HP IMAC column) pre-equilibrated in binding buffer. 25 ml binding buffer 
would then be flowed through the column to wash out any unbound protein. 20-30 ml 
elution buffer was then run through the column to elute tagged proteins. SDS-PAGE 
samples were taken at each stage of the process and analysed to ensure solubility of 
tagged proteins. 
For purifications of AVR-Pia in complex with a partner, a modified purification process 
was used. Both proteins were purified separately, until the stage following tag cleavage. 
When the complex partners were run through the Ni-IMAC column to separate them 
from their tags, both proteins were eluted simultaneously into the same tube, and 




2.6.3 Measuring protein concentration 
For proteins containing aromatic residues, the concentration was measured by 
absorbance at 280 nm using NanoDrop™ ND-1000 or NanoDrop™ One 
Spectrophotometers (Thermo Fisher). Absorbance readings were corrected using the 
calculated extinction coefficient for each protein, calculated using the ExPASy ProtParam 
online tool (Gasteiger et al., 2005). For proteins that contained no or very few aromatic 
residues, protein concentrations were measured using the Direct Detect® Infrared 
Spectrometer (Merck), which relies on the detection of amide bonds rather than a 
specific residue composition. Both these techniques enable rapid quantification of 
protein concentration in a sample, without the need for additional reagents or standard 
curves. When protein concentration was measured for an experiment, the same protein 
concentration measuring technique was used for all proteins in the experiment, to 
ensure consistency. 
2.6.4 Intact mass spectrometry 
Protein intact masses were determined by staff at the JIC Proteomics Platform, using the 
Synapt G2-Si mass spectrometer coupled to an Acquity UPLC system (Waters). Spectra 
were generated and analysed by Dr. Gerhard Saalbach. 
2.7 Analytical Gel Filtration 
Analytical gel filtration was performed at 4 oC by loading 120 μl of the protein of interest 
onto a Superdex™ 75 10/300 GL column (GE Healthcare) that was pre-equilibrated in 
the required gel filtration buffer. Proteins were diluted to 50 or 100 μM concentration in 
gel filtration buffer prior to loading, and a flow rate of 0.5 ml/min was used. For 
experiments assessing complex formation, proteins were mixed in a known ratio 
(dependent on expected oligomerisation state) and incubated on ice for at least 2 hours 
prior to loading on the gel filtration column. A total of 1.5 column volumes was eluted 
from the column (36 ml), 0.5 ml gel filtration fractions were collected, and eluent 
samples were analysed by SDS-PAGE. The Superdex™ 75 10/300 GL column has a void 




2.8 Circular Dichroism 
Circular Dichroism (CD) was performed using a Chirascan™ Plus CD Spectrometer 
(AppliedPhotophysics), which was fully purged of oxygen (using nitrogen gas) prior to 
use. Protein samples were diluted into CD buffer (20 mM potassium phosphate, pH 7.2) 
and used at 0.05-0.2 mg/ml; concentration was adjusted for each individual protein to 
maximise data quality. Generally, a high-tension voltage (HTV) measurement below 600 
V and an absorbance reading of less than 2 AU indicates sufficient quality. Data was 
collected from 180-260 nm, in 0.5 nm steps at 20 oC. Machine background and buffer 
blank runs were performed, and subsequent protein measurements were subtracted 
from the blank run. 4 traces were acquired per sample and averaged to give a final 
dataset. Chirascan™ software was used to convert readings from milidegrees (machine 
units) to mean residue molar ellipticity (MRME), which corrects the measurements to 
account for protein concentration. DichroWeb was used to assign secondary structure 
features (see Chapter 5).  
2.9 Differential Scanning Fluorimetry 
Differential Scanning Fluorimetry (also known as the thermofluor or thermal shift assay) 
is used to assess the stability of proteins, by measuring unfolding at increasing 
temperatures. This technique was used to assess the effect of metal addition to PP1c-3, 
and also for a commercial buffer screen. 
2.9.1 Assessing stability effect of Mn 
In a 50 μl total volume, 5 μg protein, MnCl2 (at 0.5, 1, 2, 4 mM final concentrations) and 
2.5x SYPRO® Orange (Invitrogen) were mixed in A4 buffer, in a white 0.2 ml 96-well PCR 
plate (Thermo Fisher) and sealed with an optical adhesive seal. Plates were spun briefly 
at 500 xg for 1 minute to mix contents and immediately loaded into a CFX96 Q-PCR 
machine (BioRad). Temperature was increased from 20 to 95 oC in 0.2 oC increments, and 
fluorescence intensity measurements were taken at each step. The melt curve first 
derivatives were calculated by machine software and plotted in Excel. Melting 




2.9.2 Screening buffer conditions 
The MD1-96 RUBIC Buffer Screen (Molecular Dimensions) was carried out according to 
the kit protocol, and DSF was carried out in the CFX96 Q-PCR machine (BioRad). Melt 
curves were plotted in Excel and examined visually to assess the buffer conditions that 
conferred the greatest increase in Tm. 
2.10 Surface Plasmon Resonance 
Protein-protein interactions were measured by SPR (surface plasmon resonance) using 
the Biacore T200 system (GE Healthcare). All experiments were run at 25 oC analysis 
temperature, in SPR running buffer (20 mM HEPES pH 7.5, 860 mM NaCl, 0.1 % Tween®-
20). 30 μl of the his-tagged effectors were immobilised onto a NTA sensor chip (GE 
Healthcare) which was activated with 30 μl of 0.5 mM NiCl2. Concentrations of 
immobilised effector were adjusted in each case to give a response of 250 RU ± 30 upon 
loading. For Rmax experiments, HMA was flowed over the immobilised effector at a flow 
rate of 30 μl/min, at 4, 40 and 100 nM concentrations. HMA was flowed over both the 
sample cell and the reference cell (a separate flow cell that did not have nickel or effector 
immobilised on the chip) for 360 sec contact time and 180 sec dissociation time. After 
HMA dissociation, 30 μl of 350 mM ethylenediaminetetraacetic acid (EDTA), pH 8.0 was 
flowed over both sample and reference flow cells to regenerate the chip. Following the 
regeneration step, SPR buffer was flowed over for 30 sec (15 μl) to remove any EDTA 
from the system prior to the next nickel loading. For experiments to determine the 
equilibrium dissociation constant, a greater range of HMA concentrations were used, and 
HMA was flowed over the sample and reference cells at 60 μl/min, for 350 sec contact 
time and 180 sec dissociation time. Chip was regenerated as before. Reference cell 
response units were subtracted for each measurement. Response for a buffer blank run 
(no HMA) was also subtracted from each measurement prior to analysis. For Rmax 
measurements, raw data was exported from machine software, and Rmax was calculated 
and plotted using Microsoft Excel. For kinetics data, the KD was determined from the 
multicycle kinetics curves using the Biacore machine software, with a fit model allocated 




2.11 Phosphatase Enzyme Assays 
2.11.1 pNPP substrate 
Protocol for phosphatase assay using p-nitrophenyl phosphate (pNPP) as substrate was 
adapted from Kelker et al. (Kelker et al., 2009). In an assay volume of 25 μl, phosphatase 
enzymes at a final concentration of 0.4 μM were mixed with pNPP substrate at final 
concentrations of 0.5, 1, 2, 4 and 8 mM. The pNPP substrate (NEB) had been made up as 
appropriate stock solutions in 150 mM Bis-Tris pH 6.5, 150 mM NaCl. The phosphatase 
assay buffer (used to dilute the enzymes and make up final volume in assay) consisted of 
50 mM Tris pH 8.0, 5 mM imidazole, 700 mM NaCl, 1 mM MnCl2. pNPP was added to start 
the reaction, and the substrate and enzyme were incubated for 15 minutes at room 
temperature. 25 μl 1 M NaOH was added to quench the reaction, and the absorbance at 
405 nm was measured immediately using the CLARIOstar® plate reader (BMG Labtech). 
Samples were tested in triplicate, and buffer blank samples were run for each pNPP 
concentration. For this assay, a commercially available phosphatase enzyme was used as 
a positive control. This enzyme was recombinant human PPP1A, expressed from E. coli 
as a full-length enzyme with an N-terminal His tag (Abcam, ab113150). Raw data i.e. 
absorbance vs. substrate concentration was plotted in Excel. 
2.11.2 Commercial peptide substrate 
An alternative method to assess phosphatase enzyme activity is to detect levels of free 
phosphate using malachite green. This was carried out using the Ser/Thr Phosphatase 
Assay Kit 1 (Merck) as described in the kit protocol, with some modifications. The 
reaction volume used was 5 μl, and was quenched with 20 μl malachite green. The final 
enzyme concentration used in the assay was 0.4 μM. The assay buffer used was standard 
gel filtration buffer (20 mM HEPES pH 7.5, 150 mM NaCl). Reactions were incubated for 
10 minutes before being quenched. Following quenching and colour development, 
absorbance at 620 nm was measured in the CLARIOstar® plate reader (BMG Labtech). 
Samples were tested in triplicate, and the assay was repeated three times. Raw data i.e. 





2.12.1 Commercial crystallisation screens 
For crystallisation, freshly purified protein was concentrated to above 5 mg/ml (up to 
20 mg/ml) and either flash frozen and stored at -80 oC, or used immediately. Prior to 
crystallography, any precipitate or dust contamination was pelleted by centrifugation at 
17,300 xg, 4 oC for 15 minutes. Supernatant soluble protein was transferred to a fresh 
tube. 
A number of commercial crystallisation screens are available, containing a wide range of 
different buffer compositions, salts and additives. For this project, the Morpheus® 
(Molecular Dimensions), PACT premier™ (Molecular Dimensions), JCSG-plus™ 
(Molecular Dimensions), Structure (Molecular Dimensions), BCS (Molecular 
Dimensions), ProPlex™ (Molecular Dimensions), PGA™ (Molecular Dimensions), 
MIDAS™ (Molecular Dimensions), PEGs suite (Qiagen), AmSO4 suite (Qiagen) commercial 
screens were used. In addition, a custom screen designed by the PX platform at JIC (Clare 
Stevenson and Dave Lawson) was used – known as the KISS screen. 
Crystallisation screens were set up as sitting drop vapour diffusion experiments. 40 μl of 
screen solution was transferred to a MRC 2 Well Crystallisation Plate (Swissci) using the 
Rainin Liquidator™ 96 pipetting system (Mettler Toledo) to aliquot all 96 wells 
simultaneously. Sitting drops were composed of 0.3 μl purified protein with 0.3 μl 
reservoir solution, and drops were dispensed using the Oryx Nano or Oryx8 
crystallisation robots (Douglas Instruments). In certain cases, where protein 
precipitated when aliquoted using the robot, only the reservoir solution was dispensed 
by the robot (0.5 μl) and 0.5 μl purified protein was added to the sitting drop by manual 
pipetting. Crystallisation plates were sealed immediately, and experiments were 
incubated at 20 oC. To monitor crystal formation, plates were imaged at regular intervals 
with the Minstrel Crystallisation Imager (Rigaku), which automatically takes images 
under visible and UV light at specified timepoints.  
2.12.2 Data collection 
Crystals of the AVR-Pia/Pikp-HMA complex were fished by Clare Stevenson from the 
Morpheus® screen. The Morpheus® screen contains cryoprotectant conditions within 
the screen composition, meaning that crystals obtained from this screen do not need to 




minimise crystal damage due to the formation of ice when the crystal is cooled (Garman 
& Owen, 2006). Crystals were frozen immediately in liquid nitrogen, and shipped to the 
Diamond Light Source synchrotron in Oxfordshire, where X-ray diffraction experiments 
were performed. Data was collected remotely on beamline DLS-i03. The dataset was 
collected at a wavelength of 0.9763 Å. 
2.12.3 Data processing 
Crystallographic data was processed using the Xia2 pipeline (Winter, 2010) and 
AIMLESS (Evans & Murshudov, 2013), as implemented in the CCP4 software suite (Winn 
et al., 2011). 
2.12.4 Molecular replacement 
For this project, the calculated electron density was interpreted by using molecular 
replacement to solve the crystallographic phase problem. This was a suitable solution in 
this case because both partners of the complex (AVR-Pia and Pikp-HMA) had already 
been structurally characterised elsewhere. The structure of AVR-Pia had been solved by 
NMR spectroscopy (PDB file 2MYW) and the structure of Pikp-HMA had been solved by 
X-ray crystallography (PDB file 5A6P). A single model from the ensemble of AVR-Pia and 
a monomer structure of Pikp-HMA were used for molecular replacement using PHASER 
(McCoy et al., 2007). 
2.12.5 Structure refinement 
Following molecular replacement, a refinement process was required to improve the fit 
between the model and the experimental data. COOT (Emsley et al., 2010) was used to 
visualise the model and experimentally-derived electron density, and manual rebuilding 
was carried out to generate a good fit. Water molecules were also added into appropriate 
regions of electron density. Successive rounds of manual rebuilding were followed by 
rounds of refinement using REFMAC5 (Murshudov et al., 2011), until the model and 
observed data were in close agreement, as assessed by R/Rfree values. Structure was 
validated using tools provided in COOT, and finally assessed by MolProbity (Chen et al., 
2010). Finalised structures were visualised in the CCP4 molecular graphics program 




2.13 Transient Expression in N. benthamiana 
2.13.1 Preparation of A. tumefaciens 
Following transformation of A. tumefaciens GV3.101 with the constructs of interest, 
glycerol stocks were made as described previously and stored at -80 oC. Glycerol stocks 
were then used to grow up bacterial cultures for infiltration. Two different methods were 
used for growing up the bacteria, but within each experiment only one method was used 
to grow up all bacteria, to ensure consistency. 
Method 1: A small amount of glycerol stock was transferred, with a pipette tip, into LB 
media (10 ml in a screw-top glass Universal) containing rifampicin, gentamycin and the 
appropriate antibiotic for the transformed plasmid (generally carbenicillin for Golden 
Gate level 1 constructs, kanamycin for P19). 10 ml cultures were set up for each 
construct, and were shaken at 28 oC and 180 rpm for approximately 40-48 hours. Each 
culture was then harvested by centrifugation at 3,400 xg for 20 minutes, or until cells 
had formed a pellet. The cell pellet was then resuspended in infiltration buffer (see 
below). 
Method 2: 20 μl glycerol stock (thawed) was spread evenly over a LB agar plate 
containing rifampicin, gentamycin and the appropriate antibiotic for the transformed 
plasmid. Plates were then incubated at 28 oC for 40-48 hours. A sterile plastic loop was 
used to scrape cells from the surface of the agar plate and resuspend them in infiltration 
buffer (see below). 
Following growth of agrobacterium cultures, cells were resuspended in infiltration 
buffer (10 mM MES, pH 5.6, 10 mM MgCl2, 150 mM acetosyringone) to give a 
concentrated solution of cells. The OD600 of a 40x dilution of this cell solution was 
measured and recorded. The OD600 measurement was then used to dilute cells in 
infiltration buffer to give stock solutions of known densities. These were then mixed in 
appropriate ratios for the experiment. For each infiltration site, the components were: 
NLR proteins (at OD600 0.4 final concentration), effectors (at OD600 0.6 final concentration 
and P19 (at OD600 0.1 final concentration). Once cells were resuspended in infiltration 
buffer, they were incubated at room temperature for 2-5 hours prior to infiltration. 
2.13.2 Growth of plants 
Nicotiana benthamiana for cell death assays were grown in controlled environment 




Plants that were infiltrated for protein extraction and immunoprecipitation only were 
grown in glasshouses with similar conditions. Plants were infiltrated at four weeks old. 
2.13.3 Infiltration 
For each Nicotiana benthamiana plant, the two youngest leaves of a usable size were 
infiltrated. A blunt syringe was used to infiltrate bacterial solution into the abaxial 
surface of the leaf. 
2.14 N. benthamiana Cell Death Assays 
2.14.1 Scoring cell death assays 
Cell death assays were carried out by infiltrating different combinations of NLRs and 
effectors (and P19) in spots on each leaf. The position of each spot was rotated around 
the leaf, to account for variation in different areas. Following infiltration, plants were left 
in the same controlled environment conditions for 5 days. 5 dpi, infiltrated leaves were 
harvested from the plant and photographed under UV and daylight. Photographs were 
then used to assign cell death scores from 0 to 6, using the developed scoring system 
(Maqbool et al., 2015). Scores for three independent repeats were displayed as box and 
whisker plots, generated using R (Team, 2008) and graphics package ggplot2 (Wickham, 
2016). 
2.14.2 Confirming protein expression 
Following photography of leaves, 3x 1 cm leaf discs were taken for each sample from the 
set of infiltrated leaves (leaves were chosen at random). These leaf discs were flash 
frozen in liquid nitrogen and ground up using a pre-chilled micropestle. 300 μl plant 
protein extraction buffer was added to the ground leaf tissue. Extraction buffer is made 
from GTEN (25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 10 % v/v glycerol) and 
supplemented with 10 mM DTT, 2 % w/v PVPP, 0.1 % Tween®-20, 1x plant protease 
inhibitor cocktail (Sigma). Leaf tissue was then pelleted by centrifugation at 20,000 xg, 4 
oC for 5 minutes. Supernatant was transferred to a fresh pre-chilled Eppendorf tube and 
centrifuged for a further 2 minutes. 20 μl of clarified supernatant (soluble protein 
extract) was mixed with 8 μl SDS-PAGE loading dye, and used for SDS-PAGE and 





2.15 Co-immunoprecipitation  
For co-immunoprecipitation (co-IP) analysis, whole-leaf infiltrations were carried out 
using the same constructs as for cell death assays, but without expression of Pikp-2, to 
prevent cell death in the tissue. 4 dpi, whole leaves were harvested from the plants with 
removal of leaf midrib. 3 leaves for each sample were combined and flash frozen in liquid 
nitrogen. Tissue was then ground up in liquid nitrogen in a pre-chilled pestle and mortar, 
before being resuspended in 2x tissue weight of ice-cold plant protein extraction buffer. 
Tissue was fully resuspended in the buffer by vortexing. All subsequent steps were 
carried out at 4 oC with pre-chilled equipment and consumables. Samples were 
centrifuged at 4,200 xg for 30 minutes, and supernatant was decanted and filtered using 
a 0.45 μm Minisart® syringe filter. 20 μl of this soluble protein extract (co-IP input) was 
taken and mixed with 8 μl SDS-PAGE loading dye. 
1 ml of soluble plant protein extract was then mixed with 20 μl of α-FLAG® M2 magnetic 
beads (Sigma), which had been equilibrated in IP buffer (GTEN + 0.1 % Tween®-20) by 
washing 4 times, and turned end-over-end for 60-90 minutes at 4 oC. Using a magnetic 
rack to separate beads and liquid, the supernatant was discarded, and magnetic beads 
were washed 5 times with ice-cold IP buffer. Bound protein was then eluted from the 
magnetic beads by adding 30 μl SDS-PAGE loading dye and heating at 70 oC for 10 
minutes. Dye was then separated from magnetic beads before loading onto a gel, along 
with the co-IP input samples. 
2.16 Western Blotting 
Following SDS-PAGE of plant protein extract (either for expression testing or co-IP), 
Western blots were carried out to visualise the proteins. Gels were transferred using the 
Trans-Blot® Turbo™ Transfer System (Bio-Rad) to a PVDF (polyvinylidene difluoride) 
membrane, according to the manufacturers protocol, using the ‘High molecular weight’ 
programme. Membranes were then blocked in 20 ml TBS-T (50 mM Tris-HCl, pH 8.0, 150 
mM NaCl, 0.1 % Tween®-20) supplemented with 5 % w/v dried milk powder for at least 
60 minutes at 4 oC with gentle agitation. Following blocking, membranes were incubated 
in TBS-T + 5 % w/v dried milk + 1o antibody overnight at 4 oC with gentle agitation. 
Antibody solution was removed, and the membrane was washed 3 times in TBS-T, with 
20 minutes incubation in TBS-T following each wash. To visualise the blots, excess liquid 




mixed and immediately applied to the membrane to provide a thin coverage. 
Chemiluminescence was detected using the ImageQuant LAS 500 spectrophotometer 
(GE Healthcare). 
Following membrane visualisation, Western blot was stripped by covering with a thin 
layer (approximately 15 ml) of Restore™ Western Blot Stripping Buffer (Thermo Fisher) 
and incubating with gentle rocking at room temperature for at least 60 minutes. 
Membranes were then washed 3 times with TBS-T and blocked again for further addition 
of antibody.  
Following application and visualisation of all antibodies, staining of total protein for each 
blot was achieved by incubation of each membrane with 15 ml Ponceau S stain (0.1 % 
w/v Ponceau S in 5 % v/v acetic acid). Excess background staining was then washed off 
with dH20, and membranes were imaged by scanning using a generic document scanner.  
In this project, the following antibodies are used for Western blot analysis. All are 
primary, HRP (horse radish peroxidase) conjugated antibodies. 
Antibody Supplier Dilution Used 
α-FLAG HRP Generon 1:5000 
α-Myc HRP Santa Cruz Biotechnologies 1:1000 






3. Cross-reactivity in 
the Pik/Pia systems 
Investigating the cross-reactivity of Pik integrated 







Integrated domains in NLRs can take many forms, and this chapter will focus on a pair of 
NLR proteins, Pik-1/Pik-2 (Zhai et al., 2011), that contain an integrated heavy metal-
associated domain between the coiled-coil (CC) and nucleotide-binding (NB-ARC) 
domains of Pik-1. As discussed for the integrated domain hypothesis, this suggests that 
an HMA domain-containing protein might have been the target of a pathogen effector. 
Functional HMA domain proteins contain a C-x-x-C motif (where C is cysteine and x is 
any amino acid) that is able to coordinate heavy metals (Abreu-Neto et al., 2013) and 
such metal-binding proteins are important in all organisms, including plants. The rice 
protein Pi21, which contains a heavy metal-associated domain, is known to be a 
susceptibility factor for M. oryzae, suggesting that these types of proteins are involved in 
immunity, and could be possible effector targets (Fukuoka et al., 2009). However, no 
specific examples of host HMA domain-containing effector targets have yet been 
published. In a recent transcriptome profiling study, it was found that four genes 
encoding proteins containing HMA domains were expressed at higher levels in Pi21-
silenced rice lines compared to wild-type Nipponbare, when the plants were treated with 
M. oryzae. This could suggest that these HMA domain-containing proteins play a role in 
the resistance to M. oryzae that is mediated by the loss-of-function of Pi21 (Zhang et al., 
2016). Aside from this involvement of Pi21 in rice immunity, metals and metal transport 
are known to be important in other plant defences, including iron redistribution in the 
response of wheat to Blumeria graminis f. sp. tritici (Liu et al., 2007). 
The Pik locus is found on the long arm of rice chromosome 11 (Zhai et al., 2011) and 
comprises seven different Pik alleles (Ariya-anandech et al., 2018). The Pik-1/Pik-2 NLRs 
are genetically linked in a head-to-head orientation and share a common promoter 
(figure 3.1-1). Pik-1 functions as the ‘sensor’ NLR that recognises its cognate effector via 
the integrated domain, while Pik-2 is the helper NLR that assists in mediating signalling 
(de la Concepcion et al., 2018). 
The M. oryzae effector recognised by the Pik pair of NLRs is AVR-Pik (Yoshida et al., 
2009). It has been shown that direct interaction occurs between the Pik HMA domain 
and AVR-Pik and that this is required for triggering an immune response to the effector 
(Maqbool et al., 2015). Both the Pik NLRs and AVR-Pik effectors are found as allelic series 




highly polymorphic and are used to readily distinguish the different alleles; it is likely 
that these different alleles evolved as part of the arms race between rice and the fungal 
pathogen (Kanzaki et al., 2012). Details of these different alleles have been discussed 
elsewhere (de la Concepcion et al., 2018; Maqbool et al., 2015) but for this project, only 
two alleles of the Pik NLRs and two alleles of AVR-Pik effectors will be discussed. These 
are the Pikp and Pikm NLR alleles and AVR-PikD and AVR-PikC effector alleles. 
 
The Pikp pair (Yuan et al., 2011) and Pikm pair (Ashikawa et al., 2008) show the greatest 
pairwise sequence variation within the large Pik-1 family (Costanzo & Jia, 2010). This 
variation is largely due to the highly polymorphic HMA domain between the two alleles 
(62 % sequence identity) (de la Concepcion et al., 2018). While the other domains within 
the two Pik-1 proteins are very similar (96-100 % protein sequence identity 
throughout), the HMA domains of the different Pik alleles differ considerably. For 
illustrative purposes, an alignment of Pikp-HMA and Pikm-HMA is shown in figure 3.1-2. 
 
Pikp and Pikm have different recognition specificities for different AVR-Pik alleles; Pikp 
is only able to recognise AVR-PikD, whereas Pikm can recognise AVR-PikD and other 
additional AVR-Pik alleles. It has therefore been proposed that the Pikp/AVR-PikD 
interaction is older in terms of evolutionary time, and that this recognition has 
subsequently been broken by other AVR-Pik effectors. This would lead to the 
development of other Pik NLRs, such as Pikm, in accordance with the plant/pathogen 
arms race. Different rice accessions studied have shown that the different Pik alleles are 
present at different frequencies across the species, and more accessions appear to 
contain Pikp than Pikm (Kanzaki et al., 2012). One AVR-Pik effector allele that is 
currently unrecognised by any Pik NLR is AVR-PikC, and this allele will act as a negative 
Figure 3.1-2: Sequence alignment of Pikp and Pikm HMA domains. 
Sequence alignment of Pikp-HMA and Pikm-HMA amino acid sequence. Shaded residues indicate 
the two well-characterised and highly polymorphic sites in the Pik-1 family.   
Figure 3.1-1: Gene schematic of Pik-1 and Pik-2. 
Diagram showing the orientation of Pik-1 and Pik-2 at the Pik locus, 





control in several experiments described in the following chapter. AVR-PikD will 
function as a positive control as it is recognised by both Pikp and Pikm. 
Another pair of rice NLRs that contain a heavy metal-associated domain is the 
RGA5/RGA4 pair. RGA5/RGA4 NLRs are able to respond to the M. oryzae effectors AVR-
Pia (Okuyama et al., 2011) and AVR1-CO39 (Cesari et al., 2013). The HMA domain is 
found in the C-terminus of RGA5, and is known as RATX1, meaning ‘related to ATX1’ 
where ATX1 is a known copper-binding protein (Cesari et al., 2013). Both AVR-Pia and 
AVR1-CO39 have been shown to physically interact with the RATX1 domain (which will 
be called the RGA5-HMA domain in this project for consistency and clarity). Cesari et al. 
showed that physical interaction of AVR-Pia was required for triggering resistance by 
studying AVR-Pia variants with two nonsynonymous polymorphisms, which prevented 
an interaction with RGA5-HMA and also prevented pathogen recognition (Cesari et al., 
2013). Ortiz et al. used NMR titration and yeast two-hybrid experiments to identify a 
candidate interaction surface between AVR-Pia and the RGA5-HMA domain. The authors 
also found that AVR-Pia could interact with other regions of RGA5 outside of the HMA 
domain, but that interaction with RGA5-HMA was required for activation of immunity 
(Ortiz et al., 2017). 
Despite the similarities between the RGA5/RGA4 and Pik-1/Pik-2 systems, it appears 
that the mechanisms of activation are very different between the two pairs of NLRs. 
While Pik-1/Pik-2 appear to use a cooperative mechanism, where the recognition of 
effector causes a positive change that allows signalling to occur via Pik-2, the 
RGA5/RGA4 pair appears to function via negative regulation, where recognition of the 
effector through RGA5-HMA derepresses signalling through RGA4, meaning that RGA4 is 
constitutively active unless repressed by RGA5 in the absence of effector (Bialas et al., 
2018; Cesari, Kanzaki, et al., 2014). However, the details of the NLR interactions and the 
resultant downstream signalling effects remain to be understood. 
As discussed previously, AVR-Pia and AVR-PikD are both members of the MAX effector 
family and share a common structural fold. The crystal structure of AVR-PikD (de la 
Concepcion et al., 2018; Maqbool et al., 2015) and the solution structure of AVR-Pia (de 
Guillen et al., 2015; Ose et al., 2015) show the similarities between these effectors. 
However, the structure of AVR-Pia has so far only been published in isolation, whereas 
AVR-PikD has been structurally characterised in complex with the HMA domain of both 
Pikp-1 and Pikm-1. In fact, recent research has shed light on the interactions of the AVR-
Pik effectors and Pik-HMA domains in some detail. In 2015, the first crystal structure of 




structure comprising a four-stranded antiparallel β-sheet and two α-helices, and its 
overall structure does not change when a complex is formed with AVR-PikD. The HMA 
domain cysteines required for metal coordination are not conserved in Pikp-HMA, so no 
metal is bound in the structure (Maqbool et al., 2015). When AVR-PikD and Pikp-HMA 
form a complex, hydrogen bonding between β-strands leads to the formation of a 
continuous β-sheet throughout the global complex structure. A second site of interaction 
involves Asp224 from Pikp-HMA, which forms salt bridge and hydrogen bonding 
interactions with AVR-PikD β-2. The final major site of interaction between Pikp-HMA 
and AVR-PikD is formed by the N-terminal extension of AVR-PikD, which protrudes out 
from the core β-sandwich structure of the effector and partially wraps around Pikp-HMA. 
Of particular importance within this region is the AVR-PikD residue His46, which forms 
interactions with Ser218, Glu230 and Val232 from Pikp-HMA (Maqbool et al., 2015). 
His46 is one of the polymorphic residues that distinguishes AVR-PikD from the other 
AVR-Pik effector alleles (Kanzaki et al., 2012). It was found that mutation of this histidine 
residue to a glutamate (which disrupts the interaction through incorporation of a large, 
charged residue) abolishes both AVR-PikD/Pikp-HMA binding in a yeast two-hybrid 
assay and recognition of the effector in planta. For this reason, the AVR-PikDH46E mutant 
has become an established negative control that is used extensively in this project. One 
observation of note is that the Glu230 residue from Pikp-HMA, which is important in 
forming a hydrogen bond with AVR-PikDH46, is replaced by a valine in Pikm, which results 
in loss of this hydrogen bond formation. The His46 residue therefore becomes less 
crucial in the AVR-PikD/Pikm-HMA interaction, and when the same AVR-PikDH46E 
mutant is tested against Pikm, an interaction in yeast two-hybrid screens is observed, 
and a weak cell death response is seen in planta (de la Concepcion et al., 2018). 
Other structures of Pik-HMA domains in complex with effectors have been solved and 
shown to have a similar conformation (de la Concepcion et al., 2018). One point of note 
is that a new construct of Pik-HMA (both Pikp and Pikm) has been made that contains an 
extension of five residues at the C-terminus compared with the previously published 
structure of AVR-PikD/Pikp-HMA in Maqbool et al. (Maqbool et al., 2015). This construct 
was made for reasons of improved stability in vitro and is used throughout this project. 
Finally, the work carried out thus far on the Pik-HMA domains has shown that, in 
solution, Pikp-HMA exists as a dimer (whether in isolation or in complex with AVR-PikD) 
whereas Pikm-HMA behaves as a monomer (de la Concepcion et al., 2018; Maqbool et al., 
2015). The authors of these studies have proposed that the dimer formation of Pikp-HMA 




The research described so far has demonstrated that there is extensive precedent for 
studying these NLR pairs with integrated HMA domains. Despite containing the same 
type of integrated domain, the mechanism of activation appears to differ significantly for 
RGA5/RGA4 and Pik-1/Pik-2. A comparison of the two systems is shown in figure 3.1-3, 
indicating the overall global domain structures and sequence similarity. A number of 
tools have been produced for structural and biochemical characterisation of these 
proteins, and model systems have been developed for understanding in planta 
interactions. This project describes the overlap and cross-reactivity of the two systems 
and describes how the effector AVR-Pia can be bound by Pikp-HMA and produce a 
response in planta. 
 
3.2 Pikp responds to AVR-Pia in planta 
3.2.1 In rice 
The trigger for this novel project was an observation made by Professor Hiromasa Saitoh, 
formerly at the Iwate Biotechnology Research Center, and now at the Tokyo University 
of Agriculture in Japan. During punch-inoculations of different rice cultivars, he observed 
consistent, partial resistance of cv. K60 (containing Pikp-1/Pikp-2) to M. oryzae Sasa2 
expressing AVR-Pia (figure 3.2-1). The same effect was not present in cv. Tsuyuake 
(containing Pikm-1/Pikm-2), suggesting that the effect was specific for the Pikp allele. 
One example of the results is shown in figure 3.2-1, which also suggests that the cross-
Figure 3.1-3: Comparison of the Pikp-1/Pikp-2 and RGA5/RGA4 systems. 
Diagram showing a comparison between the domain architecture of Pikp-1/Pikp-2 and 
RGA5/RGA4. Domains are labelled individually, where CC = coiled coil, NB-ARC = nucleotide 
binding domain, LRR = leucine-rich repeat and HMA = heavy metal-associated. Dashed 
arrows show the percentage amino acid sequence similarity between the two domains or 
proteins indicated by the arrow. A comparison of the global structure of AVR-PikD and AVR-
Pia is shown, indicating the N-terminal extension as the main structural difference between 
the effectors. Note that only the effector domain is indicated, the signal peptide is not 




reactivity does not occur in reverse, i.e. rice cultivars containing RGA5/RGA4 pair of 
NLRs (cv. Sasanishiki) do not respond to M. oryzae strains expressing AVR-PikD. 
 
3.2.2 In N. benthamiana 
Following these observations in rice, I took up the project, and first investigated whether 
the effects could be also seen in the model system Nicotiana benthamiana. In the Banfield 
lab (and others), there is precedent for using the N. benthamiana system as a simple and 
efficient model to investigate the responses of NLRs to different AVR proteins, rather 
than using the host plant and pathogen. Good correlation has been shown between the 
rice host and N. benthamiana model for the Pik/AVR-Pik system (Maqbool et al., 2015). 
In this model system, Agrobacterium tumefaciens containing genes of interest are 
infiltrated into N. benthamiana leaves, leading to transient in planta expression of the 
genes encoded – this process is known as agroinfiltration. 
Figure 3.2-1: Pikp confers partial resistance to M. oryzae expressing AVR-Pia. 
Images of sample results from rice inoculation assays by H. Saitoh. M. oryzae Sasa2 
strains expressing either no effectors (WT), AVR-PikD or AVR-Pia were punch-
inoculated onto rice cultivars containing either Pikp-1/Pikp-2 (cv. K60), Pikm-1/Pikm-
2 (cv. Tsuyuake) or RGA5/RGA4 (cv. Sasanishiki). Leaf samples were taken and 
photographed 10 dpi. R = resistant phenotype, S = susceptible phenotype, IM = 





Firstly, Pikp-1 and Pikp-2 were transiently expressed, along with either AVR-PikD, AVR-
PikDH46E or AVR-Pia. After 5 days (5dpi), there were visible signs of necrotic tissue at the 
infiltration site for Pikp-1/Pikp-2/AVR-PikD. When viewed under UV light (figure 3.2-2), 
there was auto-fluorescence seen due to the accumulation of phenolic compounds, 
characteristic of the hypersensitive cell death response (Kim et al., 2003). This indicates 
that the Pikp NLRs are able to trigger an immune response to AVR-PikD. This Pikp-
1/Pikp-2 response to AVR-PikD has been observed numerous times (Maqbool et al., 
2015) and acts as the positive control for this, and other, experiments in the project. 
Conversely, the AVR-PikDH46E mutant acts as a negative control, as the Pik NLRs are 
unable to respond to this mutant (as detailed in section 3.1), and therefore no HR-like 
cell death is visible at the infiltration site. 
For the test sample (Pikp-1/Pikp-2/AVR-Pia), there appears to be a slight yellowing of 
the tissue at the infiltration site, and a weak fluorescence under UV light (figure 3.2-2). 
This indicates that there could be a weak immune response triggered by the Pikp NLRs 
to AVR-Pia, correlating with the observations seen in rice. This assay was repeated 70 
times over three biological repeats to confirm the observation. Each repeat was then 
scored visually using a simple 0-6 HR index scale ((Maqbool et al., 2015) and shown in 
figure 3.2-2) and the scores were assembled in a box plot (figure 3.2-2). To confirm that 
each protein was correctly expressed within the leaf, protein was extracted from leaf 
tissue samples taken from the infiltration sites and Western blot analysis was used to 
confirm protein accumulation. Figure 3.2-2 shows that each protein was expressed, 
although the amount of each protein in the Pikp-1/Pikp-2/AVR-PikD sample appears 
lower than the others (as indicated in the Ponceau image for total loading). This is likely 
because the stronger immune response in this sample leads to greater cell death and 
hence lower total protein accumulation in these samples. This effect was consistently 
seen in all three biological repeats (one representative blot is shown in figure 3.2-2) and 




Pikp NLRs can respond to AVR-Pia, although the response is considerably weaker than 
the response to their ‘matched’ effector AVR-PikD. 
Figure 3.2-2: Pikp shows partial cell death response to AVR-Pia in the N. benthamiana 
model system. 
A) Scale used for visual scoring of HR-like cell death from 0 to 6 (taken from (Maqbool et al., 
2015)) used throughout this work. B) Representative leaf images taken under UV and daylight 5 
dpi showing cell death progression at infiltration sites. C) Box plot showing cell death scores for 
70 technical repeats over 3 biological repeats scored at 5dpi, with all samples shown as dots and 
outliers indicated by ‘x’. For each box, the centre line shows the median score and the edges of 
the box show the upper and lower quartiles. D) Western blot showing the expression of proteins 




To further confirm that the observations made in rice correlate with those in the model 
N. benthamiana system, the assay was repeated with expression of Pikm-1 and Pikm-2 
with AVR-PikD, AVR-PikDH46E and AVR-Pia. Despite confirmed expression of all proteins 
in the leaf tissue, the Pikm NLRs were unable to respond to AVR-Pia in planta (figure 3.2-
3). There is, in fact, a weak response to the AVR-PikDH46E negative control, as previously 
observed, due to differences in the AVR-PikD His46 interface with Pikm-HMA compared 
with Pikp-HMA (de la Concepcion et al., 2018). Overall, this result is in agreement with 
the rice assays, suggesting that the weak immune response to AVR-Pia is specific for the 
Pikp allele. 
 
Figure 3.2-3: Pikm does not respond to AVR-Pia in the N. benthamiana model system. 
A) Representative leaf images taken under UV and daylight 5 dpi showing cell death progression 
at infiltration sites. B) Box plot showing cell death scores for 70 technical repeats over 3 biological 
repeats scored at 5dpi, with all samples shown as dots and outliers indicated by ‘x’. For each box, 
the centre line shows the median score and the edges of the box show the upper and lower 
quartiles. C) Western blot showing the expression of proteins at the infiltration sites. Blot shown 




3.3 Pikp can interact directly with AVR-Pia 
3.3.1 in vitro 
3.3.1.1 Purification of AVR-Pia 
In previous biochemical and structural studies of the Pik/AVR-Pik system, the AVR-Pik 
effectors and the HMA domain of Pik-1 have been expressed using E. coli as a 
heterologous expression system. The isolated Pik-HMA domain is used because of well-
documented issues with expressing and purifying full-length NLR proteins from E. coli 
for in vitro study (Askari et al., 2012). It has previously been shown that Pikp-HMA is 
able to directly interact with AVR-PikD in vitro but not with the AVR-PikC allele (de la 
Concepcion et al., 2018; Maqbool et al., 2015). 
AVR-Pia was previously unstudied within the group (although the protein has been 
heterologously expressed elsewhere (e.g. (de Guillen et al., 2015)) but was readily 
purified from E. coli SHuffle cells, following methods developed for AVR-Pik proteins 
(Maqbool et al., 2015). It should be noted that as with other similar effectors studied in 
vitro, only the effector domain of AVR-Pia was used, and the expressed construct did not 
contain the N-terminal signal peptide, which comprises residues 1-19 of the full-length 
protein (Maqbool et al., 2015). The protein purification procedure involved a 
straightforward two-step IMAC/GF purification from cell lysate, followed by cleavage of 
a His-SUMO solubility tag and a final gel filtration step for purity. Untagged AVR-Pia 
eluted as a single monodisperse peak from the gel filtration column (figure 3.3-1); the 
small irregularity on the trace is due to a pause and restart step in the gel filtration stage, 
which is necessary for changing the fractionation plate. AVR-Pia appears to show a 
smearing pattern when analysed by SDS-PAGE (figure 3.3-1), even when an increased 
concentration of reducing agent (DTT) was added to the SDS loading dye (result not 
shown). The smearing results in the appearance of an apparent additional band on the 
gel, but no additional protein is seen at this molecular weight. This appearance was 
maintained throughout, whenever AVR-Pia purified from E. coli was analysed by SDS-
PAGE. However, despite the unclear SDS-PAGE analysis, intact mass spectrometry 
confirmed a single, full-length, species at 7534.2 Da. The expected mass for AVR-Pia is 
7536.6 Da, and the reduction of 2 Da in the actual measured mass indicates the formation 
of a disulphide bond, as would be expected for effectors containing the MAX fold (de 





3.3.1.2 In vitro interactions 
Following successful purification of AVR-Pia, interactions with Pikp-HMA and Pikm-HMA 
were assessed using both a qualitative and quantitative method. Analytical gel filtration 
is a size exclusion chromatography technique where proteins are flowed through a resin 
containing pores of different sizes. Larger particles cannot enter the pores and therefore 
elute from the column earlier, whereas smaller particles (smaller proteins in this case) 
can enter the pores, so their passage through the resin is slowed. The elution volume of 
the proteins can be detected by their absorbance at 280 nm. If two individual proteins 
are mixed and are able to form a complex, their cumulative size will lead to an earlier 
elution from the resin – seen as a peak shift to the left on the trace. When AVR-Pia and 
Pikp-HMA are mixed, there is a distinct shift, as AVR-Pia alone elutes at 15.0 ml, but when 
mixed with Pikp-HMA, a new peak is seen at 12.3 ml (figure 3.3-2A). SDS-PAGE confirms 
that both proteins can be seen under this peak. Note that Pikp-HMA absorbs poorly at 
280nm, but SDS-PAGE analysis of fractions suggests elution volume is around 12.8 ml. 
By contrast, when AVR-Pia is mixed with Pikm-HMA, no peak shift is seen on the trace 
and SDS-PAGE shows that the proteins are eluting separately (at 13.0 ml for Pikm-HMA 
and 15.4 ml for AVR-Pia) (figure 3.3-2B). 
Figure 3.3-1: Purification of AVR-Pia. 
Following cleavage of SUMO tag by 3C protease, AVR-Pia 
was flowed down a Superdex 75 26/600 gel filtration 
column, and showed a major peak on the trace at 228 ml 
elution volume. Accompanying SDS-PAGE gel shows purified 





To further investigate these binding events, we used surface plasmon resonance (SPR), 
a biophysical technique that measures the change in refractive index when one binding 
partner (the analyte, in this case the HMA protein) is flowed over a chip covered with the 
second immobilised binding partner (the ligand, in this case the effector protein). In 
order to immobilise the effector onto the chip, each effector was purified with a non-
cleavable C-terminal 6xHis tag, which bound to the Ni-NTA chip surface. The output of 
the analyte binding to ligand is shown in a change of response units (RU), and is 
proportional to the molecular mass on the surface of the chip. The maximum binding 
capacity of the chip is known as Rmax, and is dependent on the molecular weight (MW) of 
both the analyte and ligand, the level of ligand immobilisation onto the chip (Rligand) and 
the stoichiometry of the interaction. Once the theoretical Rmax has been calculated, the 
experimental RU value can be expressed as a percentage of Rmax, which gives an 
indication of the strength of binding; if the interaction between the HMA and the effector 
Figure 3.3-2: Qualitative binding analysis for AVR-Pia with Pikp-HMA and Pikm-HMA. 
A) Analytical gel filtration traces showing the elution volume of AVR-Pia alone (grey), Pikp-HMA 
alone (green) and an AVR-Pia/Pikp-HMA mixture (blue). SDS-PAGE analysis shows the fractions 
taken where indicated on the trace. Volumes shown indicate elution volumes. B) Analytical gel 
filtration traces showing the elution volume of AVR-Pia alone (grey), Pikm-HMA alone (green) 
and an AVR-Pia/Pikm-HMA (blue). SDS-PAGE analysis shows the fractions taken where 




is strong, there will be a greater proportion of HMA bound to the immobilised effector. 
𝑅𝑚𝑎𝑥 =  
𝑀𝑊 𝑎𝑛𝑎𝑙𝑦𝑡𝑒 (𝐻𝑀𝐴)
𝑀𝑊 𝑙𝑖𝑔𝑎𝑛𝑑 (𝐴𝑉𝑅)
× 𝑅𝑙𝑖𝑔𝑎𝑛𝑑 × 𝑆𝑡𝑜𝑖𝑐ℎ𝑖𝑜𝑚𝑒𝑡𝑟𝑦  
In the work conducted here, both Pikp-HMA and Pikm-HMA have high affinities for AVR-
PikD, in agreement with previously published work (de la Concepcion et al., 2018). For 
both HMAs, the %Rmax value is near to 80 % at 100 nM (figure 3.3-3). For Pikp-HMA, the 
%Rmax for AVR-Pia at 100 nM HMA concentration is 58 % (figure 3.3-3A), which is higher 
than might be expected given the apparently weak interaction suggested from the low 
immune response in planta. However, the in vitro system clearly differs quite 
considerably from the plant cell, not only in terms of environmental conditions, but also 
because only the isolated HMA domain is being considered in vitro, outside of its full-
length NLR context. In contrast, the %Rmax value for Pikm-HMA binding to AVR-Pia at 100 
nM is 2 %. Taking into consideration that the %Rmax for Pikm-HMA at the same 
concentration for AVR-PikC, which is acting as a negative control in these experiments, 
is 8 %, this suggests that there is no meaningful interaction between Pikm-HMA and 
AVR-Pia (figure 3.3-3B). 
As well as displaying binding affinities as a percentage of Rmax, SPR is commonly used to 
calculate the equilibrium dissociation constant (KD) for a given interaction. This is 
calculated by using a greater range of analyte concentrations and fitting the responses to 
a steady-state affinity model. Previously published work has determined the KD for Pikp-
HMA/AVR-PikD to be 5.9 nM and for Pikm-HMA/AVR-PikD to be 4.7 nM (de la 
Concepcion et al., 2018). Despite repeated attempts, the KD for the Pikp-HMA/AVR-Pia 
interaction could not be determined because the data failed quality tests set by the 




and may require a change of experimental conditions, such as a change of buffer or flow 
rate, to enable accurate values to be obtained. 
The overall conclusion from these in vitro experiments is that the interactions between 
the Pik HMAs and AVR-Pia in vitro correlate well with the response of full-length Pik 
NLRs to AVR-Pia in planta. 
 
3.3.2 in planta 
Figure 3.2-2 shows that there was an increased amount of HR-like cell death in leaves 
that had been agroinfiltrated with Pikp-1/Pikp-2/AVR-Pia compared to the negative 
control Pikp-1/Pikp-2/AVR-PikDH46E. However, it was not demonstrated that this 
increased cell death was due to a direct interaction in planta between the NLRs and the 
Figure 3.3-3: Quantitative binding analysis for AVR-Pia with Pikp-HMA and Pikm-HMA. 
Surface plasmon resonance bar charts showing %Rmax, the percentage of theoretical maximum 
response for HMA binding to immobilised effector, at three different concentrations of HMA 
protein. Each measurement represents an average of three results, with error bars showing 
standard deviation. Chart shown is representative of three separate experiments. A) Binding of 
Pikp-HMA to AVR-PikD (positive control), AVR-PikC (negative control) and AVR-Pia. B) Binding 




effector. Therefore, co-immunoprecipitation (co-IP) experiments were carried out to 
investigate direct binding in the plant tissue. FLAG antibody was used to 
immunoprecipitate Pik-1 NLRs from plant extract (tagged with a C-terminal 
6xHis/3xFLAG tag) and it was determined whether Pik-1 had been able to co-purify with 
the effector in each case (tagged with an N-terminal 4xMyc tag). It should be noted that 
Pik-2 was not agroinfiltrated for the co-immunoprecipitation experiments, as its 
presence would have resulted in cell death at the infiltration site, impeding the successful 
extraction of protein. While Pik-1 was clearly able to pull down AVR-PikD, its ability to 
bind directly with AVR-Pia was less clear. For three separate repeats of the co-IP 
experiment (biological repeats using different leaf tissue samples), it was shown that in 
2 out of 3 cases Pikp-1 did not co-purify with AVR-Pia, as shown in figure 3.3-4.   
However, in one experimental repeat, it appeared that AVR-Pia did co-
immunoprecipitate with Pikp-1, due to the presence of a faint band in the AVR-Pia 
sample when the eluate was visualised using the α-Myc antibody (data not shown). In 
both situations, the positive (AVR-PikD) and negative (AVR-PikDH46E) controls behaved 
as expected. This discrepancy could be a symptom of a weak interaction between Pikp-1 
and AVR-Pia or could be due to a difference in the leaf tissue itself. To resolve this, more 
repeats of the co-IP experiment would need to be carried out to reach a consensus. From 
the data obtained thus far, no proof of a direct interaction between AVR-Pia and full-
length Pikp-1 in planta has been found, but it appears that if any interaction did occur it 
would be very weak, as expected from the weak HR-like cell death. As discussed above, 
the decision was taken to not include Pik-2 in the co-IP experiments, to avoid cell death 
Figure 3.3-4: Co-immunoprecipitation 
assay investigating Pik-1 interaction with 
AVR-Pia in planta. 
Western blot showing protein input from 
plant extract (bottom panel) and the outcome 
of immunoprecipitation of Pikp-1 with FLAG 
magnetic beads (top panel), visualised with 
α-FLAG and α-Myc antibodies. Protein 
loading is shown by Ponceau stain. This blot 







and loss of protein. However, this does preclude any Pik-2-dependent interactions from 
taking place. For example, if the Pik-1/effector interaction was dependent on Pik-2, this 
would be excluded from the results. However, precedent within the lab suggests that this 
is unlikely, as previous co-IP experiments with the Pik proteins have shown an 
NLR/effector interaction in the absence of Pik-2. 
3.4 Pikp-HMA binds AVR-Pia at an unusual interface  
Following confirmation that AVR-Pia can bind Pikp-HMA in vitro, the next step was 
attempting to understand and visualise the binding interface between the two proteins. 
Solving the structure of the two proteins in complex would provide information about 
the similarities and differences between Pikp-HMA binding AVR-PikD and AVR-Pia. In 
addition, this information could be used to make informed mutations within Pikp-HMA 
to generate a stronger response to AVR-Pia. Previous structural characterisation of Pik-
HMA and AVR-Pik complexes has been carried out by co-transformation of E. coli SHuffle 
cells with an MBP-tagged Pik-HMA construct and an untagged AVR-Pik construct. Both 
partners are co-expressed and the tagged HMA domain pulls down its interacting 
effector during IMAC purification of cell lysate. The MBP tag is then cleaved from the 
HMA domain and a second gel filtration step yields purified complex for crystallography 
(Maqbool et al., 2015). When this method was attempted for the AVR-Pia/Pikp-HMA 
complex, the yield from purification was low, and the protein was prone to precipitation. 
One hypothesis is that the weak interaction between AVR-Pia and Pikp-HMA makes 
complex formation difficult in the presence of the bulky MBP tag on Pikp-HMA, leading 
to excess unbound HMA in the final sample, which is prone to precipitation upon 
concentration. Instead, a new purification method was developed to overcome these 
issues. Both AVR-Pia and Pikp-HMA were purified separately (with SUMO and MBP 
solubility tags respectively) and immediately following cleavage and removal of the tags 
from both partners, the proteins were mixed together and purified for a final time using 
preparative gel filtration. This new technique allows easier complex formation (using 
untagged proteins) but still allows removal of any un-complexed protein (via the final 
gel filtration step) – causing increased yields and reduced protein precipitation. 
Following successful purification of AVR-Pia/Pikp-HMA, the complex was used for 
crystallisation trials. Three different commercially available crystallisation screens were 
used; the PEGs suite (Qiagen), Morpheus® and JCSG-plus™ (both Molecular Dimensions). 
Two different protein concentrations were used, of approximately 10 and 20 mg/ml, 




Best quality crystals were obtained in the Morpheus® screen, using protein at a 
measured concentration of 18 mg/ml. The crystals were found in well D2 of the screen, 
and the conditions in this well were: 0.12 M Alcohols (0.2 M 1,6-Hexanediol; 0.2 M 1-
Butanol; 0.2 M 1,2-Propanediol; 0.2 M 2-Propanol; 0.2 M 1,4-Butanediol; 0.2 M 1,3-
Propanediol), 0.1 M Buffer System 1 (1.0 M imidazole; MES monohydrate (acid), pH 6.5) 
and 50 % v/v Precipitant Mix 2 (40 % v/v Ethylene glycol; 20 % w/v PEG 8000). Images 
of the crystals used for data collection are shown in figure 3.4-1. 
 
X-ray diffraction data was collected at the Diamond Light Source synchrotron in 
Oxfordshire on beamline DLS-i03. Crystals diffracted to 1.9 Å resolution. The structure 
was solved by molecular replacement using PDB files 5A6P (Pikp-HMA, (Maqbool et al., 
2015)) and 2MYW (AVR-Pia, (de Guillen et al., 2015)), followed by rounds of manual 
rebuilding and refinement. Due to the use of both members of the complex themselves 
as models for the molecular replacement, there were few residues that required 
significant changes during refinement. The loop containing the non-functional metal 
binding site between β-1 and α-1 in Pikp-HMA was found to be disordered as described 
previously (Maqbool et al., 2015) so was not included during refinement. Similarly, the 
two-residue scar at the N-terminus of Pikp-HMA (‘G-P…’) deriving from the 3C protease 
cleavage of the solubility tag was disordered. Additionally, the three residues at the C-
terminus of Pikp-HMA were disordered in this structure. 89 water molecules were 
positioned during refinement. Table 9 shows statistics for the data collection and 
Figure 3.4-1: Images of protein crystals used for 
collecting AVR-Pia/Pikp-HMA structural data. 
A) Images of protein crystals taken under visible (left) 
and UV light (right) by the Minstrel Crystallisation 
Imager (Rigaku). Images were taken 5 days after 
crystallisation trays were set up. B) Photo of a single 
protein crystal mounted on a loop prior to data 




refinement, and further details about the programs used for structure refinement and 
building can be found in Chapter 2 (Materials and Methods).  
Each partner in the complex adopts a similar overall shape to the previously solved 
structures. Pikp-HMA (de la Concepcion et al., 2018; Maqbool et al., 2015) comprises two 
adjacent α-helices opposite a four-stranded β-sheet. Currently available structures of 
AVR-Pia (de Guillen et al., 2015; Ose et al., 2015) were both solved in solution using NMR 
spectroscopy, and this represents the first AVR-Pia structure solved by X-ray 
crystallography. AVR-Pia has previously been shown to contain the six-stranded β-
sandwich that is characteristic of MAX effectors (de Guillen et al., 2015), but in the 
structure described here (figure 3.4-2) β-5 is not well-defined and appears as a loop 
joining β-4 and β-6. Within this loop, the overall shape appears similar to the effector 
structure determined by NMR spectroscopy (de Guillen et al., 2015), and residues are 
positioned in a largely similar way. One noticeable difference is a slight alteration in the 
hydrogen bonding, which may contribute to the lack of defined β-strand in the X-ray 
crystallography structure. Both structures contain a hydrogen bond between the oxygen 
atom in the backbone of Leu70 and the backbone nitrogen of Gly73. However, while the 
published NMR structure also contains a hydrogen bond between the backbone nitrogen 
of Leu70 and oxygen of Lys74, in the structure solved here, this Leu70 hydrogen bond is 
formed with a water molecule, rather than the amino acid chain. However, despite this 
region not being fully defined as a β-strand, it still forms the same conserved structure 
as seen elsewhere.  As expected from previous structural characterisation, the effector is 
stabilised by a disulphide bond between Cys25 and Cys66. 
Despite the two proteins in the complex adopting essentially identical folds to their 
published structures (in isolation), there are striking differences between the AVR-
Pia/Pikp-HMA complex and the complexes of AVR-Pik effectors with Pikp-HMA. Figure 
3.4-2A shows global representations of AVR-Pia/Pikp-HMA and AVR-PikD/Pikp-HMA 
(PDB 6G10, (de la Concepcion et al., 2018)), with the monomer of Pikp-HMA displayed 
in the same orientation for both structures. Broadly, Pikp-HMA binds AVR-PikD opposite 
its β-sheet face, whereas AVR-Pia is bound adjacent to α-1 (Asn201–Ser212) and β-2 
(Val216–Val212), creating a very different interface. Figure 3.4-2B shows this 
interaction from an alternate viewpoint. Here, it is possible to see how the β-sheet of 
Pikp-HMA aligns itself with β-3 of AVR-PikD, and how the N-terminal arm of AVR-PikD 
wraps around the other side of the HMA β-sheet. On the other hand, AVR-Pia is 
positioned alongside Pikp-HMA α-1 and β-2. In both cases, the positioning of the effector 




case of AVR-PikD, the β-strands from Pikp-HMA form a sheet with β-strands 3-5 of AVR-
PikD. For AVR-Pia, the β-strands involved are 1,2 and 6. Another striking feature is that 
while Pikp-HMA is present as a dimer in the crystal structure with AVR-PikD (as 
discussed in section 3.1), it is only a monomer in the structure with AVR-Pia. Indeed, 
AVR-Pia occupies the same binding surface as the Pikp-HMA dimer in the AVR-
PikD/Pikp-HMA structure, which explains the lack of Pikp-HMA dimerisation in this case. 
PISA analysis (Krissinel, 2015) indicates that the interface area for the AVR-Pia/Pikp-
HMA structure is just 460 Å2, compared to the much larger 986 Å2 for the AVR-
PikD/Pikp-HMA interaction (de la Concepcion et al., 2018). Additionally, the interface 
between AVR-Pia and Pikp-HMA is stabilised mainly by hydrogen bonds between the 
peptide backbone. The main contributors to these interface hydrogen bonds are Val219, 
Tyr41, Asp217 and Arg43 (figure 3.4-2C). The backbone oxygen from Leu38 in AVR-Pia 
also forms a hydrogen bond with the side chain of Arg226 in Pikp-HMA. There are fewer 
interactions between amino acid side chains – a hydrogen bond/salt bridge interaction 
is formed between the side chains of Arg43 (AVR-Pia) and Asp217 (Pikp-HMA), and the 
hydroxyl group on the C-terminal residue of AVR-Pia, Tyr85, also forms a hydrogen bond 
with Ser212 (figure 3.4-2C). An indirect interaction, mediated by a water molecule, is 
also seen between the side chains of Tyr41 and Ser204 (figure 3.4-2C). These weak 
intermolecular interactions and small interface area appear to provide an explanation 
for the weaker binding affinity seen in vitro for AVR-Pia with Pikp-HMA compared to 





Table 9: Data collection and refinement statistics for the AVR-Pia/Pikp-HMA complex 
structure. 
*The highest resolution shell is shown in parenthesis.  
**As calculated by MolProbity  




Data collection statistics  
Wavelength (Å) 0.9763 
Space group P22121 
Cell dimensions  
a, b, c (Å) 34.84, 53.44, 117.81 
α, β, γ (◦) 90.00, 90.00, 90.00 
Resolution (Å)* 48.67-1.90 (1.94-1.90) 
Rmerge (%) 5.7 (122.9) 
I/I 19.7 (2.4) 
Completeness (%)  
 Overall 100 (100) 
Anomalous 100 (100) 
Unique reflections 18107 (1151) 
Redundancy  
 Overall 12.6 (13.3) 
 Anomalous 6.8 (7.0) 
CC(1/2) (%) 99.9 (80.9) 
Refinement and model statistics  
Resolution (Å) 48.72-1.90 (1.95-1.90) 
Rwork/Rfree (%) 20.3/24.5 (35.8/41.8) 
No. atoms  
    Protein 2113 
    Water 89 
B-factors  
    Protein 54.1 
    Water 58.1 
R.m.s deviations  
    Bond lengths (Å)  0.0117 
    Bond angles (º) 1.501 
Ramachandran plot (%)**  
    Favoured 98.5 
    Allowed 1.5 
    Outliers 0 







Figure 3.4-2: Structure of AVR-Pia in complex with Pikp-HMA. 
A) Structure of AVR-Pia in complex with Pikp-HMA refined to 1.9 Å resolution by X-ray 
crystallography, compared to the structure of AVR-PikD in complex with Pikp-HMA (de la 
Concepcion et al., 2018). AVR-Pia is shown in blue, AVR-PikD in red and Pikp-HMA in gold. The 
Pikp-HMA monomer is shown in the same orientation for both structures. B) An alternative 
view of the AVR-Pia/Pikp-HMA and AVR-PikD/Pikp-HMA structures shown in A, with 
secondary structure features labelled. Pikp-HMA monomer shown in the same orientation for 
both structures. C) Details of the interface between AVR-Pia and Pikp-HMA, showing 
interactions at the peptide backbone, and side-chain interactions. Dotted lines show hydrogen 
bonds, red spheres represent water molecules. Carbons are coloured according to the chain 
(AVR-Pia in blue, Pikp-HMA in gold) with oxygen atoms shown in red and nitrogen in dark 




3.5 Addition of the N-terminal ‘arm’ 
Pikp-HMA is able to bind AVR-Pia only weakly in vitro (section 3.3.1), and it was 
hypothesised that this binding might be strengthened if AVR-Pia more closely resembled 
the ‘matched’ binding partner to Pikp, AVR-PikD. Although these effectors share only 17 
% sequence identity, their structures have shown that they share a core six-stranded β-
sandwich fold, which is known as the MAX fold (de Guillen et al., 2015). However, one 
noticeable difference between these two effectors is the presence of an N-terminal 
extension on AVR-PikD (comprising Arg31 to Pro52), that partially wraps around, and is 
held in place by, the core structure (Maqbool et al., 2015). This extension, or ‘arm’, plays 
an important part in the interaction of AVR-PikD and Pikp-HMA, as it includes the His46 
residue that is known to form hydrogen bonds/salt bridge interactions with Ser218 and 
Glu230 in Pikp-HMA ((Maqbool et al., 2015) and see section 3.1). 
Prior to solving the crystal structure of AVR-Pia in complex with Pikp-HMA, it was 
envisaged that the HMA would bind AVR-Pia in a similar orientation to AVR-PikD. Under 
this assumption, it was considered that genetically grafting the N-terminal extension of 
AVR-PikD onto AVR-Pia, might recapitulate some of the binding strength conveyed onto 
AVR-PikD by this arm. Conversely, would removing the arm from AVR-PikD weaken or 
disrupt the binding of Pikp-HMA? 
Initially, this theory was tested by Hiromasa Saitoh using Magnaporthe oryzae Sasa2 
expressing the chimera AVR-PiaNAVR-PikD and the rice cv. K60 containing Pikp NLRs (figure 
3.5-1). His preliminary results suggest that the Pikp NLRs respond more strongly to the 
AVR-PiaNAVR-PikD chimera than they do to AVR-Pia alone, although it appeared that the 
presence of the arm on AVR-Pia decreased the ability of the RGA5/RGA4 NLRs to trigger 






This provisional data was taken forward using our model N. benthamiana and in vitro 
systems. The chimeric protein AVR-PiaNAVR-PikD was made by Hiromasa Saitoh in the 
pOPIN vector suite for E. coli expression and I then generated the chimera in the Golden 
Gate vector system for in planta experiments. 
Initially, AVR-PiaNAVR-PikD was tested for stability in vitro. The protein was expressed with 
a cleavable SUMO tag in E. coli SHuffle cells, according to the normal protocol for AVR-
Pik effectors. Figure 3.5-2 shows a purification gel filtration trace for AVR-PiaNAVR-PikD 
along with SDS-PAGE analysis of the purified protein. The protein exhibits the same 
smearing gel pattern as seen for AVR-Pia, which is also included in figure 3.5-2 for 
comparison. Despite the unusual appearance when analysed by SDS-PAGE, AVR-PiaNAVR-
PikD elutes from the gel filtration column as a single, symmetrical peak, indicating that it 
is monodisperse and stable during purification. Intact mass spectrometry analysis 
showed a single peak at 10733.2 Da, which (as for AVR-Pia) is 2 Da lower than the 
expected mass of 10735.2 Da. This indicates that even with the addition of the N-terminal 
Figure 3.5-1: Addition of N-terminal extension enhances Pikp response to AVR-Pia in rice. 
Images of sample results from rice inoculation assays by H. Saitoh. M. oryzae Sasa2 strains 
expressing either no effectors (WT), AVR-PikD, AVR-Pia or AVR-PiaNAVR-PikD were punch-
inoculated onto rice cultivars containing either Pikp1/Pikp2 (cv. K60) or RGA5/RGA4 (cv. 
Sasanishiki). Leaf samples were taken and photographed 10 dpi. R = resistant phenotype, S = 





extension, the AVR-Pia portion of the chimera is likely still able to form the disulphide 
bond to stabilise the core structure. 
 
In order to investigate the response of Pikp to AVR-PikD without the influence of the 
effector’s N-terminal extension, truncated versions of the protein were cloned. Firstly, 
AVR-PikDΔ22-52 was generated, whereby the entire N-terminal arm was removed, leaving 
only the core structure residues remaining. However, upon further consideration, two 
additional (less severe) truncations were made. This was in light of the fact that a 
cysteine residue at position 54 is involved in creating a disulphide bond with Cys70 that 
stabilises the core effector structure (Maqbool et al., 2015). It is possible that trimming 
the protein so close to Cys54 may affect its ability to correctly form the disulphide bond, 
so AVR-PikDΔ22-47 and AVR-PikDΔ22-44 were generated, that still remove a significant 
portion of the extension, but do not trim so close to the core structure. Each of these three 
truncations were cloned for expression from E. coli and purified as normal for AVR-Pik 
effectors. It soon became apparent that removal of the N-terminal extension of AVR-PikD 
destabilised the protein as, despite expression of each construct, the final yields were 
very low (as seen by very faint protein bands in SDS-PAGE analysis), and it was clear that 
the versions with more of the arm residues intact were more stable (figure 3.5-3). It is 
noteworthy that the most stable of the truncations, AVR-PikD Δ22-44, is also the only 
version that leaves Asp45 intact, a residue that is known to help anchor the arm to the 
core structure via a salt-bridge interaction with Arg110 (Maqbool et al., 2015). Given the 
Figure 3.5-2: Purification of AVR-PiaNAVR-PikD. 
Following cleavage of SUMO tag by 3C protease, AVR-PiaNAVR-PikD was flowed down a Superdex 75 
26/600 gel filtration column, and showed a major peak on the trace at 209 ml elution volume. 
Accompanying SDS-PAGE gel shows purified protein, with the same characteristic smear pattern 




destabilisation caused by truncating AVR-PikD, it was decided not to pursue this 
investigation any further in vitro, as working with unstable proteins can cause results to 
be less reliable. However, it is possible that in a plant cell environment, these instability 
issues would be lessened, so AVR-PikDΔ22-52 was also cloned for in planta transient 
expression. 
 
Having generated the appropriate tools, i.e. AVR-PiaNAVR-PikD and AVR-PikDΔ22-52, the 
constructs were tested in the model N. benthamiana system for eliciting an HR-like cell 
death response by both Pikp and Pikm NLRs. Figure 3.5-4B and figure 3.5-5B show that 
neither Pikp nor Pikm are able to respond to AVR-PiaNAVR-PikD or AVR-PikDΔ22-52, as cell 
death is not observed in either of these cases. Expression testing of infiltrated leaf tissue 
(figure 3.5-4C and 3.5-5C) indicates that AVR-PiaNAVR-PikD is expressed and stable in the 
leaf tissue, suggesting that the lack of cell death response is not due to insufficient protein 
production. It is possible that the addition of the N-terminal extension has disrupted the 
binding of Pikp-HMA to AVR-Pia, either to the extent that it cannot bind the effector at 
all, or that it cannot bind in the correct orientation to trigger an immune response. In the 
case of Pikm, it appears that the addition of the N-terminal extension onto AVR-Pia has 
not enabled the NLR to bind and respond to the effector. For AVR-PikDΔ22-52, the 
accumulation of protein in the infiltration site appears very low (figure 3.5-4C and 3.5-
5C), suggesting that the instability and expression issues encountered in vitro are also 
Figure 3.5-3: Purification issues for truncated versions of AVR-PikD. 
Overlaid traces of truncated AVR-PikD variants, flowed down a Superdex 75 
26/600 gel filtration column following cleavage of purification tag, shown with 
SDS-PAGE analysis of the fractions from under the peak in each case. Truncated 





present in planta. For this reason, the truncated versions of AVR-PikD were not 
investigated any further. 
  
Figure 3.5-4: Pikp does not respond to AVR-PiaNAVR-PikD or AVR-PikDΔ22-52 in the N. 
benthamiana model system. 
A) Representative leaf images taken under UV light 5 dpi showing cell death progression 
at infiltration sites. B) Box plot showing cell death scores for 70 technical repeats over 3 
biological repeats scored at 5dpi, with all samples shown as dots and outliers indicated by 
‘x’. For each box, the centre line shows the median score and the edges of the box show 
the upper and lower quartiles. C) Western blot showing the expression of proteins at the 
infiltration sites. Blot shown is representative of 3 experiments showing similar results. 
Note: For B) and C) the data for AVR-PikD, AVR-PikDH46E and AVR-Pia (also shown in 





To further explore the ability of Pikp-HMA and Pikm-HMA to bind to the chimera AVR-
PiaNAVR-PikD, we used in vitro techniques as described in section 3.3. It was found that Pikp-
HMA could bind the chimera in analytical gel filtration studies (figure 3.5-6A), evidenced 
by a peak shift on the trace when the two proteins were mixed. In SPR (figure 3.5-7A) it 
was found that Pikp-HMA could bind AVR-PiaNAVR-PikD, and the %Rmax for this interaction 
was very similar to that of AVR-Pia (also shown in figure 3.5-7A for comparison); 60 % 
at 100nM HMA concentration. 
Figure 3.5-5: Pikm does not respond to AVR-PiaNAVR-PikD or AVR-PikDΔ22-52 in the N. 
benthamiana model system. 
A) Representative leaf images taken under UV light 5 dpi showing cell death progression at 
infiltration sites. B) Box plot showing cell death scores for 70 technical repeats over 3 
biological repeats scored at 5dpi, with all samples shown as dots and outliers indicated by 
‘x’. For each box, the centre line shows the median score and the edges of the box show the 
upper and lower quartiles. C) Western blot showing the expression of proteins at the 
infiltration sites. Blot shown is representative of 3 experiments showing similar results. 
Note: For B) and C) the data for AVR-PikD, AVR-PikDH46E and AVR-Pia (also shown in figure 




The fact that both effectors are binding to Pikp-HMA with similar affinity implies that the 
N-terminal extension has not had any impact on the strength of binding. When 
investigating Pikm-HMA, the results were more surprising. Initially, there was a peak 
shift seen from 13.2 ml to 12.4 ml in the analytical gel filtration trace when Pikm-HMA 
was mixed with AVR-PiaNAVR-PikD (figure 3.5-6B). This result suggested that the presence 
of the N-terminal extension has caused gain-of-binding for Pikm-HMA, as Pikm-HMA 
cannot bind to AVR-Pia (see figure 3.3-3). However, the SPR experiments indicated that 
the %Rmax for the AVR-PiaNAVR-PikD/Pikm-HMA interaction was very low (figure 3.5-7B), 
and that binding is effectively zero when compared to the negative control AVR-PikC. 
 
Figure 3.5-6: Qualitative binding analysis for AVR-PiaNAVR-PikD with Pikp-HMA and Pikm-
HMA. 
A) Analytical gel filtration traces showing the elution volume of AVR-PiaNAVR-PikD alone (grey), 
Pikp-HMA alone (green) and an AVR-PiaNAVR-PikD /Pikp-HMA mixture (blue). SDS-PAGE analysis 
shows the fractions taken where indicated on the trace. Volumes shown indicate elution volumes. 
B) Analytical Gel Filtration traces showing the elution volume of AVR-PiaNAVR-PikD alone (grey), 
Pikm-HMA alone (green) and an AVR-PiaNAVR-PikD /Pikm-HMA (blue). SDS-PAGE analysis shows 
the fractions taken where indicated on the trace. Volumes shown indicate elution volumes. 




The disparity in these results could be because of the very different nature of the 
techniques, given that in analytical gel filtration, the proteins are mixed together and 
incubated at 4oC for several hours prior to assessment of complex formation, whereas in 
SPR, one partner is flowed over the top of the other, in a much more fleeting interaction. 
Another factor to take into consideration is that in SPR, the effector proteins are tagged 
with an additional C-terminal 6xHis tag for immobilisation on the chip, whereas this is 
not present for the proteins being tested by analytical gel filtration. Finally, the buffer 
conditions for the two experiments differ, as the buffer for SPR contains a high 
concentration of NaCl (860 mM) to prevent non-specific interactions between the HMA 
proteins and the chip reference cell. To take these factors into consideration, the 
analytical gel filtration experiment shown in figure 3.5-6B was repeated, comparing 
AVR-PiaNAVR-PikD with and without the C-terminal 6xHis tag, in a running buffer containing 
860 mM NaCl (figure 3.5-8). The interaction between Pikm-HMA and AVR-PiaNAVR-PikD 
Figure 3.5-7: Quantitative binding analysis for AVR-PiaNAVR-PikD with Pikp-HMA and Pikm-
HMA. 
Surface plasmon resonance bar charts showing %Rmax, the percentage of theoretical maximum 
response for HMA binding to immobilised effector, at three different concentrations of HMA 
protein. Each measurement represents an average of three results, with error bars showing 
standard deviation. Chart shown is representative of three separate experiments. A) Binding of 
Pikp-HMA to AVR-PikD (positive control), AVR-PikC (negative control), AVR-Pia and AVR-
PiaNAVR-PikD. B) Binding of Pikm-HMA to AVR-PikD (positive control), AVR-PikC (negative 





was still maintained under these conditions, suggesting that the difference in results is 
due to an innate difference between the techniques. 
 
To understand how AVR-PiaNAVR-PikD is interacting with Pikp-HMA, and indeed if the 
interaction with Pikm-HMA is robust, the effector was co-purified with both HMAs in the 
same manner as for the AVR-Pia/Pikp-HMA complex (section 3.4) and put into numerous 
Figure 3.5-8: In vitro interactions of AVR-PiaNAVR-PikD with Pikm-HMA under high salt 
conditions with/without C-terminal 6xHis tag. 
Analytical gel filtration traces showing the elution volume of AVR-PiaNAVR-PikD alone (purple) and 
an AVR-PiaNAVR-PikD/Pikm-HMA mixture (grey). Top panel shows AVR-PiaNAVR-PikD without the 
additional C-terminal 6xHis tag, bottom panel shows the same experiment using tagged protein. 
SDS-PAGE analysis shows the fractions taken where indicated by corresponding symbols on the 




crystallisation trials. Unfortunately, although several protein crystals were obtained, 
they all failed to diffract X-rays when tested. 
From these results, it appears that the addition of the N-terminal extension of AVR-PikD 
onto AVR-Pia does not improve the binding and response of Pikp-HMA or Pikm-HMA. 
Both NLRs failed to respond to the chimera in planta, and the binding affinities did not 
appear to be increased in SPR experiments. This could suggest that the N-terminal arm 
remains disordered in the chimera, and does not anchor to the core structure as seen in 
AVR-PikD. This putative disorder could be one factor in the poor crystal formation for 
this protein. Additionally, the solving of the AVR-Pia/Pikp-HMA structure provided 
alternative, structure-informed, methods to improve Pikp response to AVR-Pia. 
3.6 Testing pCambia for AVR-Pia in planta assays 
In recent years, the Golden Gate method of cloning has gained popularity, and is now 
used widely for generating expression constructs (see Chapter 6). All the in planta 
experiments discussed thus far in the chapter have used this method of cloning for 
generating transient expression constructs. However, the pCambia system is also 
commonly used, and has been employed previously in the lab (Maqbool et al., 2015). The 
pCambia system is based on the pPZP family of agrobacterium vectors (Hajdukiewicz et 
al., 1994) and can drive high levels of expression, leading to stronger responses in the 
cell death assays (M. Franceschetti, personal communication). 
Given that the cell death response to AVR-Pia is quite low using the Golden Gate system, 
it was decided to try using pCambia vectors, in case this boosted the cell death to a more 
visible level. All constructs were provided by Hiromasa Saitoh, including both Pikp-1 and 
Pikp-2 NLRs in pCambia, along with AVR-PikD, AVR-PikDH46E, AVR-PikDΔ22-52, AVR-Pia 
and AVR-PiaNAVR-PikD. As well as using a different vector system, all constructs used 
alternative tags compared to those in the Golden Gate system (simply due to precedent 
in the different labs). 
Initial cell death experiments were carried out with these constructs, using the 
agrobacterium ratios previously optimised for pCambia (Maqbool, 2015). Initial results 
showed some cell death in response to the negative control AVR-PikDH46E (figure 3.6-1), 
suggesting that the NLRs expressed from the pCambia vectors were causing a slight 




was a lot of variation between cell death scores of the same sample even within the same 
experiment. 
To prevent these issues, the experiment was redesigned using the NLRs expressed from 
Golden Gate vectors and only the effectors in pCambia. This regained the specificity of 
response, and the Pikp NLRs were no longer responding to the negative control (figure 
3.6-2B). Nevertheless, the results were still somewhat surprising. Firstly, the response 
to AVR-Pia increased dramatically, but this was alongside a decrease in response to AVR-
PikD, the positive control. In fact, the response to AVR-PikD expressed from pCambia was 
lower than the response to AVR-PikD expressed from the Golden Gate vector, which was 
not expected. Additionally, there was a strong immune response seen to the chimera 
AVR-PiaNAVR-PikD (figure 3.6-2B), where there had been no response to it when expressed 
from the Golden Gate vector (figure 3.5-4). This could be due to a stronger level of 
expression driven by the pCambia promoter, or it could be because the tag on the 
pCambia construct is found at the C-terminus of the protein, rather than the N-terminus 
as in the Golden Gate system. Given that the N-terminus of the chimera could be 
disordered, having the tag at the N-terminus of the protein in the Golden Gate system 
may be causing an issue for recognition of the effector in planta. 
Figure 3.6-1: Pikp NLRs expressed from the pCambia vector trigger cell death even in 
presence of negative control in N. benthamiana. 
A) Representative leaf images taken under UV light 5 dpi showing cell death progression at 
infiltration sites. B) Box plot showing cell death scores for 60 technical repeats over 2 biological 
repeats scored at 5dpi, with all samples shown as dots and outliers indicated by ‘x’. For each 






Whereas the responses of the Pikp NLRs differ greatly when effectors are expressed from 
the pCambia system compared to the Golden Gate system, the pattern of response for 
Pikm is broadly similar (figure 3.6-2D). While the response to AVR-PikD is still weaker 
Figure 3.6-2: The impact of expressing AVRs from pCambia in the N. benthamiana model 
system. 
A) Representative leaf images taken under UV light 5 dpi showing cell death progression at 
infiltration sites for Pikp. B) Box plot (Pikp) showing cell death scores for 40 technical repeats 
over 2 biological repeats scored at 5dpi, with all samples shown as dots and outliers indicated by 
‘x’. For each box, the centre line shows the median score and the edges of the box show the upper 
and lower quartiles. C) Representative leaf images taken under UV light 5 dpi showing cell death 
progression at infiltration sites for Pikm. D) Box plot (Pikm) showing cell death scores for 34 
technical repeats over 2 biological repeats scored at 5dpi, with all samples shown as dots and 
outliers indicated by ‘x’. For each box, the centre line shows the median score and the edges of the 




than expected, Pikm NLRs still cannot respond to either AVR-Pia or AVR-PiaNAVR-PikD, in 
agreement with the Golden Gate system (see figures 3.2-3 and 3.5-5). 
Overall, the pCambia system appears to provide a tool by which we can see a much 
stronger Pikp response to both AVR-Pia and the AVR-PiaNAVR-PikD chimera, but the fact 
that the response of Pikp to the ‘matched’ effector AVR-PikD is lower than the response 
to AVR-Pia suggests that this system is less representative of the true rice/M. oryzae 
system than the Golden Gate vector system. There was much more variability in the 
pCambia-based results compared to the equivalent experiments from the Golden Gate 
system. Another difficulty encountered was that some proteins expressed from the 
pCambia vectors were harder to detect via Western blot when extracted from leaf tissue. 
This issue requires troubleshooting that was not possible during the timescale of the 
project, but means that when pCambia vectors are used for cell death assays in this work, 
it has not been possible to confirm protein expression. Therefore, despite some benefits 
to using the pCambia system, it does not appear to be the most suitable system in my 
hands for this project. 
3.7 Investigating the ‘interface’ mutants 
As discussed in section 3.4, Pikp-HMA binds AVR-Pia at a different interface to AVR-PikD. 
Following determination of the AVR-PikD/Pikp-HMA structure (Maqbool et al., 2015), a 
number of mutants had been made in the lab (by A. Maqbool, M. Franceschetti) to 
confirm and investigate the AVR-PikD binding interface in planta. One of these mutations 
in Pikp-HMA was at position Glu230 (figure 3.7-1), a key residue involved in binding 
His46 on the N-terminal extension of AVR-PikD. Glu230 was mutated to an arginine – 
causing a change from a negatively to positively charged amino acid. It was found that 
this mutation prevented Pikp from recognising AVR-PikD in planta (M. Franceschetti, 
personal communication). A further point mutation was made at the Pikp-HMA 
dimerisation interface (figure 3.7-1), to investigate whether dimer formation was of 
biological importance. Ala211 was mutated to the bulkier, negatively charged residue 
glutamate, to disrupt the close contact of the two HMAs. This mutation had no effect on 
the response to AVR-PikD in planta (M. Franceschetti, personal communication), 
suggesting that dimer formation of Pikp-HMA is an in vitro artefact, rather than having 





Given the difference in in vitro binding interfaces (see section 3.4) for AVR-Pia and AVR-
PikD, it is expected that that these two mutants (Pikp-HMAA211E and Pikp-HMAE230R) will 
respond differently when challenged with AVR-Pia in planta. Unfortunately, when this 
was investigated, the low cell death response of Pikp to AVR-Pia made it difficult to 
obtain meaningful results (figure 3.7-2) – as there was little difference in the response of 
the two mutants compared to WT Pikp. However, the results for the positive control 
AVR-PikD were as expected and as observed by others in the lab, in that Pikp-HMAE230R 
was no longer able to respond to AVR-PikD, but Pikp-HMAA211E behaved the same as WT. 
 
Figure 3.7-1: Locations of Ala211 and Glu230 on both the AVR-PikD/Pikp-HMA and AVR-
Pia/Pikp-HMA structures. 
Diagrams showing the locations for the Pikp-HMAA211E and Pikp-HMAE230R mutations in both the 




It was discussed in section 3.6 that although using pCambia vectors did not seem to be a 
good model for the native rice/M. oryzae system, it provided a technique to obtain a 
stronger response for Pikp to AVR-Pia. This could be a useful tool to help study the Pikp-
HMAA211E and Pikp-HMAE230R mutants. Additionally, using the pCambia system, it is 
possible to see a response for WT Pikp to AVR-PiaNAVR-PikD, so this could be a method to 
investigate whether the chimera is binding at the ‘AVR-Pia-like’ interface or the ‘AVR-
PikD-like’ interface. Therefore, the WT and two mutant Pikp-1 NLRs (in the Golden Gate 
vectors as before) were tested against AVR-PikD, AVR-Pia and the chimera in the 
pCambia system. The results (figure 3.7-3) suggest that the cell death response in planta 
supports the binding interfaces determined in the crystal structures. The A211E 
mutation (that breaks the Pikp-HMA dimer interface) does not affect the response to 
AVR-PikD, but completely arrests the response to AVR-Pia or AVR-PiaNAVR-PikD. In 
contrast, the E230R mutation prevents response to AVR-PikD, but leaves the response to 
AVR-Pia and the chimera unaffected. It is observed that the cell death responses 
triggered by the Pikp-HMAE230R mutant are slightly lower than the WT response, which 
could indicate either that the point mutation has hindered the response to AVR-Pia and 
AVR-PiaNAVR-PikD, or may indicate that Pikp-HMAE230R is expressed at a lower level in the 
leaf tissue. As mentioned in section 3.6, it was not possible to get good quality Western 
blots for these experiments, so this could not be confirmed. Nevertheless, these initial 
Figure 3.7-2: The Golden Gate system cannot be used to investigate the response of the 
Pikp-HMAA211E and Pikp-HMAE230R mutants to AVR-Pia. 
A) Representative leaf images taken under UV light 5 dpi showing cell death progression at 
infiltration sites. B) Box plot showing cell death scores for 50 technical repeats over 2 biological 
repeats scored at 5dpi, with all samples shown as dots and outliers indicated by ‘x’. For each box, 
the centre line shows the median score and the edges of the box show the upper and lower 
quartiles. Note: For brevity, ‘Pikp-HMAA211E’ is represented as ‘A211E’ and Pikp-HMAE230R is 




observations suggest that Pikp-HMA binds AVR-PiaNAVR-PikD at the same interface as AVR-
Pia, suggesting that the N-terminal extension has not had an impact on the binding site. 
 
Figure 3.7-3: Using the Pikp-HMAA211E and Pikp-HMAE230R mutants to investigate AVR-Pia 
and AVR-PiaNAVR-PikD binding sites in planta. 
A) Representative leaf images taken under UV light 5 dpi showing cell death progression at 
infiltration sites. B) Box plot showing cell death scores for 40 technical repeats over 2 biological 
repeats scored at 5dpi, with all samples shown as dots and outliers indicated by ‘x’. For each 
box, the centre line shows the median score and the edges of the box show the upper and lower 
quartiles. Note: For brevity, ‘Pikp-HMAA211E’ is represented as ‘A211E’ and Pikp-HMAE230R is 
represented as ‘E230R’. 
 
3.8 A Pikp-HMA/AVR-Pia/AVR-PikD complex is not formed in vitro 
Evidence obtained thus far has indicated that Pikp-HMA binds AVR-Pia and AVR-PikD at 
different interfaces both in vitro and in planta. It could be hypothesised that Pikp-HMA 
can bind both effectors at the same time, which if true, would lead to interesting 
questions about the effect on immune response in planta. To investigate this, a simple 




purified complex of AVR-Pia and Pikp-HMA was incubated with purified AVR-PikD. If 
AVR-PikD was able to bind to Pikp-HMA alongside AVR-Pia, a triple complex would be 
formed, accompanied by a peak shift on the analytical gel filtration trace. Both 
components (the AVR-Pia/Pikp-HMA complex and AVR-PikD) were first run separately 
down the analytical column to determine their elution volumes (figure 3.8-1) before the 
complex and AVR-PikD were mixed in a 1:1 molar ratio and incubated for 2 hours on ice. 
This mixture was then run down the column. No significant peak shift was observed on 
the trace (figure 3.8-1). Instead, when fractions were analysed by SDS-PAGE, it appeared 
that the peak at 13.5 ml (labelled d) was actually now composed entirely of AVR-PikD 
and Pikp-HMA, and the secondary peak (e and f) contained AVR-Pia and AVR-PikD. This 
suggests that the AVR-PikD has fully displaced AVR-Pia from a complex with Pikp-HMA. 
The free AVR-Pia now elutes later, co-eluting with excess AVR-PikD. The excess AVR-
PikD is likely present because it had only been mixed in a 1:1 complex with the Pikp-
HMA, and in vitro the AVR-PikD forms a 1:2 complex due to Pikp-HMA dimerisation. 
Overall, this experiment shows further evidence for the stronger binding affinity of Pikp-
HMA for AVR-PikD compared to AVR-Pia, and indicates that it is not possible for both 






Building upon initial observations using M. oryzae infecting rice, the work described here 
has shown that Pikp is able to respond weakly to its non-matched effector AVR-Pia and 
that the isolated HMA domain is able to bind to AVR-Pia in vitro, although more weakly 
than to AVR-PikD. This observation is perhaps not surprising, given that these effectors 
are structurally highly conserved and are both recognised by integrated HMA domains 
in rice NLRs. What is more surprising is the discovery of a novel effector binding interface 
for Pikp-HMA, where AVR-Pia binds at the site normally held by a second Pikp-HMA 
molecule in solution. The purification strategy designed to form the complex for 
Figure 3.8-1: Analytical gel filtration indicates that Pikp-HMA cannot simultaneously bind 
AVR-Pia and AVR-PikD. 
Analytical gel filtration traces showing the elution volume of AVR-PikD alone (red), a pre-
formed complex of AVR-Pia/Pikp-HMA (blue) and a 1:1 mixture of AVR-PikD and AVR-Pia/Pikp-
HMA (grey). SDS-PAGE analysis shows the fractions taken where indicated by letters a-f on the 




crystallographic studies, whereby AVR-Pia and Pikp-HMA are purified separately and 
then mixed at the final stage of purification, suggests that the AVR-Pia must be able to 
break this Pikp-HMA dimer, (which forms when the HMA is heterologously expressed 
from E. coli) and take its place in the complex. However, given that the dimerisation of 
Pikp-HMA in vitro is thought to have no biological relevance, it is likely that AVR-Pia 
breaking this dimer is also not biologically important. Interestingly, a previous study had 
used docking models to compare the expected orientation of binding for AVR-PikD/Pikp-
HMA and AVR-Pia/RGA5-HMA. The models predicted that RGA5-HMA and Pikp-HMA 
would bind their respective effectors at different interfaces (Ortiz et al., 2017), which is 
in agreement with the results shown here for AVR-Pia binding to Pikp-HMA. This could 
suggest that the change in interface is due to a property of the effector, rather than a 
property of the HMA domain. In addition, the same study by Ortiz et al. used NMR 
titration experiments coupled with validation by yeast two-hybrid and co-
immunoprecipitation to identify residues that were likely to be involved in the 
interaction between AVR-Pia and the HMA domain of RGA5. The candidate interaction 
surface of AVR-Pia identified in the study does not fully match the interaction interface 
identified here between AVR-Pia and Pikp-HMA, but some of the key residues found in 
the study are positioned at the interface between AVR-Pia and Pikp-HMA. For example, 
both AVR-Pia residues Phe24 and Thr46, which were shown to be important for effector 
recognition by the RGA5/RGA4 NLRs are at the interface with Pikp-HMA. Ortiz et al. 
found that mutation of residue Arg43 to a glycine resulted in abolished 
immunoprecipitation with the isolated HMA domain of RGA5. In the structure shown 
here (figure 3.4-2), Arg43 forms a hydrogen bond with Asp217 from Pikp-HMA, 
indicating that the some of the same residues are important for AVR-Pia to interact with 
both RGA5-HMA and Pikp-HMA. This suggests that the interfaces might be similar in both 
cases, although there is currently no crystallographic or NMR structural evidence to 
show how the AVR-Pia/RGA5-HMA interface is formed. 
While this interaction of AVR-Pia and Pikp-HMA appears to be robust in planta and in 
vitro, no such interaction has been observed for AVR-Pia binding to the Pikm allele. 
Within the different Pik alleles, the HMA domain is the most polymorphic region (de la 
Concepcion et al., 2018) and Pikm-HMA shares only 62 % sequence identity with Pikp-
HMA, although they share a similar structure (de la Concepcion et al., 2018). Further tests 
would be needed to investigate why Pikm-HMA does not form a complex with AVR-Pia. 
One notable difference is that the important Asp217 residue in the AVR-Pia/Pikp-HMA 
interface is replaced by a histidine residue in Pikm-HMA, which would no longer be able 




could significantly weaken the binding between the two proteins, although seems 
unlikely to fully account for a lack of interaction. 
In an attempt to strengthen the interaction between AVR-Pia and Pikp-HMA, and 
perhaps introduce binding to Pikm-HMA, a chimera was made whereby the N-terminal 
extension of AVR-PikD (the greatest structural disparity between the two effectors) was 
grafted onto AVR-Pia. Although this protein was stable when expressed from E. coli, it 
could not be determined whether the N-terminal arm was making a significant difference 
to the overall structure of the protein. Attempts at generating diffraction quality crystals 
of the chimera in complex with Pikp-HMA failed, which could be due to disorder. In 
planta, the addition of this N-terminal extension appears to prevent Pikp from 
responding to the effector, even though the protein is stably expressed, which could 
suggest that the arm is in some way preventing a response – possibly by blocking the 
Pikp-HMA binding site. In vitro, the binding affinity of the chimera for Pikp-HMA is very 
similar to AVR-Pia – an indication that the N-terminal arm is unable to effect any change 
in binding to the HMA. Overall, this strategy to strengthen the interaction of AVR-Pia and 
Pikp-HMA was unsuccessful. Even though in analytical gel filtration experiments, Pikm-
HMA was able to bind to the chimera, where it had previously been unable to bind AVR-
Pia, this did not hold true in SPR experiments or in planta, suggesting that the gel 
filtration results were misleading rather than of biological relevance. 
While the pCambia system did not provide a reliable model in my hands to replace the 
Golden Gate cloning method, it was interesting to observe that when the effectors were 
expressed using the pCambia vectors, the cell death response by Pikp was greatly 
increased for AVR-Pia, and found to be almost the same level for AVR-PiaNAVR-PikD, where 
there was no response seen when using the Golden Gate system. One hypothesis for this 
is that the pCambia promoter drives much higher expression than the Ubiquitin 
promoter used in the Golden Gate vector. This could be further investigated by testing 
the expression level of the effectors in planta when expressed from the pCambia system, 
which was unfortunately not possible within the timescale of this project. However, 
despite these issues, experiments carried out using the ‘interface mutants’ Pikp-
HMAA211E and Pikp-HMAE230R strengthened the idea that the addition of the N-terminal 
arm of AVR-PikD onto AVR-Pia does not change the binding interface to the ‘AVR-PikD-
like’ interface. This assay also suggests that the AVR-Pia/Pikp-HMA complex is in a 
different orientation compared to AVR-PikD/Pikp-HMA in the plant cell environment as 
well as in vitro (as seen by X-ray crystallography) because the interface mutant that 




disrupts the AVR-PikD binding site is still able to respond to AVR-Pia. This lends weight 
to the idea that the AVR-Pia/Pikp-HMA crystal structure shows the biologically relevant 
interface in N. benthamiana, despite its small interface area and weak intermolecular 
bonding. 
Despite the novel results gained from in planta study, some further improvements could 
be made to these experiments. Although negative controls (generally the non-binding 
AVR-PikD variant with a H46E mutation) were used throughout, an additional 
experiment using an empty vector control in place of the effector would be needed to 
ensure that the cell death observed was effector-dependent. By using an empty vector 
control, it would ensure that no part of the effector construct plays a role in inducing cell 
death in N. benthamiana (whether due to recognition by plant immune receptors or not). 
On a related level, the expression levels of the NLR proteins themselves should be 
considered. This transient expression of proteins in the model plant (under the A. 
tumefaciens Mas promoter) does not accurately mimic the expression levels that would 
be found in the native rice under the native promoter. It has previously been shown that 
the expression levels of NLRs correlate with the level of cell death observed, and that 
using different promoters for transient expression can significantly alter the 
observations of hypersensitive response (Zhang et al., 2004). Although this is perhaps 
not surprising, it does indicate that effector-independent changes in observed cell death 
can be an issue in such transient expression assays. 
Additionally, it would be beneficial to test RGA5-HMA under the same conditions, to be 
used as a positive control for AVR-Pia cell death. However, due to agreements in place 
between different research groups, it was not possible to work with the RGA5/RGA4 pair 
in this project. 
As described in section 3.3, it was not possible to prove a direct interaction between Pik-
1 and AVR-Pia in planta, as the co-IP experiments gave conflicting results. As discussed, 
it is hoped that further repeats of these experiments might provide more conclusive 
answers, but it is also possible that the weak interaction in this particular case might 
always lead to a varied outcome. It might be necessary to try other techniques, such as 
chemical cross-linking (Fukao, 2012) to consistently visualise the weak interaction. 
Alternatively, other techniques could be used to assess the interaction between NLR and 
effector, such as fluorescent-based in planta methods (Kerppola, 2006), although the 
additions of fluorescent tags can cause additional steric difficulties in obtaining 




Finally, a preliminary in vitro assay indicates that Pikp-HMA cannot bind both effectors 
at the same time, despite their different interfaces. AVR-PikD is readily able to displace 
AVR-Pia from the Pikp-HMA complex, presumably due to its much higher binding affinity 
in vitro. This suggests that in planta, Pikp would likely recognise AVR-PikD in preference 
to AVR-Pia if both effectors were present, due to the stronger affinity of this interaction. 
Although this provisional analytical gel filtration test was not pursued further, an 
alternative method to investigate this AVR-Pia/AVR-PikD competition would have been 
to use SPR. If AVR-Pia had been immobilised to the chip and Pikp-HMA was flowed over, 
the mass on the chip would have increased as the HMA binds. If AVR-PikD was then 
flowed over (without chip regeneration), the mass would have decreased as AVR-PikD 
pulled Pikp-HMA away from AVR-Pia. This assay would provide a different method to 
assess the effector binding competition, although it was not possible within the 
timeframe of this study. 
The work described here has shown how Pikp can respond to AVR-Pia weakly in planta 
and shows an interesting example of cross-reactivity for rice NLRs to structurally similar 
effectors. Detailed studies of how NLR domains can interact with pathogen effectors have 
important implications for agriculture, as it extends our current understanding of how 
plants combat disease. Based upon the observations described here, Chapter 4 shows 
how the project was extended into engineering an NLR that can respond more strongly 
to AVR-Pia. Although not directly applicable to agriculture at this stage, this may provide 




4. Engineering an 
enhanced response 
to AVR-Pia 
Modifying the Pikp HMA domain to trigger a stronger 






Understanding the ways in which host NLR proteins recognise pathogen effectors is key 
to unravelling the complexities of immunity and the constant evolutionary battle 
between plant and pathogen. Aside from satisfying simple curiosity, the ability to 
interpret the causes and symptoms of plant disease at the molecular level affords us the 
opportunity to try tipping the balance of immunity in favour of the plant. In recent years, 
there have been several examples of NLRs being engineered in different ways to change 
or extend their recognition ability (Cesari, 2018). One example of an NLR being 
engineered to recognise additional effectors is the case of the R3a NLR, which was 
mutated to recognise a new isoform of the P. infestans effector AVR3a (Segretin et al., 
2014). Other cases of engineering have involved the modification of a decoy protein, 
rather than the NLR itself. One such example is the A. thaliana host protein PBS1, which 
is targeted by a protease effector AVRPphB. Cleavage of PBS1 causes pathogen 
recognition and immune response through the NLR RPS5. Modification of the cleavage 
site of PBS1 to recognition sites for other protease effectors allowed RPS5 to mediate a 
response to other effectors (Kim et al., 2016). As the scientific field learns more about 
the mechanisms behind NLR-mediated plant immunity, there is capacity for further 
advances in this area. 
In the context of the Pik NLR system, recently solved structures of Pik-HMA domains in 
complex with different AVR-Pik alleles (de la Concepcion et al., 2018) have provided 
promising insights that may help rationally design modified Pik NLRs to recognise a 
broader range of AVR-Pik effectors, including the previously unrecognised allele AVR-
PikC. Using structural and biophysical techniques, as well as model plant systems, it is 
possible to assess whether engineered NLRs are likely to have changed or enhanced 
recognition when tested in their native system – in this case the rice/M. oryzae 
host/pathogen system. Whether or not the immune engineering would be robust and 
long-lasting in the field is a question that is not easy to answer. As previously discussed, 
the rate of pathogen evolution means that creating durable, broad-range resistance is a 
challenge (Zhang & Coaker, 2017). Nevertheless, modifying the amino acid sequence of 
plant NLRs and thus enabling greater resistance to disease is a powerful technique that 
is worthwhile exploring. 
Chapter 3 describes how the Pikp NLR pair is able to weakly respond to AVR-Pia in 
planta, despite being responsible for recognising the AVR-Pik effectors. This observation 




interaction was analysed. Although there is another pair of NLRs with an integrated HMA 
domain (RGA5/RGA4) that is able to recognise AVR-Pia in planta, it would be interesting 
to be able to engineer a single NLR that was able to respond robustly to both AVR-Pia 
and AVR-PikD. The AVR-Pia/Pikp-HMA (Chapter 3) and AVR-PikD/Pikp-HMA (de la 
Concepcion et al., 2018; Maqbool et al., 2015) crystal structures showed that the effectors 
bind to Pikp-HMA at different interfaces, so it may be possible to strengthen the 
interaction at the AVR-Pia binding site without significantly disrupting the binding of 
AVR-PikD at a different location. The work described in this chapter shows how different 
strategies were employed to engineer the Pikp HMA domain to respond more strongly 
to AVR-Pia. 
4.2 Structure-guided point mutations 
4.2.1 Design of mutants 
Chapter 3 describes how the structure of AVR-Pia in complex with Pikp-HMA was 
determined. By studying this structure in detail, it might be possible to identify regions 
in Pikp-HMA that could be mutated to convey stronger binding to AVR-Pia. If the proteins 
can interact more strongly in vitro, precedent suggests that this would correlate with the 
NLR triggering a stronger immune response in planta (de la Concepcion et al., 2018). The 
AVR-Pia/Pikp-HMA crystal structure revealed a 1:1 complex with the primary interface 
centred at β-2 in Pikp-HMA. Many of the interactions at the interface are hydrogen bonds 
that form between the peptide backbone of the two partners in the complex. This creates 
limited options for generating point mutations; because while changing the character of 
amino acid side chains is relatively straightforward, the innate properties of the peptide 
backbone cannot be changed. However, upon close examination of the structure, two 
residues were identified that had the potential to strengthen the AVR-Pia/Pikp-HMA 
interaction. 
The first of these mutations is an alanine positioned on β-2 (figure 4.2-1). The small 
alanine residue does not extend far into the space between the two partners of the 
complex, but it was noted that in RGA5 (the ‘matched’ NLR to AVR-Pia) the 
corresponding residue at this position in the sequence is a glutamate, which is much 
larger than alanine and negatively charged. It is possible that in the ‘matched’ interaction, 
this residue is forming contacts with AVR-Pia that helps to stabilise a complex. Therefore, 





The second point mutation to be generated is at a loop of Pikp-HMA (residues Ser212 – 
Val216) that extends into the space slightly beyond the core structure. Opposite this loop 
in the complex is a positively charged surface patch on AVR-Pia generated by the side 
chains of two arginine residues (Arg23 and Arg43), that point towards the loop of Pikp-
HMA (figure 4.2-1). The residue in the centre of the Pikp-HMA loop is a glycine, and it 
was hypothesised that replacing this glycine with a glutamate would create a long, 
negatively charged side chain that might be able to reach across the short gap between 
the two partners in the complex and form an interaction with the positively charged 
patch in AVR-Pia. In the WT complex, Arg43 is already forming a stabilising interaction 
with Pikp-HMA residue Asp217, but there is potential to strengthen the bonding in this 
area if Arg23 could form an additional interaction with the Ser212 – Val216 loop region. 
 
Figure 4.2-1: Locations of A220 and G214 
mutation sites in AVR-Pia/Pikp-HMA structure. 
Top panel indicates the location of Ala220 in Pikp-
HMA (circled). Bottom panel indicates the location of 
Gly214 in Pikp-HMA (arrow). Pikp-HMA is shown in 
gold, AVR-Pia is shown in blue (top panel) or as a 
surface representation showing electrostatic 




4.2.2 Testing in planta 
Both point mutations were generated by ordering synthetic DNA (IDT gBlocks® Gene 
Fragments) for the HMA domain and cloning back into the full-length Pikp NLR in the 
Golden Gate vector system. These mutant Pikp-1 NLRs were then agroinfiltrated into N. 
benthamiana with WT Pikp-2 and AVR-Pia, and the HR-like cell death response was 
scored as described in Chapter 3 ( see figure 3.2-2). This experiment shows that the Pikp-
HMAA220E mutant cannot respond to AVR-Pia, as no cell death was observed in planta 
(figure 4.2-2).  
 
Figure 4.2-2: Pikp-HMAA220E and Pikp-HMAG214E do not enhance response to AVR-Pia. 
A) Representative leaf images taken under UV light 5 dpi showing cell death progression at 
infiltration sites. B) Box plot showing cell death scores for 60 technical repeats over 3 biological 
repeats scored at 5dpi, with all samples shown as dots and outliers indicated by ‘x’. For each 
box, the centre line shows the median score and the edges of the box show the upper and lower 
quartiles. C) Western blot showing the expression of proteins at the infiltration sites. Blot 
shown is representative of 3 experiments showing similar results. Note: For brevity, Pikp-





This could be because the addition of a bulkier residue at that position has caused steric 
hindrance - pushing the effector away from the HMA domain, rather than strengthening 
the interaction. The Pikp-HMAG214E mutant yields cell death scores that are almost 
identical to WT Pikp-1 (figure 4.2-2), indicating that the G214E mutation has had neither 
a positive or negative effect. Possibly the glutamate side chain is unable to extend far 
enough across the gap to form the putative salt-bridge interaction with AVR-Pia Arg23, 
or even if this interaction is occurring, it may not affect the response in planta. In both 
cases, the mutant Pikp-1 NLRs were successfully expressed in planta and detected by 
Western blot analysis (figure 4.2-2C). 
4.3 RGA5/Pikp-HMA secondary structure swaps 
Using the crystal structure of AVR-Pia/Pikp-HMA to strategically design point mutations 
that could strengthen the interaction between the two partners was not successful. An 
alternative strategy is to make bigger global changes to the HMA domain to discover 
whether there is a more general region of the protein that could be engineered for a 
stronger response. If segments of Pikp-HMA are mutated to the equivalent residues from 
RGA5-HMA, it might be possible to identify key residues that allow RGA5-HMA to 
respond strongly to AVR-Pia. To achieve these modifications in a methodical manner, 
segments of RGA5-HMA were swapped into Pikp-HMA in a step-wise method according 
to secondary structure features, to help maintain the overall structure of Pikp-HMA. 
Given that the structure of RGA5-HMA is not available, Phyre2 (Kelley et al., 2015) was 
used to predict the secondary structure features of RGA5-HMA from the known structure 
of Pikp-HMA (PDB accession 5A6P, (Maqbool et al., 2015)) via the one-to-one threading 
approach. Using a sequence alignment of the two proteins and the results from Phyre2, 
the RGA5-HMA was divided up into six sections according to the secondary structure 




conserved between the two HMA domains, to minimise global structure disruption as far 
as possible. 
 
These swaps (numbered 1-6) were synthesised as described in section 4.2.2 and tested 
for response to AVR-Pia in planta. The cell death scores (figure 4.3-2B) indicate that 
Swap1, 3 and 4 have lost the ability to respond to AVR-Pia, even though they are 
expressed successfully in the leaf tissue (figure 4.3-2C). Swap2 appears to respond to 
AVR-Pia with a similar magnitude to WT Pikp, while both Swap5 and 6 appear to have 
an increased response to the effector. In each case, the NLRs and effector were correctly 
expressed within the leaf tissue (figure 4.3-2C). 
To confirm whether the swaps were able to interact with AVR-Pia in the leaf tissue, co-
immunoprecipitation was carried out for Swap2, 5 and 6. The results are not completely 
clear, but it appears that the mutations have not increased strength of binding between 
NLR and effector. For the WT (Chapter 3, section 3.3.2) it appeared that in some cases 
AVR-Pia could be pulled down by the NLR, but in other repeats it was not. For each of 
Figure 4.3-1: Design of RGA5/Pikp-HMA secondary structure swaps. 
A) Sequence alignment of RGA5-HMA with Pikp-HMA showing the boundaries for secondary 
structure swaps. B) Diagram showing the location of each secondary structure swap mapped 
onto the AVR-Pia/Pikp-HMA structure. AVR-Pia is shown in blue, Pikp-HMA is shown in gold, 




Swap2, 5 and 6, and for WT Pikp-1, figure 4.3-2D appears to show a very faint band for 
the α-Myc antibody when the tagged NLRs are pulling down the effectors. This suggests 
that there could be a weak interaction between Swap2, 5 and 6 and AVR-Pia in planta, 
but the binding does not appear to have been strengthened compared to WT Pikp-1, and 





Figure 4.3-2: RGA5/Pikp-HMA swaps can enhance response to AVR-Pia. 
A) Representative leaf images taken under UV light 5 dpi showing cell death progression at 
infiltration sites. B) Box plot showing cell death scores for 60 technical repeats over 3 biological 
repeats scored at 5dpi, with all samples shown as dots and outliers indicated by ‘x’. For each 
box, the centre line shows the median score and the edges of the box show the upper and lower 
quartiles. C) Western blot showing the expression of proteins at the infiltration sites. Blot shown 
is representative of 3 experiments showing similar results. D) Co-IP western blot showing 
protein input from plant extract (bottom) and outcome of immunoprecipitation of Pikp-1 or 
Pikp-1 mutants with FLAG magnetic beads (top). Blot is representative of 2 experiments 




One notable observation is that the swaps showing a marked increase in cell death 
response (Swap5 and 6) are not part of the effector interface seen in the AVR-Pia/Pikp-
HMA crystal structure, and in fact are on the opposite face of the HMA domain (see figure 
4.3-1). The reasons for this are not immediately apparent, but it could imply that the 
increase in cell death results from a change of interaction with a different domain of Pikp-
1, or a different immune signalling component, rather than a change in the interaction 
with AVR-Pia. If the mutations in the HMA domain are affecting intramolecular 
interactions, this could cause a change in how the immune response is triggered. 
4.4 Combining swaps enhances the response 
Following the positive changes seen in cell death response when elements of RGA5-HMA 
were transferred into Pikp-HMA, these investigations were extended by combining the 
successful swaps (Swap2, 5 and 6) to discover if this would enhance the response even 
further. These three swaps were combined in each possible combination, i.e. pairwise 
and then a triple swap (figure 4.4-1). 
 
The cell death response for each of these combinations was tested as before, and it 
appeared that certain combinations of swaps had the potential to increase the immune 
response slightly further (figure 4.4-2). Indeed, for one of the swaps (Swap2+6) the cell 
Figure 4.4-1: Design of RGA5/Pikp-HMA secondary structure swap combinations. 
Diagram showing the location of each secondary structure swap combination mapped onto the 
AVR-Pia/Pikp-HMA structure. AVR-Pia is shown in blue, Pikp-HMA is shown in gold, and 




death response appeared almost equal to that of WT Pikp for AVR-PikD. Western blot 
analysis confirmed that each swap was expressed successfully in the leaf tissue (figure 
4.4-2C). However, for co-IP experiments, the results were similar to those seen 
previously – i.e. there was inconsistency for the interaction with AVR-Pia. More repeats 
would be needed to obtain a clearer picture, but it appears overall that despite the 
increased cell death response, the interaction of the mutant NLRs with AVR-Pia is not 
stronger than for WT Pikp. In the data shown in figure 4.4-2D, none of Swap2+5, 2+6, 
5+6, 2+5+6 or WT Pikp-1 were able to pull down AVR-Pia. This implies that even if a 
direct interaction is occurring in planta, it is too weak to be visualised by co-IP. 
 The HR-like cell death assays are not quantitative, so it is difficult to assess precisely 
which swaps give the biggest increase in response. However, from a visual inspection of 
the box plots (figures 4.3-2 and 4.4-2), the best swaps appear to be: Swap2+6, Swap5+6 
and Swap5. These mutants were taken on for further investigation to try to understand 





Figure 4.4-2: RGA5/Pikp-HMA swap combinations can enhance response to AVR-Pia. 
A) Representative leaf images taken under UV light 5 dpi showing cell death progression at 
infiltration sites. B) Box plot showing cell death scores for 60 technical repeats over 3 biological 
repeats scored at 5dpi, with all samples shown as dots and outliers indicated by ‘x’. For each 
box, the centre line shows the median score and the edges of the box show the upper and lower 
quartiles. C) Western blot showing the expression of proteins at the infiltration sites. Blot shown 
is representative of 3 experiments showing similar results. D) Co-IP western blot showing 
protein input from plant extract (bottom) and outcome of immunoprecipitation of Pikp-1 or 





4.5 RGA5-HMA in Pikp-1 background is autoactive 
During testing of the RGA5/Pikp-HMA swaps, a further construct was generated that 
swapped the entire RGA5 HMA domain into the Pikp-1 background. The new construct 
was tested against AVR-Pia and an empty vector (EV) control and was found to be 
autoactive – i.e. there was a strong cell death response triggered by the NLR even in the 
absence of an effector (figure 4.5-1). 
 
Knowledge of this autoactivity calls into question the increase in cell death seen when 
different RGA5/Pikp-HMA swaps were tested. It is possible that some of the swaps have 
Figure 4.5-1: RGA5-HMA in Pikp-1 background triggers autoactive cell death in N. 
benthamiana. 
A) Representative leaf images taken under UV light 5 dpi showing cell death progression at 
infiltration sites. B) Box plot showing cell death scores for 60 technical repeats over 3 biological 
repeats scored at 5dpi, with all samples shown as dots and outliers indicated by ‘x’. For each 
box, the centre line shows the median score and the edges of the box show the upper and lower 
quartiles. C) Western blot showing the expression of proteins at the infiltration sites. Blot 
shown is representative of 3 experiments showing similar results. Note: For brevity, ‘RGA5-




retained the features that lead to autoactivity, in which case the increase in cell death 
seen in these cases is actually unrelated to AVR-Pia. 
To test whether the swaps that demonstrated a significant increase in cell death are 
actually autoactive, each of Swap2+6, Swap5+6 and Swap5 were re-tested against AVR-
Pia, but were also tested against AVR-PikD (to investigate whether the swaps retained 
the ability to recognise AVR-PikD) and an empty vector control (to test for autoactivity). 
The results (figure 4.5-2) show (as discussed in previous sections) that each mutant can 
respond to AVR-Pia more strongly than WT Pikp, in the order Swap2+6 > Swap5+6 > 
Swap5. The data also indicates that each of the mutants retains the ability to respond to 
AVR-PikD, and in fact they all respond more strongly than WT Pikp. The most interesting 
observation is the response of each mutant to the empty vector control. For Swap2+6, 
the response to the empty vector is almost identical to the response to AVR-Pia, 
indicating that the increase in cell death response was due to autoactivity rather than 
enhanced recognition of the effector. However, for Swap5+6 the response to empty 
vector is much lower than the response to AVR-Pia and for Swap5 the response to EV is 
almost non-existent. This suggests that for both Swap5+6 and Swap5, the increased 
response to AVR-Pia is effector-dependant, rather than simply an autoactivity effect. 
Figure 4.5-2C is a Western blot demonstrating that each construct has been successfully 
expressed in the leaf tissue. However, it should be noted that in the WT Pikp-1 and Swap5 
samples, there is some contamination. When the blot was visualised with the α-Myc 
antibody there appeared to be some AVR-Pia contamination in the EV lanes. This 
contamination seems to have occurred after harvesting of the leaf tissue, because there 
was no cell death response in these samples on the leaves, which would have occurred if 
there had been AVR-Pia present at the infiltration site. The expression test was repeated 
with two more biological repeats, and AVR-Pia was occasionally present as a 
contaminant in the EV lanes, although not consistently in the same samples between 
repeats (data not shown). This is likely to have been an issue with processing the samples 
and running the Western blot, because there does not appear to have been any effect on 
consistency of the cell death scoring. This experiment needs repeating to obtain better 
quality data without contamination present. 
As discussed for previous experiments, performing a co-IP indicates that none of WT 
Pikp, Swap2+6, Swap5+6 or Swap5 can consistently and irrefutably pull down AVR-Pia, 
although figure 4.5-2D shows some ambiguous bands on the blot that could possibly 




1) were able to pull down AVR-PikD, indicating that the secondary structure swaps have 
not impeded this interaction in planta. 
The autoactivity triggered by Swap2+6 is less strong than the autoactivity caused by the 
entire RGA5-HMA in the Pikp-1 background (figure 4.5-1), but the result could imply that 
α-helix 1 in the expected RGA5-HMA structure (Swap2) or β-strand 4 (Swap6) 
contributes heavily to the autoactivity. Given that the autoactivity of Swap5+6 is much 
lower than that of Swap2+6, it perhaps indicates that the greatest contribution to the 
autoactivity comes from Swap2, although it is not possible to confirm this through the 
data shown here. Indeed, neither the Swap2 nor Swap6 mutations show significant 
autoactivity alone, indicating that there could be an additive effect from the interplay of 
these two regions. Swap2 involves exchanging the non-functional metal binding loop in 
Pikp-HMA (Maqbool et al., 2015) for the equivalent region in RGA5-HMA. In Pikp-HMA, 
this loop is disordered in the crystal structure, and contains only one Cys residue in the 
region, rather than the required CxxC motif for metal-binding. In RGA5-HMA, the 
equivalent region is similarly missing the CxxC motif. It has been shown through 
additional work in the lab that this loop region has some involvement in autoactivity for 
related HMA proteins. sHMA1 is another (non-NLR) HMA domain-containing protein in 
rice and when the sHMA1 HMA domain was inserted into the Pikp-1 background, the 
resulting construct was strongly autoactive. Upon exchange of the metal-binding loop 
region of sHMA1 (namely ‘-SMPCEKS-’) with the native loop from Pikp-1 (‘-AMEGNNC’), 
the autoactivity was abolished (J. Maidment, unpublished). Although it was not possible 
within the timescale of the project, it would be interesting to find out whether mutating 
the metal binding loop in Swap2+6 would reduce the autoactivity, particularly given that 
the loop region in RGA5-HMA has greater sequence similarity to sHMA1 than to Pikp-1 
(the sequence in this region is ‘-HMPCGKS’). Given that Swap5+6 has some low level of 
autoactivity, it is also possible that Swap6 contributes to the autoactive phenotype in a 
minor way, whereas Swap5 showed little or no autoactivity. However, more experiments 
would be needed to deconvolute the various intramolecular interactions taking place 
and determine the basis of the observed autoactivity, which may be caused by a 









4.6 Purifying swaps in vitro 
Alongside the testing of swaps for HR-like cell death in planta, the constructs that had 
conferred increased response to AVR-Pia were also cloned for heterologous expression 
and purification in vitro, with the aim to characterise them and discover whether the 
increased response in planta correlated with an increased binding in vitro. In total, 
Swap2, Swap5, Swap6, Swap2+5, Swap2+6, Swap5+6 and Swap2+5+6 were all cloned 
into the pOPINM vector and expressed and purified from E. coli SHuffle cells using the 
same method as for WT Pikp-HMA. All mutants were successfully expressed (figure 4.6-
1), although the yields and stability of each protein varied quite considerably. 
 
 Intact mass spectrometry analysis for each mutant showed that full-length HMA was 
expressed in each case, but it was noted that for some of the mutants containing Swap5, 
the mass spectrometry analysis showed a peak at a molecular weight that was 2 Daltons 
lower than the expected full-length protein – this was true for Swap5 and Swap5+6 (see 
table 10). 
 
Figure 4.6-1: SDS-PAGE showing RGA5/Pikp-HMA 
swaps purified from E. coli. 
SDS-PAGE showing purified protein for a selection of 
RGA5/Pikp-HMA swaps. 
Figure 4.5-2: Some RGA5/Pikp-HMA swaps show an autoactive phenotype (see figure on 
previous page). 
A) Representative leaf images taken under UV light 5 dpi showing cell death progression at 
infiltration sites. B) Box plot showing cell death scores for 58 technical repeats over 3 biological 
repeats scored at 5dpi, with all samples shown as dots and outliers indicated by ‘x’. For each 
box, the centre line shows the median score and the edges of the box show the upper and lower 
quartiles. C) Western blot showing the expression of proteins at the infiltration sites. D) Co-IP 
western blot showing protein input from plant extract (bottom) and outcome of 





A decrease of 2 Da shown in intact mass spectrometry can indicate the presence of a 
disulphide bond – when two cysteines become oxidised, the loss of two hydrogen atoms 
leads to a reduction of 2 Da in the molecular weight. WT Pikp-HMA only contains one 
cysteine residue, so is unable to form any intramolecular disulphide bonds, but 
replacement of Pikp-HMA α-2 with α-2 from RGA5-HMA (i.e. Swap5) inserts a new 
cysteine residue. Using Phyre2 to predict the structure of Swap5 (as described in section 
4.3), it appears that the new cysteine residue has been positioned near to the cysteine 
present in α-1 (figure 4.6-2). Therefore, although it has not been proven, this might 
indicate that Swap5 can become stabilised in vitro due to the formation of an 
intramolecular disulphide bond. Mutants that contain Swap2 in addition to Swap5 (i.e. 
Swap2+5 and Swap2+5+6) do not show the 2 Da decrease in molecular weight, 
suggesting that there is no intramolecular disulphide bond formed. Although α-1 from 
RGA5-HMA (Swap2) also contains a cysteine residue, it is positioned in a slightly more 
N-terminal position in the sequence, so when Swap2 is inserted along with Swap5, the 
cysteine residues appear to be pushed further apart spatially in the structure (figure 4.6-
2) and may thus be unable to form the disulphide bond. Note that because the structures 
shown in figure 4.6-2 are only models predicted using Phyre2, they cannot give a 
definitive picture of how the residue side chains would be positioned within the actual 




Table 10: Comparison between the expected and actual molecular weights 




This preliminary characterisation of the swap proteins in vitro may help with 
understanding their intermolecular interactions, as more in planta and in vitro evidence 
of their behaviour is uncovered. 
4.7 Swap2+6 has increased affinity for AVR-Pia 
Having heterologously expressed and purified each swap that showed an increased cell 
death response to AVR-Pia, the affinities for each interaction could then be determined 
in vitro. To reduce the sample size, only the mutants with the greatest increase in 
response were tested – namely Swap2+6, Swap5+6 and Swap5. The affinities were tested 
using SPR, as described in Chapter 3. Given that, as described in section 4.5, it appeared 
that much of the response of Swap2+6 to AVR-Pia was caused by autoactivity rather than 
being effector-dependant, it was surprising to observe that the binding affinity of 
Swap2+6 for AVR-Pia had increased to 80 % of Rmax (at 100 nM analyte concentration), 
compared to 43 % for WT Pikp-HMA (figure 4.7-1A). Perhaps even more intriguingly, 
Swap5+6 and Swap5, which both showed an enhanced response in planta coupled with 
lower autoactivity, were effectively unable to bind to AVR-Pia in vitro. This lack of 
correlation between in planta response and binding in vitro suggests that there are 
additional effects contributing to cell death in planta in these cases, aside from a simple 
Figure 4.6-2: Phyre2 models of RGA5/Pikp-HMA Swap5 and Swap2+5. 
Models of Swap5 and Swap2+5 generated by a one-to-one threading method 
using Phyre2, with the template structure as Pikp-HMA (PDB accession 
5A6P). Cysteine side chains are shown in red, with the native Cys202 from 
Pikp-HMA shown in bold, and the cysteines that have been introduced by 





change in the interaction between effector and HMA domain. Further experiments would 
be needed to understand these effects. 
Using a larger range of analyte (HMA) concentrations for analysis (figure 4.7-1B), it was 
possible to obtain a value for the equilibrium dissociation constant (KD) of the 
Swap2+6/AVR-Pia interaction (figure 4.7-1). The value obtained was 10.7 nM, and while 
it was unfortunately not possible to quantify KD for the WT Pikp-HMA/AVR-Pia 
interaction (see Chapter 3, section 3.3), this value is comparable to the affinity of WT 
Pikp-HMA for its ‘matched’ effector AVR-PikD (4.0 nM determined in this experiment, 
5.9 nM determined in de la Concepcion, 2018). These SPR results show that the Swap2+6 
mutant can interact more strongly with AVR-Pia than WT Pikp-HMA, and thus an 
increased affinity has been engineered through these mutations. However, the Swap2+6 
autoactivity in planta must be addressed to make this mutation a viable construct for 
further exploration. 
Further investigations have shown that it is possible to purify a Swap2+6/AVR-Pia 
complex, using the same technique as for the Pikp-HMA/AVR-Pia complex. This purified 
protein was used for crystallography trials, and some small crystals were obtained from 
a commercial screen. Diffraction of the crystals was poor (data not shown) but this 
provides a promising first step to obtaining the structure of the Swap2+6/AVR-Pia 
complex, and discovering how the interaction of the two proteins has been strengthened 






The ability to engineer plant NLR proteins to respond more strongly to pathogen 
effectors is an exciting emerging technology. Armed with the knowledge of the AVR-
Pia/Pikp-HMA crystal structure (Chapter 3), the work described here aimed to increase 
the response of Pikp to AVR-Pia in planta by engineering the HMA domain. 
Figure 4.7-1: In vitro interactions of RGA5/Pikp-HMA swaps with AVR-Pia. 
A) Surface plasmon resonance bar chart showing %Rmax, the percentage of theoretical 
maximum response for HMA binding to immobilised effector, at three different concentrations. 
Each measurement represents an average of three results, with error bars showing standard 
deviation. Chart shown is representative of three separate experiments. Where KD values were 
obtainable, they are shown adjacent to the chart, ‘ND’ = Not Determined. B) Multi-cycle 
kinetics data for the interaction of Pikp-HMA with AVR-PikD (assuming a 2:1 fit model) and 
Swap2+6 with AVR-Pia (assuming a 1:1 fit model). Plots show the response units at each 
different analyte (HMA) concentration, with residuals plots alongside, showing difference 
between experimental and calculated data (green and red lines on residuals plots show data 





The first step was using the AVR-Pia/Pikp-HMA structure to design point mutations that 
might strengthen the binding. This proved challenging, as the proteins are held together 
predominantly by backbone interactions at the interface. The two mutants generated, 
Pikp-HMAA220E and Pikp-HMAG214E, were both unsuccessful at increasing the cell death 
response to AVR-Pia. The A220E mutation was made based on the knowledge that the 
residue in RGA5-HMA corresponding to the Pikp-HMA alanine was a dissimilar 
glutamate residue. However, the mutation appeared to have a negative impact on 
response in planta, indicating that this glutamate does not have a significant impact on 
the RGA5-HMA/AVR-Pia interaction, or that the impact is made in conjunction with other 
polymorphic residues in the region. The mutation of the small alanine residue to the 
bulky glutamate may in fact have introduced a steric clash that prevented a binding event 
from taking place. The second mutation, G214E had no effect on cell death, indicating 
that either the proposed new interaction at a loop region of the HMA was not formed, or 
did not have an impact on effector recognition. 
In order to make a difference to the Pikp response to AVR-Pia, larger changes in the HMA 
domain were necessary. Swapping regions from the RGA5-HMA domain into Pikp-HMA 
proved a successful strategy for increasing the response in planta, and combining the 
successful swaps into new mutants enhanced this response even further. However, it 
was puzzling that the enhanced cell death response did not lead to an enhanced 
interaction in planta between the mutant Pikp proteins and AVR-Pia (as shown by co-
IP). Equally puzzling was the fact that Swap5 and 6, which appeared to increase the 
immune response, were not at the expected interface with AVR-Pia. It was thought that 
perhaps the increase in cell death was caused by an intramolecular NLR interaction or 
an intermolecular interaction with another member of the signalling pathway. 
Some light was shed on these puzzles when it was discovered that RGA5-HMA in the 
Pikp-1 background was strongly autoactive, triggering an immune response even in the 
absence of an effector. With this information, it was apparent that some of the increased 
‘immune response’ may simply be due to autoactivity triggered by the insertion of part 
of RGA5-HMA. Upon investigation, it was discovered that the most ‘successful’ mutant, 
Swap2+6, fell into this category, and its entire cell death response in the presence of AVR-
Pia could be accounted for by autoactivity. However, Swap5+6 and Swap5 showed a 
much weaker autoactive phenotype, indicating that only certain regions of RGA5-HMA 
are needed to trigger the autoactivity. With the experiments carried out so far, it is not 
possible to deconvolute these observations, and more work will be needed to understand 




mutants (Swap1-6 and each swap combination) against the empty vector and 
investigating the levels of cell death for each. The interaction may in fact be more 
complicated than a single region, and could involve making further mutations to 
overcome the autoactivity. Given the similarity between the metal-binding loops of 
sHMA1 and RGA5-HMA, which are both known to cause autoactivity in the Pikp-1 
background, the first logical test would be to mutate the metal-binding loop in Swap2+6 
back to the native Pikp-1 loop, to see if that abolishes autoactivity, as seen for sHMA1 (J. 
Maidment, unpublished). For further investigation, it would be advantageous to repeat 
the autoactivity experiments using an empty vector in place of Pikp-2, to ensure that this 
autoactive phenotype is due to signalling transduced through the helper NLR, and not 
due to an additional effect. 
Another complication encountered during the testing of the mutant Pikp proteins in 
planta was the difficulties in obtaining clear results for their interaction with AVR-Pia. 
Despite an enhanced cell death response, co-IP experiments did not show a gain-of-
interaction for the mutants with AVR-Pia. However, as with WT Pikp and AVR-Pia 
(Chapter 3) it was difficult to get consistent results – for some biological repeats there 
appeared to be an interaction, whereas for other repeats no interaction could be seen. 
While it appears reasonable to conclude that any interaction between the proteins is 
weak, more repeats of the co-IP experiments would be needed to reach a proper 
consensus. 
The three swap proteins that showed the greatest increase in cell death response to AVR-
Pia were also tested for their interaction with AVR-Pia in vitro, via SPR. The results 
showed that there was little correlation between the in planta and in vitro observations. 
Despite Swap2+6, Swap5+6 and Swap5 all showing a strongly increased cell death 
response in planta, Swap5+6 and Swap5 were completely unable to bind AVR-Pia in SPR. 
Swap2+6, on the other hand, showed a strong increase in binding affinity – the KD for the 
interaction was comparable to the binding affinity of the AVR-PikD/Pikp-HMA complex. 
The disparity between in vitro and in planta studies observed with these swaps requires 
more investigation. It is possible that Swap5+6 and Swap5 can bind AVR-Pia in planta, 
but cannot bind the effector in vitro due to a factor such as the particular technique used 
or the different environment. Swap2+6 appears to be able to bind AVR-Pia strongly, so 
this remains the most promising candidate. If further investigations are able to prevent 
the autoactive phenotype, it is possible that Swap2+6 will still respond strongly to AVR-
Pia. One priority for future investigations would be the improvement of Swap2+6/AVR-




to discover which residues are responsible for enhancing the binding affinity. If only a 
few residues are involved, these single mutations could be introduced back into the Pikp-
HMA in the native Pikp-1 background. Hopefully this would lead to the same strength of 
binding, but without introducing the autoactivity from RGA5-HMA. 
An additional consideration when studying these responses is that modifying the HMA 
domain of Pikp may not generate a truly ‘RGA5-like’ response to AVR-Pia. Although a 
superficially enhanced HR-like cell death response may be seen in planta, it is not clear 
how this is being generated or what the intermediate steps might be. One immediately 
apparent feature of RGA5 is that the HMA domain is located at the C-terminus, rather 
than centrally (after the coiled-coil domain) as seen in Pikp-1. Coupled with the fact that 
Pikp-HMA binds AVR-Pia at a different interface compared to AVR-PikD, it is conceivable 
that RGA5 and Pikp-1 are sensing the effectors in a different manner and perhaps 
generating different downstream signalling responses after perception. Indeed, given 
that the RGA5/RGA4 NLR pair appears to operate in a different manner to the Pik-1/Pik-
2 pair i.e. by negative regulation rather than cooperation, it seems likely that the effector 
recognition and signalling are functioning in different ways. This could be one method 
by which the plant maintains a robust defence against M. oryzae. If two NLRs containing 
the same type of integrated domain can function through different downstream 
mechanisms, this might help to bypass any downstream signalling components that 
could be targeted by effectors. This is currently only speculation, and much more work 
would be needed to unravel the mechanisms of these NLR pairs. However, it should be 
noted that simply enhancing the strength of binding between HMA and effector may not 
be showing a full appreciation of the complexities of the signalling involved. 
Nevertheless, with some modifications and further work, the Swap2+6 mutant could 
represent an example of an engineered integrated HMA domain with an enhanced 




5. PexRD24 targets a 
host phosphatase 
Investigating the interaction of the P. infestans  effector 






In this chapter, the focus moves away from M. oryzae and MAX effectors to another 
important crop pathogen and another family of effectors – the RxLR effector family from 
P. infestans. RxLR effectors were discussed in Chapter 1 and differ from the MAX effectors 
in that they are defined not by a conserved structure, but by a conserved sequence. 
Nevertheless, as described in Chapter 1, many of the RxLR effectors are predicted to have 
conserved structural features, in the form of the WY domain fold (Chapter 1). 
The RxLR effector that will be investigated here is PexRD24 (figure 5.1-1), also known as 
Pi04314 (PITG_04314) in some publications. This project was begun as a collaboration 
with the lab of Paul Birch (at The James Hutton Institute, Dundee), who have published 
their own work on this effector (discussed below). Before the commencement of the 
project, the effector was subjected to a yeast two-hybrid screen and a putative host 
interacting protein was identified as protein phosphatase 1 (Boevink, Wang, et al., 2016). 
Aside from the possible phosphatase host target, little was known about PexRD24 prior 
to the start of the project. 
Phosphatase enzymes are vital in all kingdoms of life, as the regulation of 
phosphorylation state is important for correct post-translational modification or 
activation of many cellular components. In plants, phosphatases are known to be 
important in defence against both abiotic and biotic stress (Pais et al., 2009), and play a 
role in immune responses to some microbial pathogens. One recent example of the 
involvement of phosphatases in plant immunity is the enzyme PP2C38, which negatively 
regulates BIK1, an important signalling component for the PRRs FLS2 and EFR. 
Following perception of a possible pathogen, PP2C38 is phosphorylated, causing it to 
dissociate and allow full BIK1 activation (Couto et al., 2016). A number of other examples 
of phosphatase involvement in diverse aspects of plant immunity have been 
characterised in recent years (e.g. (Schweighofer et al., 2007; Widjaja et al., 2010)) and 
an effector from the bacterial pathogen Pseudomonas syringae, HopAO1, uses 
phosphatase activity directly to manipulate immune signalling (Macho et al., 2014). 
Exploitation of plant protein phosphorylation processes by pathogen effectors 
demonstrates the importance of phosphorylation to plant defences. 
The serine/threonine phosphatase PP1 also controls diverse processes in plants (Lin et 
al., 1998), and regulates events such as stomatal opening (Takemiya et al., 2006). The 
catalytic subunit PP1c is controlled by a diverse range of regulatory subunits, which 




motif, where R is arginine, V is valine, x indicates any amino acid and F is phenylalanine 
(Cohen, 2002). Later research has suggested that the regulatory subunits can interact 
with the catalytic subunit through a range of different surface patches and motifs 
(Heroes et al., 2013). These regulatory subunits have wide-ranging functions including 
targeting the catalytic subunit to different subcellular localisations, such as the nucleus 
(Allen et al., 1998) and targeting to specific substrates (Bollen et al., 2010). The binding 
of a regulatory subunit may not cause significant global structural changes to the 
catalytic subunit but may cause alterations in the substrate binding groove or block 
access to certain binding sites (Verbinnen et al., 2017). This can enhance or inhibit 
enzyme activity towards a particular substrate. 
PP1c has been extensively studied in mammals, and several crystal structures have been 
solved with the catalytic subunit in complex with inhibitors or regulatory subunits (for 
example (Choy et al., 2014; Hurley et al., 2007; Terrak et al., 2004)). The earliest 
structures of PP1c helped to elucidate its catalytic mechanism and shape an 
understanding of how the enzyme was regulated (Egloff et al., 1995; Goldberg et al., 
1995).  Metal ions were found bound to the catalytic subunit and have an important 
functional rather than structural role (Goldberg et al., 1995). Their identities are thought 
to be Zn2+ and Fe2+ in native PP1c (although Fe3+ and Mg2+ cannot be ruled out) but are 
substituted for Mn2+ when the enzyme is heterologously expressed from bacteria 
(Heroes et al., 2015). These structural studies have indicated that dephosphorylation is 
catalysed in a single step, and highlighted the importance of a particular histidine residue 
found at the catalytic site (Egloff et al., 1995). This histidine residue is the basis of the 
phosphatase-dead mutant described in later experiments. 
PP1c purified from bacteria has been shown to exhibit different properties and activities 
compared to native PP1c (Egloff et al., 1995). PP1c produced in E. coli is often highly 
insoluble (Peti et al., 2013), perhaps one reason why the structure of an apo PP1c has not 
been solved (Ragusa et al., 2010). A number of different strategies, such as the use of 
solubility tags and molecular chaperones, have been shown to improve yields of soluble 
protein (Peti et al., 2013). 
Since work began on this project, a collaborating group have published their findings on 
how the effector PexRD24 manipulates PP1c (Boevink, Wang, et al., 2016). PexRD24 
contains the RVxF sequence motif of a PP1c regulatory subunit (figure 5.1-1) and was 
shown to be re-localising PP1c out of the host nucleolus in in planta studies. One 
hypothesis given was that the effector may be directing PP1c to an alternative substrate 




silencing of PP1c isoforms in the host reduced the proliferation of P. infestans (Boevink, 
Wang, et al., 2016) and this observation led PP1c to be described as a susceptibility factor 
(Boevink, McLellan, et al., 2016); i.e. a host protein that aids pathogen infection (van 
Schie & Takken, 2014). Another recent example (Murphy et al., 2018) showed that a host 
kinase enzyme acts as a susceptibility factor that can be targeted by the RxLR effector 
Pi17316 from P. infestans. 
 
The work described in Boevink et al. has provided many clues about the purpose of 
PexRD24 as an effector but have not been able to elucidate its exact mode of action. In 
this chapter, investigations into obtaining stable, soluble PexRD24 and PP1c proteins in 
vitro are discussed, along with efforts to understand whether PexRD24 is affecting the 
enzyme activity of PP1c. 
5.2 PP1c isoforms can be expressed from E. coli 
Four different isoforms of PP1c were identified as possible PexRD24 interactors from a 
yeast-2-hybrid screen of a library made from infected potato cDNA (Boevink, Wang, et 
al., 2016), although only three were discussed in a later publication by Boevink et al. 
(Boevink, Wang, et al., 2016). As briefly discussed in section 5.1, working with 
phosphatase enzymes in vitro is notoriously difficult, so the first task was to discover 
whether the proteins could be purified in a stable and soluble manner for further study. 
Figure 5.1-1: Diagram highlighting sequence features of PexRD24. 
Diagram showing the amino acid sequence of the N-terminal (translocation) 
and C-terminal (effector) domains of PexRD24. The RxLR and EER motifs are 
circled in the N-terminal domain, and the RVxF motif (in this case KVTF) is 




Each PP1c construct was a different variant of the catalytic subunit of protein 
phosphatase 1. For these in vitro studies, only the C-terminal effector domain was used, 
the construct did not include the N-terminal RxLR-containing domain, which is predicted 
to be disordered in RxLR effectors (Boutemy et al., 2011). The predominant differences 
between each PP1c isoform are found at the termini (figure 5.2-1A), and these 
differences could have an effect not just on the interaction with PexRD24, but also on the 
behaviour of the protein in solution, such as its solubility. Therefore, each construct was 
subjected to a small-scale expression test, in the expression vector pOPINS3C (yielding a 
cleavable N-terminal SUMO solubility tag on the protein of interest), BL21(DE3) E. coli 
and LB media. Each construct was expressed successfully, but there was little to none of 
this protein present in the soluble fraction (figure 5.2-1B). The only isoform that 
appeared to have a noticeable level of solubility was PP1c-3. After trials using two 
different vectors, two E. coli strains and three different types of expression media (figure 
5.2-1C), it was not possible to increase protein solubility for the other isoforms. 
Therefore, PP1c-3 was scaled up in the original expression conditions (pOPINS3C, 
BL21(DE3), LB) (figure 5.2-1D). 
However, despite the purification of soluble protein there were continuing difficulties. 
For example, the purified protein began to precipitate out of solution over time and  
intact mass spectrometry analysis indicated that there was significant degradation of the 
protein, with residues largely being degraded from the C-terminus. The expected 
molecular weight of PP1c-3 (following cleavage of the His-SUMO tag) was 36885.4 Da. 
Intact mass spectrometry analysis showed that there was indeed a peak at 36884.9 Da, 
corresponding to full-length protein, but there were other species identified from the 
analysis (figure 5.2-2) at 36189.4 Da, 35147.9 Da and 34492.0 Da, which correlated with 
PP1c-3 with residues removed from the C-terminus and, in the case of the 34492.0 Da 









Although other attempts were made to obtain soluble protein for the remaining PP1c 
isoforms, these continued to be unsuccessful and will not be discussed further.  
As mentioned in section 5.1, PP1c purified from E. coli is a manganese-containing 
enzyme, so it was considered that the addition of Mn2+ ions during protein production 
may assist in the production of functional, well-folded protein. For an initial trial 1 mM 
Mn2+ (in the form of MnCl2) was added to the E. coli growth media, prior to induction of 
PP1c expression. The purified protein behaved the same with or without the addition of 
Mn2+, i.e. it was relatively unstable in solution. The secondary structure features of PP1c-
3 purified with and without the additional manganese were assessed using circular 
dichroism (CD) to determine whether the metal ions had made a difference to the overall 
structure of the protein. When overlaid (figure 5.2-3A), the far-UV spectra for the 
proteins appear very similar, indicating that the manganese has not changed the global 
structure of the protein. Although there were no distinct features in the spectra, the 
analysis appears to show a typical CD signature for a folded protein. The online analysis 
DichroWeb tool (Whitmore & Wallace, 2004) was used to assign the proportions of 
different secondary structure elements (figure 5.2-3A), and the results show a mixture 
of α-helical and β-strand elements within the protein. 
Figure 5.2-1: Intact mass spectrometry analysis of PP1c-3. 
Spectra showing different species identified by peaks in intact mass spectrometry analysis. 
Peaks of interest are circled, with the exact mass (in Daltons) labelled above each for clarity. 
 
Figure 5.2-2: Comparison of PP1c isoforms (see figure on previous page). 
A: Sequence alignment of the 4 PP1c isoforms. B: SDS-PAGE analysis of expression test 
for each PP1c isoform, tagged with an N-terminal SUMO tag. CL = crude Cell Lysate, SF = 
Soluble Fraction. Arrow indicates approximate expected location of each PP1c protein 
on the gel. C: Diagram indicating different expression conditions screened for PP1c 
isoforms, with different culture media in the top row, and different E. coli strains in the 
first column. Each cell shows the expression vector used alongside the corresponding 
media/ strain. AIM = Autoinduction media, LB = Lysogeny broth. D: SDS-PAGE analysis 
showing the purification of soluble PP1c-3 from pOPINS3C, BL21(DE3) and LB media, 





To further investigate the manganese requirements for PP1c-3, the purified protein 
(purified with additional Mn2+ in the media) was tested for thermal stability using 
differential scanning fluorimetry (DSF), also known as the thermofluor or thermal shift 
assay. This technique studies the stability of a protein by monitoring its temperature-
induced denaturation using the fluorescent dye SYPRO® Orange. SYPRO® Orange binds 
to hydrophobic residues within the protein, and as the protein is denatured (unfolded) 
with increasing temperature, the measured fluorescence is enhanced as the hydrophobic 
residues are exposed. When the derivative of fluorescence change versus temperature is 




Figure 5.2-3B shows that when PP1c-3 is purified with Mn2+ in the media, Tm is 36.0 oC. 
It should be noted that this protein had been stored at 4 oC for several days before 
running the assay, so it is likely that it was less stable than freshly purified protein. 
However, when additional Mn2+ ions are added to the assay buffer for this experiment, 
the melting temperature increases dramatically, and continues to increase with 
increasing concentrations of Mn2+ ions. When 0.5 mM Mn2+ is added to the assay buffer, 
Figure 5.2-3: Purified PP1c is stabilised by the addition of manganese. 
A: Circular dichroism (CD) analysis comparing the secondary structure features of PP1c-3 
expressed with and without Mn in the media, plot shows far-UV spectra for each. Numbers 
indicate the fraction of each type of secondary structure, where helix and strand assignments 
are divided into regular (helix/strand 1) and distorted (helix/strand 2) (Sreerama et al., 1999). 
NRMSD is the normalised root mean squared deviation. Secondary structure assignments were 
carried out using DichroWeb, solutions were obtained from the CDSSTR method using reference 
dataset 7 (Sreerama & Woody, 2000). B: Differential Scanning Fluorimetry (DSF) analysis 
showing the change in protein stability when different concentrations of Mn are added to the 
purified protein. PP1c protein had been purified with 1 mM Mn2+ in growth media. Protein 
unfolding is measured by an increase in fluorescence reading as temperature increases, and 
plots show the first derivative curves of thermal denaturation data. Numbers shown indicate 





the Tm is 62.4 oC, and when 4 mM Mn2+ is added, Tm has further increased to 66.4 oC. This 
implies that the addition of Mn2+ ions to purified protein can have a dramatic effect on 
protein stability. Therefore, in subsequent purifications of PP1c-3, 2 mM Mn2+ was added 
to the protein following purification, prior to concentration and storage of protein. 
As mentioned previously, PP1c-3 showed degradation when analysed using intact mass 
spectrometry. Several peaks seen in the analysis correlate to constructs with loss of 
residues from either the C-terminus or both the C- and N-terminus. Given that the 
purified protein appeared to be naturally degrading to these points, this suggested that 
these represented more stable constructs. Two of these constructs were cloned (figure 
5.2-4A) and expression trials were carried out. The construct PP1c-37-310, which 
comprised a removal of 6 residues from the N-terminus alongside a truncation from the 
C-terminus (giving a species at 34492.0 Da), was completely insoluble. PP1c-31-308, which 
was generated with only a truncation from the C-terminus (35147.9 Da), was 
successfully expressed and purified from E. coli (figure 5.2-4B). This implies that the N-
terminus of the protein might be important for solubility of PP1c-3. However, purified 
PP1c-31-308 still precipitated upon storage, suggesting that there are still issues with 
stability. 
In a publication regarding the stability of phosphatase enzymes from rabbit muscle, 
Zhang et al. (Zhang et al., 1994) concluded that the enzyme was stable when residues 
were truncated from the C-terminus, but not from the N-terminus, which agrees with the 
results shown here. Further, the authors remarked that loss of 33 residues (until the end 
of the conserved ‘Q-I-L-K’ residues) still allowed formation of a stable, active enzyme. 
Although the PP1c described in that paper is somewhat different to PP1c-3 used in this 
project (approximately 75 % sequence similarity) and therefore the conclusions may not 
be universally applicable for all PP1c enzymes, these findings could help to identify a 
more stable PP1c-3 construct. In addition, the corresponding cleavage of these same 
residues (truncation after the ‘Q-I-L-K’ conserved residues) from PP1c-3 yields a protein 
with greater similarity to the other PP1c isoforms, as those isoforms have a truncated C-
terminus compared to PP1c-3 (figure 5.2-1A). In Boevink et al., (Boevink, Wang, et al., 
2016) an amino acid alignment of the different PP1c isoforms from Solanum tuberosum 
trims the alignment to this same point, stating that these are the most well-conserved 
residues. Although these terminal residues in PP1c-3 could have an impact on its 
properties in vitro, it would be more informative for the sequence to closely resemble 




variants in vitro. Therefore, an additional truncation of PP1c-3 was made, PP1c-31-293, 
which removes these poorly conserved residues from the C-terminus (figure 5.2-4A). 
  
Figure 5.2-4C shows the purification of this construct, using the same expression 
conditions as WT full-length PP1c-3. Following successful purification of PP1c-31-293, 
intact mass spectrometry indicated that full-length PP1c-31-293 was present in the 
sample, with no indication of protein degradation. One interesting observation, which 
was seen consistently when this protein was purified, was an additional peak in the 
spectrum at a molecular weight 32 Da larger than the full-length protein (a peak at 
33465.8 Da). The consistency in the appearance of this species in different protein 
preparations suggests that it is not simply a contaminant and could indicate some 
protein modification. In intact mass spectrometry analysis, such species can usually be 
identified through a database of common protein modifications on individual residues. 
However, no explanation for the source or identity of this species has yet been found. 
Given that the protein degradation issue appeared to have been solved by the generation 
Figure 5.2-4: Generating truncated versions of PP1c-3. 
A: Diagram showing the location of truncation sites for each version of PP1c-3. B: SDS-PAGE 
analysis showing PP1c-31-308 at each stage of purification from pOPINS3C, BL21(DE3) and LB 
media, +3C = sample after addition of 3C protease, pur. = purified protein. C: Superdex 75 
26/600 gel filtration trace of PP1c-31-293 following cleavage of SUMO tag by 3C protease. Major 





of this new construct, this truncation version of PP1c-3 (PP1c-31-293) was used for 
subsequent enzyme assays and for some of the later crystallisation trials. 
Boevink et al. (Boevink, Wang, et al., 2016) described the production of a phosphatase-
dead version of PP1c-1, which had completely attenuated enzymatic activity due to 
mutation of a key catalytic histidine. Therefore, the equivalent point mutation was 
generated in PP1c-3, namely a mutation of His129 to an alanine, using an overlapping 
PCR method. Having generated the mutant construct (in both the WT and PP1c-31-293 
backgrounds), expression trials were carried out using the same expression conditions 
as for WT PP1c-3. However, it appeared that mutation of this key catalytic residue also 
affected the solubility of the protein, and it was not possible to achieve protein solubility 
using WT expression conditions. PP1c-3H129A was then tested in a medium-throughput 
expression screen, where two different expression vectors, four different E. coli strains, 
two different chemical chaperones and two different types of media were tested (figure 
5.2-5A). None of these combinations were successful at producing soluble protein 
(results not shown). Following this screening, it was found that small amounts of soluble 
PP1c-3H129A could be purified when co-expressed with the GroEL/GroES chaperones. The 
pGro7 plasmid (Takara Chaperone Plasmid Set #3340) was cotransformed with the 
expression construct and induced using L-arabinose, prior to induction of PP1c-3H129A. 
With the assistance of the molecular chaperones during expression, full-length PP1c-
3H129A was expressed (figure 5.2-5B) and purified, although there appeared to be a large 
proportion of the protein forming aggregates. The largest peak marked with an ‘x’ in 
figure 5.2-5B was analysed by SDS-PAGE and appeared to contain the protein of interest 
(result not shown). However, the elution volume is only 115 ml, which indicates that the 
protein is present as an aggregated, rather than monomeric form. The smallest peak on 
the trace, at 167 ml also contained PP1c-3H129A, and was at the correct elution volume to 
correlate with monomeric protein. Only the fractions corresponding to the monomeric 
protein were taken and used in further experiments. This phosphatase-dead version of 





5.3 PexRD24 can be expressed from E. coli 
Expression of full-length PexRD24 was more straightforward than PP1c. Although 
several different expression conditions were tested during screening, the most 
successful were those using pOPINS3C, an arabinose-inducible E. coli strain and LB 
media. However, during the final gel filtration purification stage, the peak on the trace 
showed a tail effect (Figure 5.3-1A), which could indicate a number of issues. It is 
possible that the protein is interacting non-specifically with the resin in the gel filtration 
column, and therefore taking longer to elute from the column, or could indicate that there 
is some degradation of residues from the purified protein, leading to truncated species 
eluting from the gel filtration column. SDS-PAGE analysis of the purified protein shows 
multiple bands at the expected size (Figure 5.3-1A), supporting the degradation theory. 
Finally, intact mass spectrometry showed that although full-length PexRD24 was present 
in the sample at 10429.5 Da, there were several other peaks in the spectrum. One of these 
peaks, at 7631.3 Da, is slightly ambiguous as it appears to be a truncation of PexRD24, 
but it could correlate with either a truncation from the C-terminus (cleavage of 24 
residues from the C-terminus gives a molecular weight of 7631.0 Da), or could be a 
truncation primarily from the N-terminus (cleavage of 20 residues from the N-terminus 
and only 5 residues from the C-terminus yields a species with a molecular weight of 
7631.8 Da). Analysis using the RONN online disorder prediction tool (Yang et al., 2005) 
indicated that the N-terminal region of the protein might be disordered (figure 5.3-1B). 
Figure 5.2-5: Generating a phosphatase-dead mutant of PP1c-3. 
A: Grid showing different expression conditions screened for PP1c-3H129A. Within each square, E. 
coli strain used is shown in the top row (BL21, AI = arabinose-inducible, R2I = RosettaTM 2 pLacI, 
soluBL21), expression vector used in shown in the middle row (pOPINF or pOPINS3C), chemical 
chaperone is shown in the bottom row (no chaperone, DMSO or ethanol). This same grid plan 
was screened for both LB and PowerBroth™ media. B: Superdex 75 26/600 gel filtration trace of 
PP1c-3H129A following cleavage of SUMO tag by 3C protease. ‘X’ indicates suspected elution 
region of aggregated protein. Arrow indicates peak on the trace where POI was found, at 167 ml 




Disordered regions of a protein can be more prone to degradation, because they are not 
folded or held together and stabilised by intramolecular interactions. This might suggest 
that the major truncation seen in the intact mass spectrometry analysis corresponds to 
loss of N-terminal rather than C-terminal residues, although it has not been proven.  
A truncated construct, corresponding to cleavage of this putative disordered N-terminus, 
was generated but proved difficult to express (results not shown). Therefore, despite 
these potential degradation issues, the full-length PexRD24 construct was used for all 
further experiments. Although multiple bands could be seen in SDS-PAGE analysis, the 
protein was soluble and could be stored at high concentrations without significant 
precipitation. An additional consideration is that it is not yet known how PexRD24 
interacts with PP1c-3 (as discussed in section 5.1). PP1c interacting proteins frequently 
contain short amino acid motifs that ‘dock’ onto the surface of PP1c (Heroes et al., 2013), 
and, aside from the RVxF motif known in PexRD24, it is unknown which other areas of 
the effector might be important for interaction. Indeed, Heroes et al. (Heroes et al., 2013) 
discuss that PP1c-interacting motifs are often found in regions that are intrinsically 
disordered, but that become more ordered upon interaction with PP1c. Although it is not 
clear how far this would apply to a pathogen effector, it may be detrimental to cleave off 
putative disordered regions of PexRD24, in case they are important for interaction with 
PP1c-3. 
Once purified, PexRD24 was analysed using circular dichroism. The spectrum (figure 5.3-




proteins (Greenfield, 2006). DichroWeb analysis indicates that PexRD24 contains 
around 48 % helical structure (figure 5.3-1C).  
As discussed in section 5.1, PP1c regulatory subunits often contain an ‘RVxF’ motif, which 
is important for binding to the catalytic subunit. Boevink et al. had generated an RVxF 
mutant of PexRD24 (Pi04314mut, here called PexRD24mut), where each of these 
residues was mutated to an alanine, generating a KVTF > AAAA mutation. This construct 
was shown to no longer interact with PP1c isoforms in yeast or in planta, and could not 
re-localise PP1c from the nucleolus (Boevink, Wang, et al., 2016). Using the same 
Figure 5.3-1: Purification and characterisation of PexRD24. 
A: Superdex 75 26/600 gel filtration trace of PexRD24 following cleavage of SUMO tag by 3C 
protease. Peak seen at 207 ml elution volume, with ‘tailing’. Accompanying SDS-PAGE shows 
fractions taken from under the peak. B: RONN disorder prediction (Yang et al., 2005) showing 
the probability of disorder for each residue in the amino acid sequence. Residue labelled in 
orange is putative site of N-terminal cleavage identified by intact mass spectrometry. C: Circular 
dichroism (CD) far-UV spectrum for PexRD24. Numbers indicate the fraction of each type of 
secondary structure, where helix and strand assignments are divided into regular (helix/strand 
1) and distorted (helix/strand 2). NRMSD is the normalised root mean squared deviation. 
Secondary structure assignments were carried out using DichroWeb, solutions were obtained 





construct as in Boevink et al., this mutant was cloned into pOPINS3C and expression was 
trialled from E. coli under the same conditions as for WT PexRD24. PexRD24mut was 
expressed on a small scale and partially purified using a Ni-IMAC column (figure 5.3-2). 
A clear band in SDS-PAGE analysis appears to show expression of soluble, full-length 
protein (tagged with a His-SUMO tag at the N-terminus). Another band seen by SDS-PAGE 
is at the correct molecular weight (approximately 13 kDa) to be the His-SUMO tag alone 
(which would also bind to the Ni-IMAC column and elute along with the tagged protein). 
This indicates that the solubility tag might be detaching from the PexRD24mut protein 
after expression, although untagged PexRD24mut cannot be obviously seen on the gel. 
This preliminary trial indicates that PexRD24mut can be expressed in a soluble form 
from E. coli. 
 
It was hypothesised that this mutant would no longer be able to form a complex with 
PP1c, and a co-expression study was carried out using PexRD24mut and PP1c-3 (data 
not shown). The rationale behind the co-expression was that His-SUMO tagged 
PexRD24mut would not be able to co-purify with untagged PP1c-3, and therefore PP1c-
3 would flow through a Ni-IMAC column without binding, whereas PexRD24mut would 
bind to the column and emerge when eluted with high concentrations of imidazole. 
Unfortunately, the experiment proved inconclusive. A superior experiment would have 
been to use analytical gel filtration or SPR to assess complex formation in vitro, but as 
described later in section 5.4, it was not possible at this stage. Therefore, no conclusions 
could be drawn about the ability of the KVTF > AAAA mutant to bind to PP1c-3 in vitro. 
Figure 5.3-2: Expression and partial purification of PexRD24mut. 
SDS-PAGE showing the expression and partial purification of the KVTF > AAAA PexRD24 mutant 
(PexRD24mut). BI = Before Induction of protein expression, CL = crude Cell Lysate, SF = Soluble 
Fraction, UB = Unbound, i.e. flow through from loading SF onto Ni-NTA column, W = Wash, i.e. 
flow through from washing Ni-NTA column with buffer, Eluate = SUMO-His tag protein eluted 




5.4 Interaction of PexRD24 and PP1c 
Having shown that both PexRD24 and PP1c-3 could be expressed and purified in vitro, 
the next stage was to determine whether they could form a complex. Initial experiments 
used analytical gel filtration to assess complex formation between the two proteins. 
However, the results did not indicate that any complex was formed between the two 
partners (see later and figure 5.4-3B). This might indicate that the two proteins do not 
form a complex in vitro, but another explanation is that the instability of the proteins – 
i.e. the tendency of PP1c-3 to precipitate out of solution and the N-terminal degradation 
of PexRD24 – prevents formation of a complex in vitro. If the proteins were more stable, 
it is possible that they would be able to form a complex. 
The next strategy was to co-express the two partners in an attempt to stabilise the 
proteins. For this co-expression strategy, a His-SUMO tagged construct of PexRD24 and 
an untagged construct of PP1c-31-293 were cotransformed into arabinose-inducible E. coli 
and expressed in LB media. During IMAC purification, the His-SUMO tagged PexRD24 
should co-elute with the untagged PP1c-31-293 if the two proteins form a complex. By 
allowing complex formation before the proteins are purified, the partners should not 
have degraded or precipitated, giving a better chance for successful complex formation. 
Figure 5.4-1A shows that co-purification was successful, as SDS-PAGE analysis shows 
two major bands in the purified protein at the approximate correct size to be PexRD24 
(10.4 kDa) and PP1c-31-293 (33.4 kDa). It was noted that the trace from the final 
purification gel filtration stage (figure 5.4-1B) showed a tailing effect on the peak, which 
could be an indication of degradation. However, intact mass spectrometry of the purified 
protein complex indicated that both full-length proteins were present in the sample. This 
suggests that co-expression has not only allowed complex formation, but has also 
stabilised the proteins. After four weeks of storage at 4 oC, a repeat intact mass 
spectrometry analysis indicated that there was some degradation of the effector, 
suggesting that there was not complete protein stabilisation, but increased stability 
compared to PexRD24 expressed alone. Additionally, there was still some precipitation 
of the complex at high protein concentrations, but this was to a lesser extent than PP1c-
31-293 alone. Overall, it is possible to purify a PexRD24/PP1c-3 complex by co-expression, 





Despite the progress with stabilising proteins through complex formation, the regular 
occurrence of protein precipitation leads to reduced yield and potential issues with 
measuring protein concentration accurately. Not only this, but protein that is unstable 
could give misleading results in experiments, such as false negatives in protein 
interaction assays. Therefore, a commercial buffer screen from Molecular Dimensions 
(RUBIC Buffer Screen MD1-96) was used to screen for more suitable buffer conditions 
that might enhance stability. Previously, all proteins had been purified in a standard gel 
filtration buffer containing 20 mM HEPES (pH 7.5) and 150 mM NaCl (with Mn2+ added 
to PP1c-3 after purification), but this screen tests a range of different buffer systems, salt 
concentrations and pH. The screen is performed using a DSF method as described in 
section 5.2. Samples of the protein (in the standard gel filtration buffer) were added to a 
96-well screen containing different combinations of buffer conditions, and SYPRO® 
Orange dye was added. The protein was then subjected to incremental temperature 
increases, with fluorescence readings being taken at each temperature as the protein 
unfolded. Instead of plotting the derivative curves (as described in section 5.2), here the 
raw data was plotted, and an example curve is shown in figure 5.4-2A, indicating the 
features of each trace. As shown, Tm is defined as the temperature at which half maximum 
fluorescence is achieved. The traces for each buffer condition in the screen were analysed 
Figure 5.4-1: Purification of a PP1c-31-293/PexRD24 complex. 
A: SDS-PAGE analysis showing the expression and purification of the PP1c-31-293/PexRD24 
complex, where PP1c-31-293 is untagged, and PexRD24 is tagged with an N-terminal SUMO tag. CL 
= crude Cell Lysate, SF = Soluble Fraction, +tag = partially purified complex before removal of 
solubility tag, pur. = purified protein. B: Superdex 75 26/600 gel filtration trace of PP1c-31-
293/PexRD24 complex following cleavage of SUMO tag by 3C protease. Peak seen at 166 ml 




visually, by plotting groups of traces together that allowed comparison of a single 
variable e.g. increasing imidazole concentration. The conditions that yielded the highest 
Tm from each group were then plotted together, and so on until the highest-ranking 
buffer conditions could be identified. Sample traces for some of the buffer conditions are 
shown in figure 5.4-2B, indicating how the changes in buffer can greatly affect the 
thermal stability of the proteins. For example, it is clear from figure 5.4-2B that buffer 
condition C2 is extremely destabilising, because the fluorescence intensity is high even 
at low temperatures – this indicates that the protein has become unfolded as soon as it 
encounters the buffer condition, before it has been heated. By contrast, the trace for 
buffer condition D12 shows low fluorescence intensity at low temperatures before a 
sharp increase with clearly defined Tm at approximately 60 oC. Broadly, this indicates 
that buffer condition D12 would be much more suitable for the PexRD24/PP1c-3 
complex than buffer condition C2. Following visual analysis, the most stabilising buffer 
conditions were found to be sodium phosphate buffer with a high salt concentration at 
neutral pH. The highest Tm overall was conferred by buffer condition D4, which 
contained 100 mM sodium phosphate (pH 7.5) and 250 mM NaCl. These parameters 
were used to create a new gel filtration buffer. One difficulty to overcome was that MnCl2 
cannot be readily added to this new buffer because the Mn precipitates as manganese 
(II) phosphate. Therefore, it was not possible to add additional Mn2+ to the protein after 
purification, as had been standard practise. Instead, 1 mM MnCl2 was added to the media 
prior to inducing protein expression, anticipating that the protein will take up Mn2+ as 
required during expression. The PexRD24/ PP1c-31-293 complex was then purified using 
the new phosphate buffer, and it was clear in the final gel filtration stage that the elution 
peak was larger and more symmetrical than when the complex was purified using the 
standard HEPES-based gel filtration buffer (figure 5.4-2C). Following purification, the 
final yield was significantly increased, and the protein itself was more stable and less 
prone to precipitation. This indicates that the increased salt concentration and use of a 
phosphate buffer system is advantageous for protein stability. In addition, both partners 
of the complex were purified separately in the same phosphate buffer. PexRD24 
appeared to be successfully purified, and the previous ‘tailing’ effect seen on the gel 
filtration trace (see figure 5.3-1A) is reduced by the higher ionic strength of the 
phosphate buffer. PP1c-3 could also be concentrated to much higher concentrations 






Figure 5.4-2: The PP1c-31-293/PexRD24 complex is more stable in a phosphate-based 
buffer. 
A: Representative DSF melt curve from a buffer screen. The graph shows fluorescence intensity 
plotted against temperature. 1: At low temperatures the protein is folded, and SYPRO® orange 
cannot bind. 2: The gradient of the curve increases as the protein begins to unfold, allowing 
SYPRO® orange dye to bind to hydrophobic residues in the core, increasing fluorescence. 3: The 
fluorescence intensity reaches a maximum as all the protein is unfolded. 4: Dye begins to 
dissociate from the protein, reducing fluorescence levels. The point at which the fluorescence 
intensity is half its maximum value is where 50% of the protein is unfolded. The corresponding 
temperature at this point is known as Tm – the melting temperature of the protein. B: DSF 
analysis showing the change in PP1c-31-293/PexRD24 complex protein stability in different 
buffers. Plot shows fluorescence intensity plotted against temperature. Graph shows 6 example 
curves from the commercial buffer screen, labels indicate their position in the grid. C: Superdex 
75 26/600 gel filtration traces of PP1c-31-293/PexRD24 complex following cleavage of SUMO tag 




Since the optimised buffer conditions appear to enhance the stability of PP1c-31-293 and 
its complex with PexRD24, it was considered that the stabilisation might allow the 
proteins to form a complex in vitro, rather than just through co-expression. This would 
open up a number of possibilities for different experiments, including biophysical 
analysis to quantify the interaction of the two proteins. Previous experiments showed 
that mixing purified PexRD24 and PP1c-3 and assessing complex formation by analytical 
gel filtration was unsuccessful, because no obvious peak shift was seen to indicate 
complex formation, and traces were of poor quality. A trace showing this experiment 
using proteins purified in the HEPES gel filtration buffer is shown in figure 5.4-3B. For 
this experiment, no complex formation is evident, as two small peaks in the mixed 
protein sample can be seen at similar elution volumes to each protein alone. Note that in 
this comparison experiment, full length WT PP1c-3 was used, rather than the truncated 
PP1c-31-293.  
The same experiment was then repeated using proteins that had been purified in the 
optimised phosphate gel filtration buffer. The analytical gel filtration column was also 
equilibrated in this buffer. Both PP1c-31-293 and PexRD24 were run separately, and a 
PP1c-31-293/PexRD24 complex generated by co-expression was also assessed to give an 
expected elution volume. Finally, PP1c-31-293 and PexRD24 were mixed together and 
incubated for 7 hours on ice prior to running down the gel filtration column. Figure 5.4-
3A shows that the traces for PP1c-31-293, PexRD24 and the complex generated by co-
expression all show single, symmetrical peaks. There is a clear peak shift from 11.1 ml to 
10.3 ml when PP1c-31-293 is co-expressed along with PexRD24. When the two proteins 
are mixed together in a 1:1 ratio in vitro, the peak on the trace is less clear. It appears to 
be a double peak, with the two maxima at 9.8 and 10.7 ml (figure 5.4-3A). It is not obvious 
why the peak should appear in this way – it is possible that there could be a different 
oligomerisation state being formed when the proteins are mixed in vitro, leading to 
slightly different elution volumes (for example, if the PexRD24:PP1c-3 complex was in a 
2:1 ratio rather than a 1:1 ratio, this could account for the peak at 9.8 ml, which appears 
to indicate a larger molecular weight than the size of a 1:1 complex, but smaller than the 
size of a 2:2 complex). Alternatively, there could just be a deformity in the peak that gives 
a misleading indication of the elution volume. Nevertheless, there appears to be a 
definite peak shift when the two partners are mixed in vitro – if no complex was formed, 
peaks would be expected at the same elution volumes as the uncomplexed proteins (11.1 
and 12.8 ml). This gives a promising indication that using the stabilising phosphate 
buffer for protein purification allows PP1c-3 and PexRD24 to form a complex when 




gel filtration experiment needed, alongside accompanying SDS-PAGE analysis of the 
fractions for confirmation of results.  
 
Alongside experiments to study the biochemistry of PP1c and PexRD24, a key 
breakthrough into learning how they interact would be to obtain the atomic structure of 
the two proteins in complex. Gaining structural insights into how PexRD24 binds to the 
PP1c host target might give some indication of what impact the effector has, if any, on 
the conformation and/or activity of the enzyme. To achieve this, numerous 
crystallisation screens were set up for the purified PP1c-3/PexRD24 complex. These 
screens were set up for both full-length PP1c-3 and for PP1c-31-293, as well as using 
Figure 5.4-3: Stabilised proteins allow PP1c-31-293/PexRD24 complex formation in vitro. 
A: Overlaid analytical gel filtration traces showing the elution of PP1c-31-293 (blue) and 
PexRD24 (red) alone, along with PP1c-31-293/PexRD24 both mixed together in vitro (green) 
and co-expressed as a complex (grey). All samples purified in phosphate gel filtration buffer, 
and experiment was run in the same buffer. Volumes indicate elution volumes. B: Comparison 
with experiment in A, using the standard HEPES gel filtration buffer for the experiment and 
protein purification. Overlaid analytical gel filtration traces showing the elution of (full-length) 
PP1c-3 (blue) and PexRD24 (red) alone, along with PP1c-3/PexRD24 mixed together in vitro 





protein that had been purified in both the standard HEPES-based gel filtration buffer and 
the optimised phosphate buffer. Numerous protein crystals were obtained from 
commercial screens, but they were usually flat or needle-like and of insufficient quality 
to test for X-ray diffraction. Images of a sample of these crystals are shown in figure 5.4-
4, along with descriptions of their crystallisation conditions. Crystal quality was 
improved upon using the more stabilised PP1c-3 construct (PP1c-31-293) and using the 
phosphate gel filtration buffer for protein purification, so it is possible that further 
screening and optimisation of the complex would yield diffraction-quality crystals in the 
future. 
 
Figure 5.4-4: Images of sample PP1c-3/PexRD24 crystals. 
Photographs of PP1c-3/PexRD24 crystals grown in different commercial crystallisation screens. 
Labels indicate the conditions of crystallisation. Centre: Colour photo of PP1c-31-293/PexRD24 
complex crystals, purified in phosphate gel filtration buffer, from PACT™ screen (Molecular 
Dimensions). Clockwise from top: PP1c-3/PexRD24 complex crystals, purified in HEPES gel 
filtration buffer from PACT™ screen. PP1c-3/PexRD24 complex crystals, purified in HEPES gel 
filtration buffer from PACT™ screen. PP1c-31-293/PexRD24 complex crystals, purified in HEPES 
gel filtration buffer, from PEGs suite (Qiagen). PP1c-31-293/PexRD24 complex crystals, purified in 





5.5 Effect of PexRD24 on PP1c enzyme activity 
Phosphatase enzymes are responsible for dephosphorylating numerous substrates in 
plant and animal cells (see section 5.1). One hypothesis for PexRD24 targeting PP1c is 
that the effector is manipulating the enzyme activity for the benefit of the pathogen. To 
test this hypothesis, assays were designed to confirm the activity of purified PP1c-3 in 
vitro, and test whether PexRD24 has any effect on the enzyme activity.  
An important consideration throughout the phosphatase assays was the availability of 
manganese ions. For the enzymes to be active, it was found that Mn2+ was an essential 
component of either the assay buffer itself or the buffer containing the purified protein. 
Addition of Mn2+ during expression of the protein was not sufficient to generate an active 
enzyme. When PP1c-3 was purified in a HEPES-based gel filtration buffer, 2 mM MnCl2 
was added to the purified protein, but in the case of PP1c-3 purified in a phosphate-based 
buffer, MnCl2 (1 mM) was added only to the assay buffer, to minimise precipitation of 
manganese phosphate. 
A further issue encountered when designing the phosphatase activity assays was that 
PP1c-31-293 and PexRD24 could not form a complex when mixed in vitro. Later 
experiments using an optimised purification buffer indicated that complex formation 
might be possible when the proteins are stabilised (see section 5.4), but these results 
were not available when designing the enzyme assays. Therefore, the only method 
available to obtain the two proteins in complex was through co-expression. By necessity, 
this means that in the enzyme assays, the PP1c-3/PexRD24 complex studied is from a 
different protein preparation obtained using a slightly different methodology (i.e. co-
expression). The experiment would be better controlled if the same preparation of PP1c-
3 could be directly compared with and without the presence of PexRD24, but given that 
this was not possible, this variable needs to be taken into consideration when 
interpreting the results. With the advancement of a buffer that promotes protein 
stability, future work on this project could focus on improving this aspect of the assay. 
Two different methods were used to measure the phosphatase activity of PP1c-3. The 
first method uses a generic threonine phosphopeptide (K-R-pT-I-R-R) (Merck) as a 
substrate for the enzyme (figure 5.5-1A). When the phosphatase enzyme 
dephosphorylates the peptide, the reagent malachite green is used to detect free 
phosphate in the buffer, yielding a green colour generated by a complex of malachite 
green, molybdate and phosphate formed under acidic conditions (Feng et al., 2011), that 




293 complex formed by co-expression, and the phosphatase dead mutant PP1c-3H129A 
(made in the PP1c-31-293 background). Initial tests were carried out to identify the 
optimum enzyme concentrations and reaction times to use in the assay. An observation 
from these tests was that the complex appeared much more efficient at 
dephosphorylation activity than the phosphatase enzyme alone. Low concentrations of 
complex were able to hydrolyse much more substrate in a given time period than the 
same concentration of phosphatase alone (data not shown). Indeed, in the results for the 
assay (figure 5.5-1A) the absorbance at 620 nm (directly related to the amount of free 
phosphate) is higher (up to two-fold increased) for the PexRD24/ PP1c-31-293 complex 
than for PP1c-31-293 alone. This suggests that the enzyme activity of PP1c-3 is enhanced 
by PexRD24. There could be a number of reasons for this effect. It is possible that the 
effector is promoting an enhanced phosphatase activity. An alternative explanation is 
that when the phosphatase is purified as a complex, it is more stable than phosphatase 
purified as an isolated catalytic domain (described elsewhere in this chapter), and the 
more stable enzyme might be expected to have a higher rate of activity. The negative 
control PP1c-3H129A showed no activity at all, indicating that it has been successfully 
generated as a phosphatase-dead mutant. This assay was repeated three times and 
comparable results were obtained for each repeat. Figure 5.5-1A shows the results for 
this assay displayed as the raw data – i.e. absorbance at 620 nm. This raw data can be 
converted to the amount of phosphate released by generating a standard curve (using 
malachite green to detect known concentrations of phosphate in solution). Using the 
standard curve, the absorbance readings can be converted to picomoles of phosphate for 
the unknown concentrations of phosphate released by the enzyme. However, difficulties 
were encountered in obtaining a fully linear standard curve, and it was decided to plot 
raw data to avoid any over-interpretation of the results. Upon further optimisation of the 
assay, it would be possible to convert to a more standard representation of the 
phosphatase assay results. 
Although the assay described above demonstrated the success of generating active PP1c-
3 in vitro, it was unclear if the perceived increase in activity upon complexation with 
PexRD24 was simply due to enhanced stabilisation of the enzymes. Following 
development of the optimised buffer for purification of PP1c-3, the phosphatase assay 
was repeated. However, a crucial factor in stabilising PP1c-3 in solution is the addition 
of phosphate to the purification buffer, and an assay that relies on the detection of free 
phosphate in solution is obviously unsuitable in this situation. Therefore, a new assay 
needed to be identified that would not rely on the detection of free phosphate. In this 




phosphatase, is converted to p-nitrophenol. Under alkaline conditions, this product is 
converted to the p-nitrophenolate ion, which absorbs at 405 nm, and appears yellow 
(Lorenz, 2011). By detecting the presence of p-nitrophenolate, the phosphate in the 
assay solution deriving from the buffer composition should not affect the results. For this 
provisional experiment, the assay was not optimised for enzyme concentration or 
reaction time, and the same final enzyme concentration (0.4 μM) was used as described 
for the previous assay. The protocol for the assay was adapted from a phosphatase 
activity assay by Kelker et al. (Kelker et al., 2009). Substrate concentration was used 
according to this published protocol. As shown in figure 5.5-1B, the curves for PP1c-31-
293 and the PP1c-31-293/PexRD24 complex are not saturating, indicating that the enzyme 
is fully turning over even 8 mM substrate in the 15 minute reaction time. To obtain better 
results, the concentration of enzyme may need to be lowered, or the concentration of 
substrate increased. As expected, the negative control showed no enzyme activity. A 
commercially-available purified phosphatase had also been purchased for use as a 
positive control. The recombinant human PPP1A protein purchased from Abcam 
(ab113150) showed significantly lower activity than PP1c-3. The proteins share around 
82 % sequence identity and are originally sourced from different organisms (human and 
S. tuberosum). Both proteins were generated by recombinant expression from E. coli, but 
the commercially purchased enzyme includes an N-terminal His tag, which has been 
cleaved off in the case of PP1c-3. An additional consideration is that it was not possible 
to confirm the concentration of the enzyme supplied. The manufacturers data sheet 
shows the enzyme to be at 5 μM concentration, but the small quantity available meant 
that it was not practical to confirm this using equipment in the lab, as it would have used 
up a significant quantity of the sample. This means that it is not certain that the enzyme 
was actually used at 0.4 μM as presumed. Therefore, although the positive control was 
used as accurately as possible, and chosen to be as close as possible in sequence identity 
to the PP1c-3 enzyme, it was not a suitable control for use in this instance. 
The assay using the stabilised proteins in phosphate buffer was only carried out once 
due to time constraints. However, it demonstrates that the PP1c-3 protein can cleave the 
pNPP substrate. Interestingly, despite the need to modify the concentrations of substrate 
and enzyme, the absorbance readings of PP1c-31-293 in complex with PexRD24 appears 
to be higher than the enzyme alone, as seen for the previously described assay. The 
consistency of this effect suggests that it is not related to a particular condition of either 
assay (such as buffer composition, or substrate used) but it is still not clear whether the 




specific for the interaction of PexRD24. Further experiments would be needed to 
determine this. 
Overall, the phosphatase assays carried out thus far have demonstrated that PP1c-31-293 
is an active enzyme, that is capable of removing phosphate from two different synthetic 
substrates in vitro. It also appears that when PexRD24 is bound to PP1c-31-293, it does not 
inhibit the activity of the enzyme. The fact that the activity of the PP1c-31-293/PexRD24 
complex appears greater than for the enzyme alone cannot be fully accounted for 





Figure 5.5-1: Enzyme assays suggest that PexRD24 does not inhibit PP1c-3 activity. 
A: Diagram outlining the mechanism of the phosphatase assay involving a synthetic 
phosphopeptide substrate with detection by malachite green. Scatter plot shows absorbance at 
620 nm for different concentrations of phosphopeptide substrate, turned over by PP1c-31-293, 
PP1c-31-293/PexRD24 complex or the PP1c-31-293H129A negative control. Measurements were 
taken in triplicate and assay was carried out three times, error bars represent standard 
deviation. B: Diagram outlining the phosphatase assay mechanism using pNPP as the substrate. 
Scatter plot shows absorbance at 405 nm for different pNPP substrate concentrations when 
turned over by PP1c-31-293, PP1c-31-293/PexRD24 complex, the PP1c-31-293H129A negative control, 
or the PPP1A control enzyme (Abcam). Note: PP1c-31-293 construct is used throughout, for all 






The goal of this project was to use structural biology and biochemistry to understand 
how the P. infestans effector PexRD24 manipulates its host target protein phosphatase 1. 
It was hoped that obtaining structural information about how the proteins interact, and 
discovering if the effector altered enzyme activity, would complement the work by Paul 
Birch’s lab in studying the localisation and interaction of the two proteins in planta. 
Initial expression screens indicated that only one of the PP1c isoforms identified from 
the original yeast-2-hybrid screen, PP1c-3, could be expressed in a soluble manner from 
E. coli. The other isoforms remained insoluble, despite numerous trials. It should be 
noted that this includes PP1c-1, the isoform discussed at length in Boevink et al. 
(Boevink, Wang, et al., 2016). Unfortunately, it was not possible to characterise this 
particular isoform in vitro, but it was hoped that the conclusions made in this work about 
the behaviour and activity of PP1c-3 would also be applicable to PP1c-1.  
As discussed in section 5.1, it is well documented in the literature that protein 
phosphatases can be unstable when expressed from E. coli and purified in vitro. Using 
molecular chaperones, altering buffer conditions and stabilisation with interacting 
proteins are all well documented techniques for obtaining soluble phosphatase proteins, 
and these methods were adopted for PP1c-3. Initial purification attempts focussed on 
the use of different E. coli strains and solubility tags, but this was later diversified. For 
the phosphatase dead mutant PP1c-3H129A, soluble protein was particularly elusive, and 
only obtained via co-expression with the GroEL/GroES chaperones. Difficulties with 
obtaining the soluble protein led to slow progress in several areas of the project. 
Progress was made by truncating PP1c-3 to make a more stable construct, PP1c-31-293, 
which was less prone to degradation, but the protein would still readily precipitate out 
of solution when stored. 
A further observation made when PP1c-31-293 was analysed by intact mass spectrometry 
was that there appeared to be an additional species, alongside the full-length protein, 
present in the sample that was 32 Da larger than the molecular weight of the full-length 
PP1c-31-293. This species was seen repeatedly when analysing PP1c-31-293, either alone or 
in complex with PexRD24. The identity of this species was not found, but could represent 
a post-translational modification of the protein, for example the oxidation of a 
methionine side chain (Gerhard Saalbach, personal communication). However, there 




side chains can affect the stability and properties of a protein, but whether or not this 
putative modification had any impact on protein stability is not possible to determine. 
One problematic result of the instability of PP1c-3 (and the degradation of PexRD24) was 
that it was not possible to obtain complex formation by mixing purified proteins in vitro. 
This limited the experiments that could be carried out, as biophysical techniques require 
measuring the actual process of complex formation to assess strength of binding. 
One area of focus for the project was designing an assay to test the enzyme activity of 
PP1c-3, and how it was affected by PexRD24. Preliminary assays showed that both full 
length PP1c-3 and the PP1c-31-293 truncation were active enzymes, but the phosphatase 
activity was dependent on manganese ions being provided to the purified protein. 
However, when studying the effect of PexRD24 on the enzyme activity, these assays 
relied on the effector being co-expressed and co-purified with the enzyme. This made it 
difficult to assess whether any alteration of enzyme activity was due to the stabilisation 
of the enzyme through co-expression, or whether it was due to a specific input from the 
effector. At high concentrations of substrate, the absorbance (as an indicator of enzyme 
activity) was enhanced about two-fold when the effector was present, and this effect 
could simply be due to the enzyme being better folded in its active state when stabilised 
by a partner. It is known that the PP1c catalytic subunit is heavily reliant on regulatory 
subunits for specifying localisation or substrate in vivo, so it might be expected that the 
catalytic subunit would be stabilised by a partner, as it does not function in isolation in 
vivo. To test this further, PP1c-3 could be co-expressed with another phosphatase-
interacting protein, and the activity examined to see if the same effect occurs when PP1c 
is stabilised by a different partner. However, one conclusion that can be drawn from the 
assays is that the effector is not inhibiting the enzyme in vitro. This relates to the study 
by Boevink et al. because the authors tested the enzyme activity of GFP-tagged PP1c 
purified from plant tissue and found it to be active whether or not it was bound to 
PexRD24. In addition, a phosphatase-dead version of PP1c did not enhance pathogen 
colonisation to the same extent as active enzyme, indicating that phosphatase activity is 
required for PexRD24 function (Boevink, Wang, et al., 2016). It should be noted that 
testing enzyme activity in vitro using artificial substrates may not be giving an accurate 
picture of the enzyme activity in vivo. For example, this heterologously expressed PP1c 
is manganese-dependent, but the metal ions incorporated in vivo are thought to be Fe2+ 
and Zn2+ for eukaryotes. The addition of Mn2+ ions to the enzyme are considered to 




2017). Nevertheless, without knowledge of the native PP1c substrates, this provides a 
useful starting point for understanding PexRD24 action in more detail.  
Boevink et al. proposed that PexRD24 may be affecting salicylic and jasmonic-acid 
defence signalling pathways. Alongside a role in PP1c re-localisation, regulatory subunits 
can have a role in modifying the substrate specificity of the enzyme. For example, the 
regulatory subunit MYPT1 causes a significant change in the catalytic site of PP1c to 
enhance its activity towards a particular substrate, in this case myosin (Terrak et al., 
2004). If the enhancement of the catalytic activity of PP1c observed here in the presence 
of PexRD24 is not simply due to stabilisation of the protein in vitro, it may mean that 
PexRD24 is in some way altering the catalytic site of the enzyme to have an enhanced 
activity towards the substrates. An alteration of catalytic site could mean that PexRD24 
is not only re-localising the enzyme but altering its specificity for a particular substrate, 
such as a component of the salicylic or jasmonic-acid defence signalling pathway. 
However, in the absence of any structural information at present, this remains 
speculation.  
Late on in the project, a major breakthrough occurred with the identification of a buffer 
composition, using phosphate and higher sodium chloride concentration, that stabilised 
PP1c-3 in vitro. The purified protein could be used at higher concentration without 
precipitation, and a preliminary analytical gel filtration experiment indicated that the 
stabilising buffer might now allow complex formation to occur in vitro. Although not 
feasible within the time scale of the project, it would now be possible to carry out, for 
example, SPR experiments to quantify the strength of binding between PP1c-3 and 
PexRD24. This could also be extended to testing the interaction between the RVxF 
mutant, PexRD24mut, and PP1c-3, to confirm that this interaction motif mutant no 
longer binds to PP1c-3. Similarly, it would be interesting to test whether the 
phosphatase-dead mutant, PP1c-3H129A, still interacts with PexRD24, despite the 
mutation in its catalytic motif. Being able to achieve complex formation by mixing rather 
than co-expressing the proteins would also allow for better control in enzyme activity 
assays, as the same preparation of enzyme could be used when mixed with the effector 
and when tested in isolation. 
Finally, the structural characterisation of the interaction of PP1c and PexRD24 was one 
aim of the project. Although the crystal structure has not been uncovered within the 
timescale of the project, crystals have been generated, which could be further optimised. 




influences the enzyme, and what the function might be in re-localising it out of the 
nucleolus in planta. 
Overall, the major outcome for this project has been the optimisation of techniques to 
generate stable PP1c and PexRD24 for studies in vitro. This required considerable effort, 
perhaps unsurprising given the known issues with purifying stable PP1c (Peti et al., 
2013). Now that a stabilising buffer and optimal constructs have been developed, it 
might be possible in the future to understand in greater detail how PexRD24 manipulates 











Recent insights into plant immunity have revealed a sensitive, complex system for 
detecting and responding to plant pathogens (Wu et al., 2018). Threats to global food 
security mean that studying devastating diseases of our food crops is more important 
than ever. Both the pathosystems explored in this PhD thesis are of huge importance to 
agriculture, and both M. oryzae and P. infestans represent model organisms for fungi and 
oomycetes respectively. The theme that runs throughout this thesis is using the study of 
molecular protein-protein interactions to gain new understanding of how host and 
pathogen proteins interact. It is of fundamental importance to analyse these interactions 
at the biochemical and structural level, because this enables us to understand how we 
can manipulate these interactions to benefit the plant. However, these two projects 
ultimately explore the intricacies of host/pathogen interaction from both sides of the 
battlefield. In the case of the effector PexRD24 interacting with a host phosphatase 
enzyme, it is possible to see the pathogen exploiting a host system, namely the use of 
additional subunits to target a generic enzyme, to enhance disease. On the opposing side, 
the ability of the host plant to turn a putative HMA domain-containing pathogen target 
into a detection system by integrating it into an immune receptor that can recognise 
sequence-divergent pathogen effectors, namely AVR-Pia and AVR-PikD, is a powerful 
tool in defence. In both cases, it would appear that we can witness the elegance and 
complexity of the plant/pathogen immunity arms race. 
There are still many unanswered questions regarding recognition and signalling events 
in response to effector proteins. The recent explosion in research surrounding the 
integration of non-canonical domains into NLR proteins has provided new models that 
can shed light not just on how immune receptors are functioning, but also give clues 
about possible effector targets. Research into these integrated domains is therefore 
important for all areas of plant immunity. This project has expanded the field of research 
on integrated domains by showing how an integrated domain in the Pik-1 NLR can 
recognise an effector, AVR-Pia, that is also recognised by a different NLR pair containing 
an evolutionarily related but distinct integrated domain. Although the response to the 
‘mismatched’ effector AVR-Pia is considerably weaker than for the ‘matched’ effector 
AVR-PikD, there are some interesting implications for this work, as it appears that Pik-1 
is binding two sequence-unrelated effector proteins at different domain interfaces, and 
yet is still able to trigger an immune response. It would be fascinating to discover 
whether the differential binding also leads to different intramolecular and 




Similar experiments could be carried out to investigate whether the same cross-
reactivity would occur for another effector that is recognised by the RGA5/RGA4 pair of 
NLRs, AVR1-CO39. It would be interesting to draw parallels between AVR-Pia and AVR1-
CO39, which are also two sequence-divergent MAX effectors, but are recognised by the 
same NLR. On the other hand, it would be valuable to reverse the experimental design 
and examine more closely whether the cross-reactivity exists for the RGA5/RGA4 NLRs 
responding to AVR-PikD. Given the clear differences in location of integrated domain and 
effector binding interfaces between the Pik-1/Pik-2 and RGA5/RGA4 pairs of NLRs, it 
would be interesting to uncover the level of plasticity in the system i.e. whether both 
pairs of NLRs are capable of recognising both effectors. 
Although relatively little is currently known about the host targets of AVR-Pia and AVR-
Pik effectors, it seems likely that the targets are highly similar or the same, given that 
they are recognised by such similar integrated HMA-containing domains. Therefore, it 
could be possible that the differential binding of the effectors by their immune receptors 
is related to how the effectors bind their target. It could be that the two effectors bind 
two different surfaces of a host protein, exerting different effects on it and thus different 
effects on the host plant; possibly emphasising an important role for the target protein 
in immunity or host cell function. This could also link to the different ways in which the 
HMA domain is integrated into RGA5 and Pik-1; possibly an attempt to expose the most 
important binding surface for each effector in the full-length context of the NLR. 
However, with little knowledge of the full-length NLR structure or inter-/intra-molecular 
interactions, this is only speculation. Further investigations into the function and nature 
of host target(s) will shed light on these theories. The concept of diverse pathogens 
producing multiple effectors that converge on certain conserved target proteins has been 
discussed previously, with the speculation that using sequence-divergent effectors in a 
redundant manner to target certain host proteins might help to alleviate the threat posed 
by plant immune receptors – if a plant is able to recognise one effector, another effector 
might be able to achieve the same pathogenicity role without recognition (Weßling et al., 
2014). As a striking example, two sequence-divergent effectors from Pseudomonas 
aeruginosa show significant functional convergence, as both can play a role in pathogen 
invasion of both prokaryotic and eukaryotic cells (Jiang et al., 2014). 
There has been considerable recent progress in identifying putative effectors using 
bioinformatic approaches and identifying host targets using screening approaches (Dalio 
et al., 2018). However, the importance of using a range of methods to validate predicted 




uncovered. Part of this project involved the careful testing of an interaction between a 
pathogen effector, PexRD24, and its host target, PP1c, showing that an observation made 
in a yeast two-hybrid screening procedure was maintained for purified proteins in vitro. 
Next, obtaining structural information for how PexRD24 is binding to its PP1c host target 
would be extremely useful, alongside the characterisation of the interaction using 
biophysical techniques. This may help provide new information regarding the changes 
that PexRD24 causes when it interacts with PP1c, whether it causes changes to the 
overall structure of the protein, manipulates the catalytic site or makes an allosteric 
change. Crucially, this could provide clues about the role of the effector in pathogen 
infection. This research contributes to a growing field of knowledge about the effector 
biology of P. infestans. 
 Both the effectors that formed the major focus of this research (AVR-Pia and PexRD24) 
are part of distinct effector families with conserved characteristics. AVR-Pia is part of the 
MAX family, and contains a conserved core fold, while PexRD24 is part of the RxLR 
family, which contains a conserved sequence motif, predicted to be involved in effector 
translocation. Greater knowledge of the members of these conserved effector families 
may help with an understanding of their similarities and differences. While it is clear that 
a conserved structure does not necessarily equal a conserved function within these 
groups, further research will help to cement knowledge of why pathogens evolve 
numerous effectors around the same framework. It seems likely that the basic core 
structure confers stability or ease of translocation within the host (de Guillen et al., 
2015). Continuing research could not just help to identify new effector proteins within 
these families, but perhaps identify new effector families with conserved structural and 
sequence motifs. 
Both projects discussed in this thesis contribute to the general understanding of 
immunity, but particularly for the work on AVR-Pia recognition, there is potential to 
build on this in the future for engineering rice, and other, NLR immune receptors. The 
ability to manipulate the rice NLR Pik-1 to recognise AVR-Pia more strongly in the model 
plant N. benthamiana has potential for future experimentation. Although additional work 
is required to remove the autoactivity of the engineered receptor, this work could lead 
onto testing of the receptor in rice plants. Challenging the engineered rice with M. oryzae 
strains containing both AVR-PikD and AVR-Pia would test the efficacy of the system. By 
studying effector families with conserved features, it might be possible to discover ways 





Alongside implications for engineering in the native host plant rice, it is known that 
integrated domains are found in the immune receptors of many other important crop 
plants, including wheat, maize and soybean (Sarris et al., 2016). Recent examples have 
shown the importance of integrated domains in a variety of these crops. For example, in 
wheat, NLR proteins containing a zinc-finger BED domain are known to provide 
resistance to another fungal disease, the yellow stripe rust fungus (Marchal et al., 2018). 
Engineering of integrated domains in one plant species could have wider implications, 
partly because some features might be applicable across different types of domain, but 
also because the same type of integrated domain is often found in multiple plant species. 
For example, heavy metal-associated domains are also predicted to be integrated in 
some NLRs found in rapeseed (Sarris et al., 2016). The use of effector proteins to target 
host phosphatase enzymes is also found beyond oomycetes, and examples are known in 
bacterial pathogens, such as Ralstonia solanacearum, a soil-borne pathogen with a wide 
host range. A recent example showed that a Type III effector from R. solanacearum could 
interfere with host cellular homeostasis by indirectly targeting protein phosphatase 2A 
(Popa et al., 2016). Phosphatase enzymes are so important in all forms of life that 
targeting by pathogenic organisms appears to be conserved in different pathosystems. 
Expanding the field of research in this area could have wider implications in the future; 
by using shared knowledge, the opportunities to develop new and broader resistance 
strategies for a variety of crops are exciting.   
Gaining an increased understanding of molecular plant-pathogen interactions through 
structure/function studies brings us a step closer to engineering the plant immune 






Using a new Golden Gate vector suite for expression of 






The choice of vector system for expressing proteins is important and a key first step in 
successful protein production. The choice of vector can depend on a number of factors, 
including ease of cloning and compatibility with other systems. Crucial for heterologous 
protein production is the consideration of, for example, appropriate promoters and 
solubility tags to enable expression of soluble, stable, high yielding proteins. Many 
different vector systems and cloning strategies have been developed, each of which may 
have different uses and advantages for a particular situation (Celie et al., 2016). 
One versatile system is the pOPIN vector suite (Berrow et al., 2007), designed by the 
Oxford Protein Production Facility (OPPF). This collection of vectors enables a range of 
constructs to be produced, giving scope for different solubility tags at either the N- or C-
terminus of the protein. An additional advantage of this system is that the vectors are 
suitable for use in a range of expression hosts, including E. coli, insect and human cell 
lines. Finally, the In-Fusion® (Takara Bio) cloning procedure is rapid and single-step, 
enabling efficient insertion of constructs into the pOPIN vectors. The pOPIN vector suite 
is currently used universally in the Banfield group for heterologous protein expression 
from E. coli, allowing production of proteins for structural and biochemical work. 
Despite the pOPIN vector suite being well-established and successful within the lab, it 
does have a small number of drawbacks. To test different solubility tags, the construct in 
question needs to be separately cloned into different pOPIN vectors using the In-Fusion® 
enzyme for each reaction. The In-Fusion® mix is expensive, and if many constructs need 
to be screened, the cost could be a limitation. In addition, the Banfield group frequently 
uses in planta model systems to correlate biological data with results obtained in vitro. 
Currently, this requires recloning all constructs from pOPIN vectors into the vectors used 
for in planta transient expression. This is time consuming and uses additional resources. 
In 2008, a new cloning strategy was devised that was heralded as a ‘One Pot, One Step’ 
technique and was named ‘Golden Gate’ (Engler et al., 2008). Golden Gate cloning uses 
Type IIS restriction enzymes that cleave outside of their recognition sequence, leaving 
four base pair overhangs that can be of any identity. By selecting these overhangs 
rationally, it is possible to create seamless joins in the construct without making any 
vector assembly scars. Carefully and specifically chosen overhangs allow all the different 
parts of the vector (promoters, tags, terminators etc.) to be mixed together with the 
acceptor vector at the same time (i.e. ‘One Pot, One Step’), because the specific overhangs 




agreed system of 4 bp overhangs, known as the MoClo modular cloning strategy (Weber 
et al., 2011), resources can be readily shared between groups, because all parts of the 
same type have the same overhangs (Patron et al., 2015). This presents the opportunity 
to mix and match parts such as promoters and tags without the need for additional steps 
(e.g. designing primers or PCRs), allowing greater variety with only a few standard DNA 
parts. Golden Gate cloning and the MoClo system are now used as standard within the 
lab for generating constructs for agroinfiltration and in planta studies. Assembling 
various parts in the acceptor vector is cost effective, because the same DNA parts can be 
used to make multiple constructs, requiring only the readily-available Type IIS 
restriction enzymes BsaI and BpiI, and T4 DNA ligase, which is used to reassemble the 
parts. In general, Golden Gate cloning is very efficient, although if a large number of parts 
are being inserted into the vector, this can reduce the efficiency and make cloning slightly 
more problematic. 
Golden Gate cloning is therefore more cost-effective and somewhat more versatile than 
the pOPIN vector suite. A proposed strategy to take advantage of this was to make the 
pOPIN vector backbone compatible with a Golden Gate cloning system, which would 
allow constructs to be cloned for both E. coli and in planta expression in the same 
manner, whilst keeping the benefits of the pOPIN vector for driving protein expression 
from the E. coli host. This chapter describes my participation in the project to develop 
such a system and test its viability. 
For the following work, Mark Youles (TSL SynBio) was responsible for design and 
generation of all vectors. Cloning and expression of different constructs was carried out 
by me in each case. 
Designing the pOPIN/GG vector system 
To generate a hybrid of the pOPIN and Golden Gate systems, the principle is to make an 
expression system that has the features of the pOPIN vector, but can be cloned into using 
the standard Golden Gate overhangs and cloning techniques. This new hybrid vector will 
be known as ‘pOPIN/GG’. As described above, this combines the power of pOPIN for 
soluble protein production with the Golden Gate system, which is both cheaper to use 
and also compatible with the lab’s work using in planta transient expression (see Chapter 
3 and 4). 
In the pOPIN system, different vectors are used to achieve constructs with different tags 




an N-terminal SUMO tagged construct and pOPINE encodes a C-terminal 6xHis tag. In the 
Golden Gate system, only one type of acceptor plasmid is required for cloning, because 
the acceptor backbone does not contain any promoters, terminators or tags; these must 
all be inserted during the digestion-ligation reaction when the coding sequence is 
inserted. In the case of the pOPIN/GG system, the vector would be a hybrid between 
these two cases. The pOPIN backbone already contains the T7 promoter and terminator 
for inducible expression in E. coli, so these parts do not need to be added during cloning. 
However, for versatility, the vector needs to be capable of receiving different solubility 
and affinity tags at the N- and C-termini of the construct. To achieve this using the Golden 
Gate overhang system, it is necessary to design two different pOPIN/GG vectors – one for 
C-terminal tagging and one for N-terminal tagging. For simplicity, only the vectors for N-
terminal tagging will be discussed – namely vectors F1, F3 and F5. (Vectors for C-
terminal tagging are named F2, F4 and F6, but will not be discussed further). 
To make a complete pOPIN/GG construct containing a coding sequence and N-terminal 
tag, three parts are needed. 
1) The acceptor vector. This acceptor plasmid is made from the pOPIN backbone, with 
a RFP (red fluorescence protein) Golden Gate-compatible cassette inserted in place of 
the native lacZ selection gene and plasmid-encoded His tag. This Golden Gate cassette 
contains the correct Golden Gate MoClo assembly standard overhangs to allow insertion 
of an N-terminal tag and coding sequence in the correct order. Namely, it uses the ‘CCAT’ 
5’ overhang for joining to the start of the N-terminal tag and the ‘GCTT’ overhang for 
joining the 3’ end of the coding sequence into the vector. BsaI sites flank these overhangs 
to allow digestion during cloning. This process works in the same way as normal Golden 
Gate cloning, except that in this case, only two parts need to be inserted because the 
promoter and terminator are already in the backbone. 
2) The N-terminal tag. Any Golden Gate compatible N-terminal tag can be used in the 
pOPIN/GG system, meaning that it is possible to recapitulate many members of the 
pOPIN suite with a single acceptor vector e.g. using an N-terminal 6xHis tag makes an 
equivalent construct to POPINF, an N-terminal 6xHis-SUMO tag would recapitulate 
pOPINS3C etc. N-terminal tags for Golden Gate cloning are readily available from TSL 
SynBio, using the compatible overhangs and BsaI sites as usual. 
3) The coding sequence. One advantage of the pOPIN/GG system is that any Golden 
Gate compatible level 0 coding sequence can be cloned directly into the pOPIN/GG level 




need for additional PCR steps, which would normally be required if testing a construct 
in planta using the Golden Gate system and in vitro using the pOPIN suite. Any coding 
sequence with compatible overhangs and BsaI sites can be used in the pOPIN/GG vectors. 
The description above shows that, in theory, using the hybrid system of pOPIN and 
Golden Gate should be relatively straightforward. However, the system required 
development and testing to ensure it was working as expected. Three rounds of 
correction were required, and the adaptations and tests are described below. 
Vector development and testing 
For the first generation of the pOPIN/GG vector, now called F1, the Golden Gate-
compatible cassette was inserted into the pOPIN backbone using EcoRI and BamHI 
restriction. Within the cassette, BpiI sites were included so that the constructs made in 
the pOPIN/GG plasmid (in effect a Golden Gate level 1 vector) could be cut out and cloned 
into a Golden Gate level 2 vector, using a digestion-ligation reaction, if required. This 
acceptor vector was then used to clone an N-terminal 6xHis tag and the coding sequence 
of a test protein CpTIE-TED, here abbreviated to ‘TED’. TED was used as a test protein 
for these constructs because it is known to be highly expressed from the pOPINF vector 
(Walden et al., 2015) so provides a useful way to directly compare the pOPIN suite and 
pOPIN/GG vector. The main features of this construct are shown in figure 0-1.  
Figure 0-1: Features of the pOPIN/GG vectors. 
Diagram showing the different features of the pOPIN/GG vector - versions F1, F3 and F5, used 
for generating an N-terminally tagged construct. ‘…’ represents varying sequence of varying 
lengths, ‘x’ represents a single base of varying identity. Letters indicate different features: 
a: EcoRI site 
b: BpiI site  
c: ‘CCAT’ Golden Gate vector overhang, incorporating the ‘ATG’ start codon for the N-terminal 
protein tag 
d: ‘AATG’ Golden Gate overhang, incorporating the ‘ATG’ coding sequence start codon, which 
will present as a methionine residue scar in the expressed protein. 
e: Stop codon for coding sequence 
f: ‘GCTT’ Golden Gate vector overhang 
g: BpiI site 
h: Duplicated bases (redundant) 




Figure 0-1 shows the restriction sites, BpiI sites, and overhangs used for joining the parts. 
One additional feature is four duplicated base pairs (labelled ‘h’) just inside the BamHI 
site. These bases were included through an error during cloning and perform no 
function. The stop codon at the end of the TED coding sequence is shown labelled ‘e’. One 
important feature to note is that the ‘AATG’ overhang that joins the 3’ end of the N-
terminal tag to the 5’ end of the TED coding sequence (labelled ‘d’) causes the translation 
of a methionine residue between the tag and the coding sequence, which remains as a 
scar in the final expressed protein. 
Figure 0-2 shows the result of an expression trial from this F1 construct. TED was 
expressed from pOPINF, to act as a comparison. Both plasmids were transformed into an 
E. coli expression strain and a simple expression test was performed on a small scale. 
Cells were lysed to check for soluble expression, but the proteins were not purified. 
Figure 0-2 shows that for pOPINF, a clear band of overexpressed protein is visible by 
SDS-PAGE, around 28 kDa (the actual expected size of the construct is 23.3 kDa). This 
protein is present both in the lysed cells and in the soluble fraction, indicating that the 
TED protein is readily expressed from pOPINF, as previously published (Walden et al., 
2015). However, for the pOPIN/GG vector, no overexpressed protein can be seen at the 
equivalent location on the gel. This test was repeated with other constructs (data not 
shown) and similar results were seen, indicating that expression from the pOPIN/GG 
vector was not working as expected.  
 
One explanation for the lack of expression is that the addition of the extra bases in the 
pOPIN/GG vector compared to pOPINF (principally the EcoRI/BamHI restriction sites 
for inserting the Golden Gate cassette, and the BpiI sites for putative onward cloning), 
Figure 0-2: Testing expression from the pOPIN/GG vectors. 
SDS-PAGE analysis of CpTIE-TED (TED) protein expression from E. coli, 
comparing the pOPINF vector and pOPIN/GG vector (versions F1, F3, 
F5). CL = crude Cell Lysate, SF = Soluble Fraction. Arrow indicates 
expected location of the TED protein on the gel. Note: For brevity, 





are causing issues with expression. The additional bases have been positioned between 
the T7 promoter and the transcription start site, which could lead to non-functional 
transcription. To help cut down the additional sequence between the promoter and the 
N-terminal tag, the non-essential BpiI sites were removed from the cassette. In addition, 
the four duplicated bases (labelled ‘h’ in figure 0-1 F1 diagram) were removed, as these 
are redundant. This adapted vector was called F3, and expression was tested as 
described for the F1 version. Figure 0-2 shows that in this case, there did appear to be 
soluble TED protein expression from the pOPIN/GG vector, as a band of overexpressed 
protein can be seen around 28 kDa in both the whole cell lysate and the soluble fraction. 
This suggests that reducing the number of additional bases between the promoter and 
expression construct have enabled transcription. However, the relative abundance of 
protein expressed from the pOPIN/GG system is much lower than from pOPINF. 
Repeated expression tests (data not shown) indicate that this is seen consistently. 
Although expression was possible from the pOPIN/GG F3 vector, the lower levels of 
protein production could cause significant issues. TED proteins are highly soluble and 
stable, meaning that even with lower expression levels, there is still a clear protein band 
visible by SDS-PAGE. However, for a protein that is expressed at a lower level from the 
pOPIN vector suite, a depletion of around 50% from the pOPIN/GG system compared to 
pOPIN could mean that obtaining viable yields of soluble protein is not possible. Given 
that protein produced from E. coli is commonly used for biochemical assays or 
crystallography, using a vector that drives high levels of expression is very important. 
Therefore, the pOPIN/GG system is not a feasible replacement for the pOPIN suite unless 
it can produce comparable levels of protein. Further modifications were designed to 
make the pOPIN/GG vector almost identical to its pOPIN parent. To do this, the unwanted 
EcoRI site was cut out using an EcoRV/XbaI exchange, resulting in a plasmid that was 
free of the 5’ EcoRI scarring. The pOPIN template vector was also found to naturally 
contain the required ‘CCAT’ 5’ overhang, meaning that the fusion point between the 
pOPIN backbone and the Golden Gate N-terminal tag became completely seamless 
(figure 0-1, version F5). Having this portion of the vector completely identical to pOPINF 
should hopefully allow the promoter to drive expression at the same levels. Upon testing, 
it was found that this was indeed the case (figure 0-2) because the expression of soluble 
TED protein is now similar between pOPINF and pOPIN/GG F5 version. From the SDS-
PAGE analysis shown in figure 0-2, it does seem that the amount of protein expressed 
from pOPIN/GG F5 may be slightly lower than from pOPINF, but the levels are 
comparable. The discrepancy may be due to some of the other, minor differences 




before being used for Golden Gate cloning (all BsaI and BpiI restriction sites in the 
backbone must be removed, or the restriction enzymes will cleave the vector backbone 
during the digestion-ligation reaction). However, overall, the pOPIN/GG vector F5 
version is functional after the modifications made. 
Mep1 protein expression using pOPIN/GG 
The ‘TED’ protein described previously, which was used to test the viability of the 
pOPIN/GG vector, has been extensively tested before in the lab (Walden et al., 2015), and 
is known to be stable and highly expressed. Next, the new pOPIN/GG system (the F5 
vector) was used for expression of a protein that was unfamiliar. This protein, Mep1, is 
an effector protein from Magnaporthe oryzae (Yan & Talbot, 2016) and is largely 
uncharacterised (plasmid provided by the group of N. Talbot). Mep1 was cloned into 
pOPIN/GG F5 with an N-terminal 6xHis tag, and was expressed from BL21(DE3) E. coli 
in LB media. The effector was purified using an IMAC/GF technique, and figure 0-3 shows 
the final gel filtration step during purification, with accompanying SDS-PAGE analysis. 
Intact mass spectrometry analysis (data not shown) showed that full-length Mep1 was 
successfully purified, indicating that the pOPIN/GG system also works for a different, 
previously uncharacterised protein. 
Figure 0-3: Expression of Mep1 from the pOPIN/GG vector F5. 
Following cleavage of 6xHis tag by 3C protease, Mep1 was flowed 
down a Superdex 75 26/600 gel filtration column and showed a 
small peak on the trace at 189 ml elution volume (poor protein 
absorbance at 280 nm). Accompanying SDS-PAGE analysis shows 






The aim of this project was the development of a vector that was suitable for expressing 
high yields of soluble protein in the E. coli heterologous expression system, whilst also 
being compatible with the Golden Gate cloning method used to produce constructs for in 
planta studies. Several iterations and rounds of testing were required to produce a 
functional vector. It was found that non-existent or low levels of transcription were 
caused by additional bases that were inserted into the pOPIN backbone to make it Golden 
Gate compatible. Removal of all additional bases between the promoter region and 
transcription start site enabled functionality to be restored. Cloning of constructs into 
the new vector is simple and efficient, as only two parts (the coding sequence and tag) 
need to be inserted into the acceptor vector. One point of note is that the pOPIN/GG 
cloning method is not completely scarless. Due to the nature of the overhangs in the 
MoClo assembly standard, a methionine residue is made in the expressed protein 
between the N-terminal tag and the protein of interest (POI). The result of this is that 
when the protein is cleaved from its purification tag using 3C protease, the remaining 
scar is three residues long ‘Gly-Pro-Met-POI’ as opposed to the two-residue scar on a 
protein expressed from a pOPIN vector (‘Gly-Pro-POI’). It is hoped that this additional 
residue will not cause any issues for the purified protein. This chapter has described the 
successful use of pOPIN/GG to express two proteins with an N-terminal 6xHis tag, but 
the vector has the capacity to accept a range of other N-terminal tags. Future work and 
testing by others will explore the use of other tags, and their relative success compared 
to equivalent vectors from the pOPIN suite. As mentioned, equivalent versions of each 
pOPIN/GG vector were generated for making C-terminally tagged constructs. Initial tests 
have indicated that these vectors are working correctly, but further work is required. 
Overall, the design and generation of the new pOPIN/GG vector system has been a 











List of DNA primers used throughout project 
Name Sequence Use 
PP1c A1-1F AGGAGATATACCATGGCTCAAAATGGGCAGGGGATAGAAC Cloning PP1c into pOPINA 
PP1c A1-1R GTGGTGGTGGTGTTTTCACAAGAACCGAGGTTTTCTATCAGC Cloning PP1c into pOPINA 
PP1c A1-2F AGGAGATATACCATGGCACAAAATGAGCATCAGCAGCAG Cloning PP1c into pOPINA 
PP1c A1-2R GTGGTGGTGGTGTTTTCATAAAAACCGAGGTTTTCTATCTG Cloning PP1c into pOPINA 
PP1c A3-2F AGGAGATATACCATGGACCCTGCAGCTGTCGATAGGATTATTG Cloning PP1c into pOPINA 
PP1c A3-2R GTGGTGGTGGTGTTTTCACATCATAAACTTATTTTTCTTCTCTG Cloning PP1c into pOPINA 
PP1c D2-2F AGGAGATATACCATGGACCAGAATGTGTTGGATGATATAATAAC Cloning PP1c into pOPINA 
PP1c D2-2R GTGGTGGTGGTGTTTTCATGCTTTGGAATTAAAAAAGGACTTC Cloning PP1c into pOPINA 
PP1c A2-1truncF AGGAGATATACCATGGGATTAATAGAGCCTGCTGTTCTTG Cloning PP1c into pOPINA 
PP1c A2-1truncR GTGGTGGTGGTGTTTTCATGGCTTCAGTATCTGGAACGAACAC Cloning PP1c into pOPINA 
D2_35148_f_1059 AAGTTCTGTTTCAGGGCCCGGACCAGAATGTGTTGGATGATATAATAAC Cloning truncated PP1c-3 
D2_35148_r_1060 ATGGTCTAGAAAGCTTTAAGTAGTTGTACTTCCAAAGCTGAATTTGG Cloning truncated PP1c-3 
D2_34492_f_1061 AAGTTCTGTTTCAGGGCCCGGATGATATAATAACTAGGCTTCTTGAAG Cloning truncated PP1c-3 
D2_34492_r_1062 ATGGTCTAGAAAGCTTTATTTAGCAGTAGTTGTACTTCCAAAGCTG Cloning truncated PP1c-3 
4314_trunc_f_1088 AAGTTCTGTTTCAGGGCCCGAGCTTCAAGCTGAAGAGGTTTGGAG Cloning truncated PexRD24 
4314_8225_r_1089 ATGGTCTAGAAAGCTTTACGAGTTGGTTTTGTAGATACGAGCTCG Cloning truncated PexRD24 
4314_7631_r_1090 ATGGTCTAGAAAGCTTTAGATACGAGCTCGGACTTTGTTCGA Cloning truncated PexRD24 
PP1cD2-1FF_982c AAGTTCTGTTTCAGGGCCCGATGGACCAGAATGTGTTGGATGATATAATAAC Cloning PP1c-3into pOPINS3C/F 
PP1cD2-1FR_983c ATGGTCTAGAAAGCTTTATGCTTTGGAATTAAAAAAGGACTTC Cloning PP1c-3into pOPINS3C/F 
Oligo 04314_298FF AAGTTCTGTTTCAGGGCCCGGATTTGCTTGGGCTTTTTGCCAAGAGCAAGC Cloning PexRD24 into pOPINS3C/F 




D2QILK_r_1167 ATGGTCTAGAAAGCTTTATTTTAATATTTGAAAGGAGCACATTAATG Cloning truncated PP1c-3 
1275_Mep1_fwd AAGGTCTCTAATGCATGAGGCCAGCGCCGGTACC Cloning Mep1 into pOPIN/GG 
1276_Mep1_rvs AAGGTCTCTAAGCTTAGATACCATTGTCTTTATGGTCGGGCCT Cloning Mep1 into pOPIN/GG 
1303_PiaPikDN_S3C_fwd AAG TTC TGT TTC AGG GCC CGG AAA CGG GCA ACA AAT ATA TAG Cloning AVR-PiaNAVR-PikD into pOPINS3C 
1304_PiaPikDN_S3C_rvs ATG GTC TAG AAA GCT TTA GTA AGG CTC GGC AGC AAG CC Cloning AVR-PiaNAVR-PikD into pOPINS3C 
1316_TEDGG_fwd AAGGTCTCTAATGTCTCCGACGGGTGGTCTGCAAAC Cloning TED into pOPIN/GG 
1317_TEDGG_rvs AAGGTCTCTAAGCTTACGGCGTCACGAATTTGGTGCCC Cloning TED into pOPIN/GG 
1374_AVRPikD-N_S3C_fwd AAGTTCTGTTTCAGGGCCCGGAATGCTTCTGGTTCATGTTC Cloning truncated AVR-PikD into pOPINS3C 
704-AVR-Pik-Rev ATGGTCTAGAAAGCTTTAGAAGCCCGGACGTTTTTTACC Cloning truncated AVR-PikD into pOPINS3C 
1375_AVRPikD-N_A_fwd AGGAGATATACCATGGAATGCTTCTGGTTCATGTTCAAAAAC Cloning truncated AVR-PikD into pOPINA 
959RevAVRFLpOPINA GTGGTGGTGGTGTTTTTAGAAGCCCGGACGTTTTTTAC Cloning truncated AVR-PikD into pOPINA 
PikD-For-pOPINE-962 AGGAGATATACCATGGGGAGCGATAGCGAAGTGAAC Cloning AVR-Pik into pOPINE 
1385_AVRPia_pOPINE_rvs GTGATGGTGATGTTTGTAAGGCTCGGCAGCAAGCC Cloning AVR-Pia into pOPINE 
PikD-Rev-pOPINE-963 GTGATGGTGATGTTTGAAGCCCGGACGTTTTTTAC Cloning AVR-Pik into pOPINE 
1467_AVRPikD-NE1_S3C_fwd AAGTTCTGTTTCAGGGCCCGGGCATCCCGGTCCCGGAATGC Cloning truncated AVR-PikD into pOPINS3C 
1468_AVRPikD-NE1_A_fwd AGGAGATATACCATGGGCATCCCGGTCCCGGAATGC Cloning truncated AVR-PikD into pOPINA 
1469_AVRPikD-NE2_S3C_fwd AAGTTCTGTTTCAGGGCCCGGACCATCCGGGCATCCCGG Cloning truncated AVR-PikD into pOPINS3C 
1470_AVRPikD-NE2_A_fwd AGGAGATATACCATGGACCATCCGGGCATCCCGGTCCC Cloning truncated AVR-PikD into pOPINA 
1497_AVRPiaPikDN_GGN_fwd AAGGTCTCTAATGGAAACGGGCAACAAATATATAGAAAAACGCGC Cloning AVR-PiaNAVR-PikD into lvl1 GG 
1498_AVRPia_GGN_fwd AAGGTCTCTAATGGCGCCAGCTAGATTTTGCGTCTATTACG Cloning AVR-Pia into lvl1 GG 
1499_AVRPia_GGN_rvs AAGGTCTCTAAGCCTAGTAAGGCTCGGCAGCAAGCCAATCCGG Cloning AVR-Pia into lvl1 GG 
1510_PikDN_GGN_fwd AAGGTCTCTAATGGAATGTTTTTGGTTTATGTTTAAAAACAACGTACG Cloning truncated AVR-PikD into lvl1 GG 




718-Pik-p1-For AAGTTCTGTTTCAGGGCCCGGGTCTGAAACAAAAAATCGT Cloning Pikp-HMA into pOPINM 
1164_Pikp+5aa_rev ATGGTCTAGAAAGCTTTAATCTTTATTTGCTTGCGAGACTTGCAGCAGTTC Cloning Pikp-HMA into pOPINM 
1719_RGA5fullswap_fwd TTGGTCTCACAGAAAGATAGTTGTTAAGGTGCACATGCCATGCGG Cloning RGA5-HMA into pCR8 
1720_RGA5fullswap_rvs AAGGTCTCACGTCTTTCTCAACTAACTCCACCATCAAGAGCTCGGCG Cloning RGA5-HMA into pCR8 
GW1F GTTGCAACAAATTGATGAGCAATGC Sequencing pCR8 
GW2R GTTGCAACAAATTGATGAGCAATTA Sequencing pCR8 
M13F TGTAAAACGACGGCCAGT Sequencing pCR8 
M13R CAGGAAACAGCTATGACC Sequencing pCR8 
T7 promoter TAATACGACTCACTATAGGG Sequencing pOPIN 
T7 terminator TAGTTATTGCTCAGCGGTGG Sequencing pOPIN 
T7 terminator (pOPINRev) CACCACCTTCTGATAGGCAG Sequencing pOPIN 
GG_level0_F (1180) CGTTATCCCCTGATTCTGTGGATAAC Sequencing GG 
GG_level0_R (1181) GTCTCATGAGCGGATACATATTTGAATG Sequencing GG 
level_1_R (1182) GAACCCTGTGGTTGGCATGCACATAC Sequencing GG 
level_1_F (1183) CTGGTGGCAGGATATATTGTGGTG Sequencing GG 
pCambiaF GGCTCGTATGTTGTGTGG Sequencing pCambia 
1076_PikP1 int 1 TGGAGGCAAAACAACGG Sequencing Pikp-1 
1077_PikP1 int 2 GGTCGTCTGGTCAGGAGG Sequencing Pikp-1 
1078_PikP1 int 3 ATTTGGAGATTTTGTATGTGG Sequencing Pikp-1 
1081-PikP1 int seq GTTGCGAGCACTGGAGG Sequencing Pikp-1 
1097 Pikp1 int seq rev GAAGTGCGTTCCCAAGG Sequencing Pikp-1 
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